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Summary
The average time a drug requires to successfully appear into the market
is around 1520 years. Structure-based techniques play a determinant role
in many moments of this long process and computer-based approaches are
becoming always more popular, for they are cheap and fast. Computer-
based approaches to structure-based drug discovery are also very common in
Academia, both in the field of development and application. Moreover, most
of the software currently used in this field is being developed in Academia.
In this doctoral thesis two main topics are covered: virtual screening by
the means of docking and the application of molecular dynamics simulations
to macromolecular systems of interest.
Two projects employed virtual screening: the search for inhibitors of
cathepsin B and the search for allosteric effectors of cathepsin K. The two
projects are ideally linked because in both the active site of the enzyme was
not targeted. In the cathepsin B project, the so called occluding loop was
chosen to show that inhibition of this enzyme could be obtained without
targeting the active site. In the cathepsin K project, a putative allosteric
pocket was targeted. The pocket was found by a method that considers
the residue conservation in evolutionarily linked protein families and then
confirmed by two independent structure-based methods.
Two other projects involved molecular dynamics simulations of biolog-
ical macromolecules: designed armadillo repeat proteins and the CRY1
protein of Arabidopsis. In both projects, the evaluation of local and con-
formational flexibility played a major role. The first one employed static
homology modelling and molecular dynamics simulations not only to gen-
erate a putative structure of an armadillo repeat protein, but also for im-
proving its dynamical behavior, which could not have been inferred from a
static structure only. The second project helped to explain the effect of a
single-point mutation of the CRY1 protein of Arabidopsis thaliana. Molec-
ular dynamics simulations of the two systems were run and the difference
of activity between them was explained in terms of different flexibility of
the protein surface close to the mutation.
XI

Zusammenfassung
Die durchschnittliche Zeit, die ein Medikament braucht, um erfolgreich auf
den Markt zu kommen, beträgt 15-20 Jahre. Struktur-basierte Methoden
spielen eine entscheidende Rolle an vielen Stellen dieses langen Prozesses
und computer-basierte Ansätze werden immer beliebter, da sie kostengün-
stig und schnell sind. Computer-basierte Ansätze für die struktur-basierte
Identifikation neuer Medikamente werden sehr häufig in der Wissenschaft
verwendet, sowohl auf dem Gebiet der Entwicklung als auch für Anwen-
dungen. Darüber hinaus wird ein Grossteil der aktuellen Software dieses
Gebiets in der Wissenschaft entwickelt.
In dieser Doktorarbeit werden zwei Hauptthemen behandelt: virtuelles
Screening durch Docken und die Anwendung von Moleküldynamik-Simula-
tionen auf makromolekulare Systeme.
Bei zwei Projekten wurde virtuelles Screening verwendet: die Suche nach
Inhibitoren von cathepsin B und die Suche nach allosterischen Effektoren
von cathepsin K. Die zwei Projekte sind ideal miteinander verbunden, da
beide nicht auf das aktive Zentrum der Enzyme abzielten. Im cathepsin B
Projekt wurde die sogenannte occluding loop gewählt um zu zeigen, dass
das Enzym inhibiert werden kann, ohne das aktive Zentrum des Enzyms
anzugreifen. Im cathepsin K Projekt wurde eine mutmassliche alloster-
ische Bindungsstelle ausgewählt. Die Bindungstasche wurde mit Hilfe einer
Methode gefunden, die den Erhalt der Aminosäuresequenz bei evolutionär
verbundenen Proteinfamilien berücksichtigt, und anschliessend durch zwei
unabhängige struktur-basierte Verfahren bestätigt.
Zwei weitere Projekte beinhalten Moleküldynamik-Simulationen von bi-
ologischen Makromolekülen: entworfene Armadillo Repeat-Proteine und
das CRY1 Protein der Arabidopsis. In beiden Projekten spielte die Eval-
uation der lokalen und konformationellen Flexibilität eine zentrale Rolle.
Beim ersten wurden statisches Homologie-Modelling und Moleküldynamik-
Simulationen verwendet, um nicht nur eine mutmassliche Struktur eines Ar-
madillo Wiederholungsproteins zu generieren, sondern auch sein dynamis-
ches Verhalten zu verbessern, das allein aus einer statischen Struktur nicht
XIII
hätte abgeleitet werden können. Das zweite Projekt diente der Erklärung
der Auswirkung einer Einzelmutation des CRY1 Proteins von Arabidop-
sis thaliana. Moleküldynamik-Simulationen beider Systeme (Wildtype und
Mutierter) wurden durchgeführt und der Unterschied ihren Aktivitäten mit
einer unterschiedlichen Flexibilität der Proteinoberfläche in örtlicher Nähe
zur Mutation erklärt.
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Chapter 1
Introduction
In the introduction of the thesis several topics will be covered: the drug
discovery and development process, structure-based drug design (docking,
de-novo design, and scoring), and molecular dynamics simulations of macro-
molecules. These topics are strongly interconnected and knowing their ap-
plicability and possibly also limitations is fundamental to the understanding
of how drugs are developed.
In 1913, the German scientist Paul Ehrlich coined the Latin phrase
corpora non agunt nisi fixata, that can be literally translated to bodies
do not act, unless they are bound, and poetically to molecules are not
biologically active, unless they are bound to one or more receptors and
therefore trigger or block some biological response, and most of the efforts
of the computational methods presented in the thesis try to predict whether
a drug binds to an enzyme (docking and de-novo design), and, if it happens,
how strong is the interaction (scoring).
Moreover, since proteins and drugs are not fixed entities, as crystal
structures suggest us, molecular dynamics simulation is another important
aspect of drug design. Section 1.9 briefly explains the basis of molecular
dynamics.
1.1 The drug discovery process
Drug discovery can be provocatively described as an expensive and time-
consuming activity that mostly fails[42]. Retrospective analyzes of the
pharmaceutical industry market performed during the nineties estimated
that new drugs needed 14 years in average to appear into the market, each
one costing about 800 million dollars. Additionally, one compound ev-
ery nine that enters clinical trials eventually hits the market. Even if the
1
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Figure 1.1: From target identification to the market. The figure
schematically represents the phases of the development of a new drug
entity. Redrawn from [42].
aforementioned scenario could have changed a bit during the last years, a
meaningful message remains: drug discovery is a tough activity and wrong
decisions taken at the initial steps of the development often have a very
deleterious influence on the success of the drug candidate. It's common
for pharmaceutical industries to have more than one compound in develop-
ment, also to cover and minimize the possible failure of a drug candidate.
Not to mention that, if the marketed drug is a blockbuster, the revenues
will be impressive.
A general scheme of the process of drug discovery is depicted in figure
1.1. The phases are the usual, accepted way to describe the process, but
the directions and divisions are not always so neat as it appears from the
scheme. Nevertheless, the process is here presented in several separated
moments[42], as it follows.
1.1.1 Target identification
Naturally, the first step is the identification of a relevant protein target
such as enzymes or receptors. The identification of a target necessarily
requires some level of validation and the starting point is establishing a
biological and biochemical rationale for why affecting a particular target will
have the desired therapeutic benefit. Establishing a rationale is particularly
necessary for structure-based drug design.
1.1.2 Hit identification
A compound that binds to the target and shows the desired biological effect
is called hit. The most common way to find an initial hit is by screening a
compound library which can consist of natural products or substrate ana-
logues/mimetics, an in-house library of compound, a commercial library,
2
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or a targeted library1. Compounds can be screened experimentally, for
example with High Throughput Screening (HTS), or computationally (Vir-
tual Screening, by means of docking, for example). The outcome of HTS
is a pool of compounds whose activity is also checked for reproducibility
in experimental conditions different from the HTS ones, and whose chemi-
cal structure and purity have been checked. Depending on the size of the
screened library, hit identification requires typically 612 months and sig-
nificant resources.
1.1.3 Hits to leads
This is one of the most delicate phases of drug development. It is usual to
re-synthesize the hits for a complete validation and often dramatic changes
in the chemical template are made for establishing the essential core of the
lead compound. Structure Activity Relationships (SAR2) are established,
as well as physio-chemical and ADMET3 properties, chemical tractability,
synthetic accessibility, and the Intellectual Property (IP) position on the
hit compound and the derived series. Setting the right requirements in this
phase is crucial for the lead optimization and it is one of the most challeng-
ing aspects of medicinal chemistry. This phase usually lasts 6 months, even
if complicate syntheses and biological assays can definitely elongate it.
1.1.4 Lead optimization
The main goal of this phase, the most resource-intensive in drug discovery,
is to develop one or more compounds with particular properties. Affinity
for a target and selectivity are desired properties as well as drug-like prop-
erties and cell permeability. Selectivity requirements can be less stringent
1A targeted library is a library of compounds that complies with some criteria, such as
particular hydrogen bonding patterns. For instance, kinases have mostly one conserved
hydrogen bond donor and one acceptor in the so called hinge region. Several kinase
inhibitors have one hydrogen bond acceptor and one donor in the correct geometry for
satisfying optimal bonding pattern.
2Structure Activity Relationship is a very important moment of drug discovery in
which medicinal chemistry plays a significant role. Several modifications to the hit are
introduced to study their impact on the compound activity. The modifications can be
introduced, for example, by analogy to a known active compound; by a rationale based
on the structure of the complex between the biological target and the hit, also obtained
by computational means like docking; or by the modifications of functional groups with
isosteres.
3ADMET is an acronym that stands for Absorption, Distribution, Metabolism, Ex-
cretion and Toxicity. All these processes are what the body does to the drug and
pharmacokinetics (PK) is the discipline that analyzes those aspects.
3
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if the drug is devoted to an acute condition (such as cancer, where the ad-
verse effects related problems are less severe than the condition). The main
changes introduced in the compound at this point of development are not
in the center of the molecule, but rather in the periphery. Remarkably,
very small and subtle changes can have a very dramatic effects when tested
in cells or in vivo (for example, inserting a single methyl on a phenyl ring
can introduce a reactive site for cytochrome oxidation, therefore increasing
the clearance by excretion). This phase can last 1836 months. After lead
optimization, one or more compounds are available with the desired crite-
ria of efficacy on animal models, with a demonstrable mode of action and
acceptable pharmacokinetics (ADMET).
1.1.5 Pre-clinical trials
This phase is setting up and preparing the compounds for testing in humans.
This includes scale-up synthesis (a synthesis effective on the milligrams
scale might not be successful on the hundreds of grams scale), formulation,
toxicology, and design of the clinical trials. Most of this phase is covered by
a stringent regulatory regime and it is strongly required to work according
to certain legal guidelines.
1.1.6 Clinical trials
This is the most expensive and time consuming part of the development of
a new drug. It is conventionally separated in three stages.
Phase 1. Assessment of drug candidate's safety. A small group of healthy
volunteers are given the compound and the pharmacokinetics properties of
the drug are assessed. This might take up to several months. About 70%
of the drugs pass this phase.
Phase 2. Assessment of drug efficacy. A bigger group of persons affected by
the condition to be treated takes part to a randomized double-blind exper-
iment4, where the drug is mainly tested for efficacy and for safety. About
only 30% of the projects successfully complete phase 1 and 2. After the
completion of phase 2, a compound can be considered a drug. Phase 2 can
last from several months to years.
Phase 3. Assessment of effectiveness, benefits, and possible adverse reac-
tions. The drug is administered from several hundreds to several thousands
4A double-blind test is a way of eliminating the subjective bias on the patient and
the experimenter, whose outcome can be the placebo effect. Shortly, in a double-blind
test, neither the patient, nor the experimenter know whether the (experimental) drug or
a placebo is dispensed.
4
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of patients, and this phase usually lasts many years. It's usual to compare
the drug effectiveness with existing treatments on the market for assessing
increased benefits. These trials provide the necessary data for obtaining
approval by the regulatory authorities.
Even after the drug appears into the market, continued trials and moni-
toring are required (the phase 4 ). Some rare adverse effects can appear
only when a drug is given to many people. Around 20 drugs have been
withdrawn from the market for this reason in the last 10 years5.
1.2 Structure-based drug discovery
Computational structure-based drug discovery plays a fundamental role in
medicinal chemistry. In two recent reviews[46, 52], the authors notice that
no drug has been hitherto discovered entirely by structure-based compu-
tational methods, mostly because these methods contribute essentially to
the early phases of drug-discovery, such as lead finding and lead optimiza-
tion. Interestingly, the number of projects for which structure-based drug
discovery has played fundamental a key role is around 10.
1.2.1 Non-structure-based drug discovery
When the structure of the target is unfortunately unknown, the previously
obtained Structure Activity Relationship data (SAR) can be used, for exam-
ple, to build up a pharmacophore model6. The compound series employed
for the SAR study is superimposed and the geometry and the spatial con-
strains of the pharmacophoric groups are then screened in compounds li-
braries, assuming that the computer-generated conformation is very similar
to the bio-active one. Additionally, active compounds can be found by simi-
larity searching using known binders as templates, assuming that molecules
5Famous examples of drugs withdrawn from the market are cerivastatin/Lipobay
(2001) and rofecoxib/Vioxx (2004). The first was a drug used to lower cholesterol levels
in blood, thus preventing cardiovascular diseases. It was withdrawn because it caused
rhabdomyolysis, a rapid breakdown of skeletal muscle, which can lead to kidney failure
because of the renal toxicity of myoglobin, an oxygen-binding protein found in the muscle
tissue. The second drug was a non-steroidal anti-inflammatory drug, which was with-
drawn because of increased risk of hearth attack and stroke associated with long-term,
high-dosage use.
6The IUPAC definition of pharmacophore is an ensemble of steric and electronic
features that is necessary to ensure the optimal supra-molecular interactions with a
specific biological target and to trigger (or block) its biological response model for the
positioning of key features like hydrogen-bonding, charged and hydrophobic.
5
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with the similar shape bind in the same fashion (even if sometimes it is not
the case[5]). The similarity can be a simple scaffold similarity7 or a more
complicated search for molecules that share in the same volume the same
steric and electronic properties (a very good program for this task is ROCS,
by OpenEye, Inc.).
However, the aim of this introduction is to illustrate concisely the structure-
based drug discovery methods, such as docking and de-novo design.
1.2.2 Basic concepts
Some basic concepts for the understanding of the thesis are succinctly intro-
duced. The terminology employed in the field refers to the small molecule
as ligand or binder and to the protein, to which the ligand binds, as re-
ceptor. In structure-based drug design, the chief experimental source for
obtaining structures is X-ray crystallography. It is possible by several ex-
perimental means to obtain the cocrystallization of a protein and a bound
small ligand, often an inhibitor. A particular receptor-bound conformation
of a ligand is called pose or binding mode. Moreover, the binding geome-
try found in the experimentally determined structure is often called native
pose, native binding mode, or X-ray pose. A binding pocket is a
part of the (solvent accessible) surface of a macromolecule to which usu-
ally a (small) molecule binds. It can be defined from the position of a
cocrystallized compound in an X-ray structure (see figure 1.2), or by geo-
metric analysis[56], if the structure is devoid of such a binder. The active
site of an enzyme is the portion of space in which the enzymatic activity
is performed. Usually the largest binding pocket of an enzyme is also its
active site. Other auxiliary pockets near the active site define the speci-
ficity pockets or sub-pockets, which are exploited by natural or artificial
ligands for increasing their affinity and selectivity to the receptor.
A common and computationally efficient approximation introduced for
the calculation of interaction energies is the pair-wise additive approxi-
mation. According to it, the interaction energy of one atom with the rest
of the system is calculated as the sum of this atom with all the others in
a pair-wise manner. This approximation does not take into account the
simultaneous interaction between three or more atoms, such as polarization
effects.
7For example, if it is known that the important pharmacophore is a pyrimidine and
a morpholine, one can screen for those moieties in bigger libraries.
6
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Figure 1.2: Binding pocket definition. In the docking procedure
developed in our group (see section 1.7) the binding pocket (red surface)
is usually defined from a cocrystallized compound (white carbons, stick
representation) of an X-ray structure and consists of residues which are
in close contact (distance ≤ 5 Å) with the aforementioned compound.
1.3 Ligand docking, issues and challenges
Since 1971 to nowadays, the number of public available protein crystal
structures has increased from 7 to more than 550008 and thousands new
structures are being added every year. This massive amount of structural
information is also flanked by several collections of databases of purchasable
compounds. For example, the freely accessible ZINC database[44] contains
more than 13 million compounds9.
Since 1982, when Dock[55], the first small molecule to protein dock-
ing program, was described, many new and different programs have been
developed and the most used in academia and industry are: Dock, Fred,
Glide[26], Gold[45], FlexX[67], and AutoDock[32], just to name a few.
Docking programs mainly differ for the computational algorithm em-
ployed for finding the bioactive conformation (exploration of the confor-
mational space), for placing it correctly in the binding pocket, and for
calculating the interaction energy between the pose and the receptor. In
other words, docking is solving the molecular recognition problem in bio-
logical systems. A recent review by Stahl[4] covers the main interactions
responsible of ligand binding and molecular recognition. The calculation
of the interaction energy will be discussed more in detail in section 1.5 by
illustrating the scoring process. Docking programs are designed for being
able to identify, reproduce and optimize specific attractive interactions be-
tween the two partners. Requirements of docking software are speed and
reliability, and usually speed is achieved at the expense of reliability. Speed
8http://www.rcsb.org/pdb/statistics/contentGrowthChart.do accessed on April 6,
2010.
9http://zinc.docking.org
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Figure 1.3: SMILES. Benzene and adenine as 2D and SMILES nota-
tion.
is required for the efficient virtual screening of large libraries of compounds.
Section 1.7 provides an example of a docking software.
Normally, the 3D X-ray conformation of the binder is not fed to the
docking program and ligand conformations are automatically generated
from a 1D representation like SMILES[80] (see figure 1.3 for an example
of SMILES representation) with an energy-minimized geometry, and the
most appropriate tautomeric form and protonation state.
1.3.1 Correctness of docking
An RMSD (Root Mean Square Deviation, see section 1.9.4) between the
native X-ray pose and the docked poses of lower than 2 Å is generally
considered a success. An RMSD of 2 Å is not too permissive, even if,
in a limit case, it can be interpreted as a rigid translation of 2 Å of the
molecule from its original position. In fact, unless the resolution of the
crystal structure is very high, there is an inherent uncertainty in the position
of the native pose. Additionally, docking programs are generally unable to
reproduce deviations of bond distances and angles from the equilibrium
value, as sometimes observed in native conformations.
1.3.2 Importance of the tautomeric form
The tautomeric form[59] and the protonation state of the ligand and the
receptor can play a determinant role in binding[74]. A molecule exhibits
tautomerism if it is representable by two or more structures, which are con-
nected by the movement of an hydrogen from one atom to another of the
same molecule. The prediction of the most appropriate tautomeric form
is of utter importance because each tautomer of a single molecule substan-
tially differs from each other in electrostatic properties, hydrophobicity, tree
dimensional shape, and chemical reactivity. For example, the proton shift
8
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Figure 1.4: Tautomerism. Four frequent examples of tautomerism in
medicinal chemistry are shown.
from the enol-form to a keto-form (see figure 1.4) of a molecule changes the
alcohol group into a carbonyl group, hence transforming a hydrogen bond
donor to an acceptor and this inversion of reactivity can have a determinant
role in ligand binding. The importance of tautomers is not only restricted
to computational efforts. A recent analysis of the frequency of marketed
drugs that can tautomerize[59] showed that of the 1791 compounds, 1334
or 74% exist as only one tautomer. The remaining 26% have an average of
three tautomers.
1.3.3 Importance of the protonation state
If a particular chemical group of the ligand or the receptor is neutral or
charged, the erroneous assignment of the formal charge through the proto-
nation state can also have severe effects on the correctness binding. The
protonation state plays a very important role for proteins, too. In fact,
at physiological pH (circa 7.4), it is generally assumed that the guanidine
group of the side chain of arginine (pKa=12.4810) and the -amino group
of lysine (pKa=10.54) are protonated (positively charged), while the car-
boxy groups of the side chains of aspartic and glutammic acids (pKa=3.39
and pKa=4.07, respectively) are not protonated (negatively charged). The
properties of the histidine side chains (pKa=6.04, imidazole) are even more
difficult to predict. Additionally, the exact orientation of the N and O atoms
10The pKa values have been taken from Fundamentals of Biochemistry, by D. Voet,
J. G. Voet, and C. W. Pratt, John Wiley and Sons, 1999.  A very kind present of
Prof. Antonio Baici to the author of this doctoral thesis.
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of asparagine and glutamine, and of the imidazole ring of histidine, is virtu-
ally indistinguishable, except for protein structures at very high resolution.
The same problem arises for the position of hydrogens bound to aspartic
and glutammic acids, and to the C-terminus (if the pH is acidic enough),
and to the Nδ or N of histidine side chains. One solution11 to orient those
residues according to hydrogen bond networks[17]. Widely used software
for the enumeration of tautomeric forms and the prediction of pKa values
are: LigPrep and Epik (Scrödinger, LLC), and QuacPac (OpenEye, Inc)12.
Moreover, it is generally assumed that, upon binding, there is no change
in the protonation or tautomeric states for the receptor and the ligand, but
the exact protonation state strongly depends on the dielectric conditions
imposed by the local environment. For example, an acidic ligand group
which is placed in an apolar or in a positively charged protein environ-
ment will become less acid or more acid, respectively, compared to aqueous
solution.
1.3.4 Re-docking, cross-docking, apo-docking, and the
induced fit problem
During the docking process, docking programs frequently modify only tor-
sional angles of a molecule, leaving bond distances and bond angles unal-
tered.
Given a cocrystallized receptor-ligand complex, a good docking program
should be able to reproduce the X-ray binding mode of the ligand (the re-
docking experiment), that is finding the bioactive conformation of the ligand
and placing it correctly in the binding pocket.
If several X-ray structures of compounds cocrystallized with the same
protein are available, a more interesting docking experiment is the cross-
docking experiment (an exhaustive and insightful article on cross-docking by
Verdonk is [77]). In this experiment, one tries to dock all the cocrystallized
compounds in all the receptors structures13 and it is not uncommon that
this experiment fails to reproduce the native X-ray binding pose for some
11Several on-line servers are devoted to checking and validate crystal structures. One
of the most used is MolProbity: http://molprobity.biochem.duke.edu/
12http://www.schrodinger.com and http://www.eyesopen.com, respectively.
13For example, if one has two crystal structures (A and B) of the same receptor with
two different cocrystallized compounds (a and b), one docks the compound b in the
receptor A and the compound a in the receptor B.
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ligands. If the normal success rate for re-docking experiments is 70100%14,
the success rate for cross-docking experiment is usually 4050%.
In fact, upon binding, some side chains of the receptor (or even the back-
bone) can modify their torsional state to better accommodate the ligand
(induced fit, see section 1.3.5), and the resulting conformation might be un-
favorable to the binding of another compound. The problem is particularly
important if the protein structure has been produced through homology
modeling and the position of some side chains of the binding pocket is
ambiguous. Moreover, if for the same receptor a holo-structure and a apo-
structure are available, it is not uncommon that docking the co-crystallized
compound to the apo-structure will fail (apo-docking) because some side
chains in the apo-structures assume rotameric states which are unfavor-
able to the binding of the compound. Some docking protocols have been
devised to cope with the problem of the induced fit with a soft docking strat-
egy, that attenuates the steric clashes[69], or allowing different rotameric
states in the side-chains[27] without allowing backbone movements. More-
over, it has been shown[64] that fixing the backbone, and allowing only
side chains movements, can be responsible of docking failures. There are
also approaches for including backbone mobility for improving docking ac-
curacy: performing parallel docking using different conformations of the
protein[11]; using computational techniques such as normal mode analysis
to perturb a crystal structure into relevant structures suitable for docking,
especially when loop movements are involved[12]; combine experimentally
determined structures originating from multiple conformations[16].
Unfortunately, a common speed-up technique for docking, that is pre-
calculating the pair-wise interactions in a dense 3D lattice comprising active
site space, thus providing a look-up table, can not be used if several receptor
conformations are employed. Side chains movements would modify the
structure and make this approach too time-consuming, because one should
recompute the look-up table for each new rotameric state. Recently, it has
been shown that, using elastic potential grids[49], it is possible to adapt the
pre-calculated 3D lattice to (small) variations in the binding pocket.
The problem of not keeping the protein fixed during docking, or allowing
a protein structure minimization after docking, is that unfavorable repulsive
interactions (locally introduced strain) can be dissipated to such an extent,
by absorption by other parts of the structure, that they become unrecog-
14A success rate close to 100% for a particular target could have several reasons.
The docking program could be the best one ever written or, more likely, the performance
assessment could slightly biased because it is performed on targets belonging to the same
protein families on which the docking program has been optimized.
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nizable. It's therefore advisable to allow flexibility of only those side-chains
that are known to adapt to ligand binding.
Finally, the role of conserved water molecules in crystal structures is
gaining more importance[34]. The degree of conservation of the water
molecules is hard to estimate and it is not clear how to classify tightly and
loosely bound water molecules. Neglecting a tightly bound water molecule
during docking can result in a high penalty for desolvation, therefore a un-
favorable contribution to the binding affinity. The unfavorable contribution
to the binding affinity is important when the water molecule makes more
than two hydrogen bonds with the receptor[9]. In fact the hydroxyl group,
which is the closest organic group to water, lacks the other hydrogen of
water. Many docking protocols can easily include water molecules as a part
of the receptor.
1.3.5 Induced fit or conformational selection?
Briefly, two different theoretical models describe the conformational changes
of the receptor occurring upon ligand binding: induced fit and conforma-
tional selection.
Induced fit, formulated by Koshland in 1958[54], postulates that first a
molecule binds to a receptor and then the conformational changes in the
macromolecule follow.
On the contrary, conformational selection[75] postulates that a free en-
zyme exists in an equilibrium of different conformations sub-states and that
the ligand preferentially binds to one or more sub-states, therefore shifting
the equilibrium in such direction.
The conformational selection hypothesis is computationally appealing
because it implies that it is possible to study a free enzyme with molecular
dynamics simulations and then utilize some of the snapshots for docking.
An example of the influence of conformational selection on docking is pre-
sented in section 1.9.5.
1.4 De-novo design
While docking tries to find the best arrangement of a particular molecule
inside a binding pocket of an enzyme, the aim of de-novo design is con-
ceptually different. During a de-novo design experiment, new molecules
are generated inside the binding pocket, through the coupling of building
blocks such as fragments or by growing algorithms. This task is generally
very difficult because of the very huge search space involved. The gener-
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ation of new molecular entities is often against their synthetic feasibility,
and this aspect can reduce the usefulness of such programs. Several pro-
grams such as SMoG[18], SPROUT[29], LigBuilder[79], and GANDI[19] are
available for de-novo design. Section 1.8 provides an example of a de-novo
design software (GANDI).
1.5 Scoring
After a docking or a de-novo design experiment is performed, many poses
are generated (see figure 1.5), and a scoring function is always used to dis-
tinguish docked or newly generated poses whose binding mode resembles
a native binder from others. The scope of virtual screening is therefore
to filter a set of molecules extracted from a database by discarding com-
pounds which are likely to be inactive, prior to enzymatic tests, and keeping
compounds which are likely to be active. Docking and de-novo algorithms
implement energy functions, that are used to select energetically favorable
poses, thus more likely to bind, but usually such energy functions are not
sophisticated.
The problem of molecular recognition is very important (especially in
biology) and scoring functions should be able to capture the physical princi-
ples responsible for binding. Importantly, scoring functions have to be suffi-
ciently fast, efficient. For example the LIE method[1] for predicting binding
energies is based molecular dynamics simulations and therefore requires sev-
eral hours for a single pose. It is certainly not suitable for screening a big
library of compounds.
Scoring functions have to provide the user with several requirements.
First, the docked poses have to be ranked correctly. For example, in a re-
docking experiment, the pose with the most favorable score, thus ranked
first, should be the closest (RMSD) to the native co-crystallized confor-
mation. Second, the trend of the experimental binding energies should be
reproduced, that is ligands should be ranked the same according to their
score and to the experimental binding energy. Third, docking can be used
as a virtual screening tool. The scoring functions should be able to select
an active molecule from a pool of (many) inactive decoys[33]. Fourth, ac-
tive and inactive compounds of a single chemotype should be distinguished.
Often, after a lead compound is found, small chemical modifications are in-
troduced to improve its potency. Scoring functions should be able to rank
correctly the compound derived from a very similar scaffold. For example,
more sophisticated and time demanding scoring functions can be able to
distinguish the activity of closely related molecules, or for compound that
13
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Figure 1.5: Typical results of docking. The receptor is in blue and
the co-crystallized pose in red. The first 20 docked poses are in black.
A very similar situation can be also obtained by de-novo design.
Figure 1.6: A hard test for scoring functions. Oxazole and isox-
azole are two isomers and scoring functions sensitivity can be not high
enough to apreciate the difference.
contain only slightly differing groups. In the oxyazole example (see figure
1.6), the distance of oxygen and nitrogen in the two isomers is too small for
being apreciated by the sensitivity of simple scoring functions.
Scoring functions could be divided into three classes: force-field-based,
empirical, and knowledge-based scoring functions. (For comprehensive re-
views, see the reviews by Klebe[31] and by Stahl[70]).
It's important to notice that scoring functions usually correlate with
molecular size[76] (see figure 1.7). For this reason, it is often better to
compare compounds not on their calculated binding energy (or score), but
14
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Figure 1.7: Scoring functions dependence on molecular size. A
typical dependency of the Chemscore on the heavy atom count. It is a
result of the docking of about 100 000 random compounds, with varying
molecular weights. The error bars reflect the variance in the Chemscore
values. Reproduced from [76].
on the binding efficiency, obtained by dividing their binding energy by their
molecular weight or the heavy atom count (ligand efficiency).
1.5.1 Force-field based scoring functions
Force-field based scoring functions consist of the pair-wise non-bonded inter-
action terms (van der Waals and electrostatic contributions). For example,
the CHARMM[7, 6] van der Waals interaction energy between the atom i
and the atom j is approximated with a 12-6 Lennard-Jones potential:
VLJ = i,j
((
Rmin,i,j
ri,j
)12
− 2
(
Rmin,i,j
ri,j
)6)
where ri,j is the distance between the two atoms; i,j =
√
ij, i and j are
constants characteristics of the strength of the van der Waals interaction
of the two atoms; Rmin,i,j = (Rmin,i + Rmin,i)/2, where Rmin,i and Rmin,j
are constants characteristics of radii of the two atoms. The repulsive 1/r12
term dominates when the separation between the atoms is small. The
−1/r6 term is attractive and dominates when the separation of the two
atoms increases. Alternatively, when soft-docking protocols are employed
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to allow some minor steric clashes between the ligand and the receptor, the
12-6 Lennard-Jones potential is usually scaled to a more attenuated 8-4 one,
where the repulsive term is less predominant. The electrostatic interaction
term between two atoms is described in CHARMM by the Coulomb law:
Velec =
qiqj
4pir
where qi and qj are the partial charges of the atoms i and j,  is the dielectric
constant, and r is the separation between the two atoms. Force-field scoring
functions were among the first to be introduced in docking and scoring, but
they tend to overweight polar interactions. For example, when a salt-bridge
is established, its calculated coulombic interaction energy is very favorable
and often three or four times higher than the total van der Waals interaction,
and this effect can generate artifacts. It has been shown in an assessment
study of several scoring functions[24], that the influence of the protonation
state of ligand and protein deeply affects the performance of force-field
scoring functions, if the partial charges are not correctly assigned. However,
taking into account the desolvation energies[71, 40] can compensate for
this problem because salt-bridges have a high desolvation penalty which
counterbalances the coulombic energy.
1.5.2 Empirical scoring functins
Empirical scoring functions, also known as regression-based scoring func-
tion, try to correlate the experimental ∆G of binding of protein complexes
of determined structure to an empirical function, which is essentially a
weighted sum of many terms which are thought to contribute to the free
energy of binding15. The individual weights of the terms are determined
by means of multiple linear regression. Usually, hydrophobic interactions
and hydrogen bonding contributions are introduced, as well as entropy con-
tributions. Two examples are the ChemScore[22] and the LIECE scor-
ing functions[40]. The scoring function of ChemScore is based on the fol-
lowing terms: hydrogen bonds, metal interaction16, lipophilic interactions
and number of frozen rotatable bonds. The hydrogen bonds term is also
scaled down for deviations from the most favorable geometry. The lipophilic
term is calculated for all lipophilic atoms of the ligand and the receptor.
Lipophilic atoms are chlorine, bromine and iodine (not in the ionic form),
15http://lpdb.chem.lsa.umich.edu/ and http://www.pdbbind.org are comprehensive
collections of experimentally measured binding affinity data (Kd, Ki, and IC50) for the
protein-ligand complexes deposited in the PDB database.
16An example of metal interaction is the NFe bond in the Heme.
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sulfurs (when not hydrogen bond donors or acceptors) and carbons (when
are not bound to a heteroatom). The metal interaction term is a simple
contact term. One interesting term is the frozen rotatable bonds term that
represents the entropy loss of the ligand upon binding. A frozen rotatable
bond is a non-terminal bond, in which the atoms on the both sides of the
bond are in contact with the protein. The regression for calculating the
relative weights of the single terms was calculated on a training set of 82
X-ray complexes (17 aspartic peptidases, 15 serine peptidases, 15 metallo
peptidases, 16 sugar-binding proteins and 19 other proteins).
The LIECE scoring function is a hybrid between a force-field and an
empirical scoring function, because it consists of the weighted contributions
of van der Waals and electrostatics (the sum of coulombic interactions and
desolvation penalty) to the binding free energy:
∆Gbind = α∆EvdW + β∆Gelec
It differs from a pure force-field based scoring function because of the re-
gression based weighting of the force-field energy contributions. Differently
from ChemScore, LIECE is not trained on several different targets, but on
the protein target only, when two conditions are satisfied: first, one co-
cristallized X-ray structure of an inhibitor must be available; second, at
least a series of inhibitors (preferably congeneric to the cocrystallized one)
of which the binding energy has been experimentally determined has to
be available. If other series of inhibitors are available and their binding
mode can be determined by docking, they can be employed, too, with some
caveats. The regression for calibrating LIECE's weights (α and β param-
eters) is then done on all the known inhibitors. Ideally, for achieving the
best predicting ability, the inhibitors potency should span several orders of
magnitude, from very low nano-molar to high micromolar, and the inhibitor
molecular weight distribution should be similar to the one of the library that
is being scored. An example of a LIECE model I built for BRAF kinase is
presented in figure 1.8.
One disadvantage of LIECE is that its predicting power decreases for
proteins with a large active site, when the training set for the regression does
not explore all sub-pockets. This observation has been made by Dr. Marino
Convertino while testing LIECE on his project on β-secretase, whose active
site is large and deep. The original training set consisted of large pep-
tidic and peptido-mimetic compounds. The weights determined for large
compounds were not particularly suitable for scoring the smaller drug-like
compounds he docked. Finally, LIECE is very sensitive to even very small
variations of the binding pocket conformation, therefore, one has to check
for transferability of the α and β parameters whenever a new structure of
17
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the receptor is employed for docking. While the ChemScore scoring function
is transferable among different protein families, LIECE is not transferable,
albeit it is still transferable among a single protein family (general LIECE
model on kinases[53]). In the general LIECE models developed on three ki-
nases (Cdk2, Lck, and p38), the α and β parameters are α =0.2898±0.0075
and β =0.0442±0.0074. In my LIECE model on BRAF kinase (see figure
1.8), which was not used for the regression of the general LIECE model,
the parameters are α =0.2857±0.0120 and β =0.0531±0.0128.
1.5.3 Interpolation vs. extrapolation
The calculated binding free energy of regression-based scoring functions is
usually obtained by interpolation, that means that the experimental data
cover a certain free energy range in a sparse manner and the predicted
energy value is obtained from the regression curve in a portion of space
within the aforementioned range.
In the example of figure 1.8, the two inhibitor series (red and black sym-
bols) cover a range of activity from a ∆G of binding of -13 to -5 kcal/mol,
but their average ∆G of binding is -10 and -7 kcal/mol. For this reason, the
affinity range between -9.5 and -7 kcal/mol, for which just a few compounds
are present, will be more likely predicted by extrapolation and not by in-
terpolation, as the figure might wrongly suggest. As for the simpler case of
linear regression, the standard error of values derived by extrapolation is
higher than for values derived by interpolation.
1.5.4 Knowledge-based scoring functions
Knowledge-based scoring functions are built from statistical analyzes of
experimentally determined structures of complexes, assuming that particu-
lar frequent interatomic distances, occurring more often than the average,
reference value, represent favorable contacts. For the derivations of these
functions, one has to define a set of atom types for the protein and for the
ligand and has to count all the possible pairs in binned distance intervals.
PMF[63] and DrugScore[30] are two well known examples.
In the DrugScore function, potentials were derived for the following atom
types: C.3 (carbon sp3), C.2 (carbon sp2), C.ar (carbon in aromatic rings),
C.cat (carbon in amidinium and guanidinium groups), N.3 (nitrogen sp3),
N.ar (nitrogen in aromatic rings), N.am (nitrogen in amid bonds), N.pl3
(nitrogen in amidinium and guanidinium groups), O.3 (oxygen sp3), O.2
(oxygen sp2), O.co2 (oxygen in carboxylate groups), S.3 (sulfur sp3), P.3
(phosphorus sp3), F (fluorine), Cl (chlorine), Br (bromine), Met (Ca, Zn,
18
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Figure 1.8: A LIECE model of BRAF kinase. The LIECE model
has been parametrized using two different sets of inhibitors (red and
black symbols in the plot).
Ni, Fe). Some atom types have low occurrence and thus were grouped
together: S.2 (sulfur sp2) and S.3, N.4 (positively charged nitrogen) and
N.3. To derive potentials in DrugScore, a non-redundant set of protein-
ligand complexes was extracted from ReLiBase17, an annotated database of
receptor-ligand complexes.
In figure 1.9 some statistical preferences are represented. The prefer-
ences can be divided into two classes: polar and apolar interactions. The
polar ones have a marked maximum for distances between atom pairs of
2.53 Å and the apolar are significally preferred with respect to the ref-
erence state for distances between atom pairs of 3.56 Å. The reference
state is calculated as arithmetic mean over all normalized pair correlation
functions. It may be regarded as a mean interaction preference between
17http://www.ccdc.cam.ac.uk/free_services/relibase_free/
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Figure 1.9: DrugScore statistical preferences. Frequency g(r) of
polar/charged (left), non-polar and aromatic interactions (center). The
optimal geometry of a carbonyl-alcohol hydrogen bond can be deduced
from the statistical preferences (right) as a function of their distance.
The peak of the C.2-O.3 preference is at 3.45 Å, the one of O.2-O.3 is
at 2.55 Å and the equilibrium distance of the C.2-O.2 bond is 1.22 Å.
The resulting calculated C.2-O.2-O.3 angle is 128 degrees, in agreement
with the values in the PDB database. Therefore, the directionality of the
bond is implicitly contained in the statistical preferences. Reproduced
from [30].
averaged atom-types, thus mainly representing non-specific contributions
from dense packing.
The advantage of knowledge-based scoring functions is that they are
more transferable. Moreover, desolvation, entropic and other effects that
drive binding are implicitly taken into account by the procedure. Less
populated states are given less statistical preference, therefore probably
avoiding docking artifacts.
Finally, while protonation states are important for methods such as
LIECE, which are based on rigorously calculated electrostatics, they are
not problematic for scoring functions like DrugScore or PMF, because they
are not taken into account for building the model as the assignment of atom
types does not require knowledge of the protonation state.
1.6 Assessing virtual screening performance
The performance of a virtual screening campaign can be evaluated when
the number of active compounds in the database is known or can be reliably
estimated. Usually, only a small subset of compounds, such as the 50100
best ranking compounds, is selected for experimental tests.
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Enrichment factors
The Enrichment Factor of a selected subset of a database, usually the 5%
or 10% (EF5% and EF10%, respectively), is the ratio between the percentage
of active compounds in the selected subset and the percentage of the entire
database:
EF% =
Hitsselection
Hitstotal
· NCtotal
NCselection
where NCtotal is the number of compound of the database and NCselection
is the number of compounds in the selected subset. Hitstotal is the whole
number of hits in the database and Hitsselection is the number of hits in the
selected subset.
For example, let's assume that 20000 randomly chosen molecules from
a chemical library form a database of not active compounds towards a
particular target. Known inhibitors of this target, for example 50, are
included into this database and, then, the whole database, consisting of
known active and inactive molecules, is screened by docking and scored. A
perfect docking and scoring would rank the 50 known inhibitors in the first
50 places. Unfortunately, this is rarely the case and docking and scoring
programs must be assessed for their ability of fishing active compounds
out. In the first 10% of the database there are 2005 molecules, and only 27
known inhibitors are correctly retrieved. The enrichment factor would be
EF10% = (27/50)(20050/2005) = 5.4
Importantly, the maximum theoretical enrichment factor is the percentage
at which it is calculated. In the aforementioned example:
EF10%, max = (50/50)(20050/2005) = 10.0
The performance of several docking and scoring algorithms can be therefore
assessed and compared for the highest enrichment factor.
Enrichment curves
Enrichment factors do not consider how fast known active molecules are
retrieved from a pool of inactive ones and the same enrichment factor can
therefore be obtained if the active compounds are grouped together in the
best positions of the list, or if they are sparse in the analyzed list, or, in a
limit case, if they are all grouped together at the bottom of the analyzed
list.
Enrichment curves are useful for coping with this issue. Enrichment
curves report the percentage of active compounds as a function of the frac-
tion of screened library. The steeper is the curve and larger is the area under
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Figure 1.10: Enrichment curves. Five enrichment curves are plotted.
The steepness and the area under the curve of the yellow curve is bigger
than the one of the black curve, and therefore its model is better at
finding true active molecules. Reproduced from [53]
the curve, the better is the procedure at finding true active compounds (see
figure 1.10).
1.6.1 Consensus scoring
It appears natural that combining results from such a number of scoring
functions can lead to an increase in scoring performance[23]. Intuitively, if
several different scoring functions always put a certain compound in the first
ranked positions, it is more likely that it is a true active, than a compound
that is always scored low. For example, an evaluation of docking results of
three popular docking programs with seven scoring functions[3] found an
improvement with respect to the docking score of the of circa 10% with
the best scoring function, 2540% with the two best scoring functions, and
65-70% with the three best scoring functions. A successful use of consensus
scoring has been reported in a high-throughput docking study that resulted
in the identification of inhibitors of plasmepsin[25]. Consensus scoring is
therefore a very powerful tool for increasing the success rate rate of docking
campaigns.
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Figure 1.11: The in-house docking procedure. First, the molecule
is divided into three fragments by DAIM; second, the fragments are
docked into the active site by SEED; third, the molecule is placed into
the active site by FFLD, using the precalculated fragment positions as
anchors to drive the positioning. Reproduced from [53].
1.7 An example of a docking approach
A docking strategy example will be given based on the docking suite devel-
oped in my research group. The underlying idea of this particular approach
is the fragment based drug-design by linking ligand fragments. Briefly, if
fragments are known to (weakly) bind a protein, linking them will most
probably generate a better binder. Following this framework, the in-house
docking approach takes advantage of the interplay of three programs:
• DAIM[51] (Decomposition And Identification of Molecules)
• SEED[58] (Solvation Energy for Exhaustive Docking)
• FFLD[8, 14] (Fragment-based Flexible Ligand Docking)
In this docking procedure, a molecule is fragmented and the best positions
of the fragments in the binding pocket drive the optimal placement of the
whole molecule (see figure 1.11). The real generation of novel molecules by
linking fragments is briefly illustrated in the de-novo design (section 1.4).
First, given the 3D structure of a molecule, DAIM automatically gener-
ates a triplet of fragments of a given molecule by cutting single, non terminal
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Figure 1.12: Clustering of benzamidine by SEED. Several posi-
tions of benzamidine are generated by SEED in the S1 pocket of Throm-
bin (not shown) and they are clustered together. The poses shown here
are the members of the most favorable cluster. The sphere in red is the
geometrical center of the cluster.
rotatable bonds and by avoiding to remove functional groups. Valences are
then filled either with a hydrogen, or with a methyl, if adding a hydrogen
would create a hydrogen bond donor which was not present in the origi-
nal molecule. Of the all possible fragments that can be obtained by single
bond cleavages, DAIM automatically chooses three fragments to represent
the pharmacophore of the molecule.
Second, SEED exhaustively docks the three fragments to a binding
pocket with an accurate force-field based scoring function comprising de-
solvation energy. The fragment is docked in all the possible positions in
the volume of the binding pocket and that particular attention is given to
the hydrogen bonds, for which all the possible reasonable solid angles be-
tween the donor and the acceptor (D-H· · ·A) are sampled. Fragments and
receptor conformations are kept rigid during the docking. To reduce the
complexity of the system, all the docked positions of the fragments (nor-
mally several thousands) are clustered together, according to 3D similarity
(see figure 1.12) and only the geometrical centers of the most energetically
favorable positions are kept as anchors for the final step of the docking
procedure.
Third, FFLD generates a number conformations (several hundred of
thousands) of the molecule with a genetic algorithm18 and uses the geomet-
18A genetic algorithm (GA) is a search technique used in many disciplines for finding
solutions of optimization problems. GAs are inspired by evolutionary biology and from
it they borrow words such as chromosome, fitness, mutations, selection, recombination,
et cetera. A random generated population of molecules is generated and optimized
through many iterations of the algorithm. In the case of FFLD, the chromosome
of every molecule contains informations on the rotatable bonds angles, therefore the
GA perturbates only the conformation of the molecule. The fitness function which is
optimized by the GA is a force-field based one (see section 1.5).
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rical centers of SEED as anchors to drive the docking of the conformers.
Since the same fragment can be present in more than one molecule19, an
important speed-up is gained by using the previously obtained results of
SEED for more than one molecule processed by FFLD. It's noteworthy
that FFLD can only dock compounds that have at least three fragments
because only in this way it can unambiguously place a conformation.
Eventually, the geometry of all the docked poses generated by FFLD
is optimized by the program CHARMM[7, 6]. This paper by Huang and
Caflisch[41] is a good and comprehensive review of all docking campaigns
involving DAIM/SEED/FFLD.
1.8 An example of de-novo design
I will briefly illustrate GANDI (Genetic Algorithm based de-Novo Design
of Inhibitors) because I took place to the software testing and therefore
also suggested modifications and new features, some of which have been
successfully implemented by the developer, Dr. Fabian Dey.
The principal idea of GANDI is growing molecules into the binding
pocket of a receptor by coupling previously docked fragments with suitable
linkers, both chosen from a pool. The fragments are initially docked with
SEED, which ensures their best position into the binding pocket and cal-
culation of an accurate binding energy, and then provided to GANDI. In
the example of figure 1.13, three fragments are first docked: a furan and a
benzene in hydrophobic pockets of the receptor, and a pyrrole in a polar
environment and establishing a hydrogen bond with the receptor. Then,
GANDI couples the fragments with linkers, in the example an ester and an
amide group. GANDI does not modify the torsional angles of the fragments
and the linkers, but many different conformations of both can be provided,
therefore providing a certain degree of flexibility. The bond directionality
is given by the connection vectors, which are the red arrows in the linkers
and the black arrows for the fragments. The connection vectors are usually
all the heavy-atom→hydrogen vectors, but they can defined by the user.
The difference between fragments and linkers is that linkers must have at
least two connection vectors. Therefore, the same molecule can be at the
same moment docked with SEED as a fragment and provided to GANDI
as a linker, if it has two or more connection vectors. In the example, even
if only some are shown, benzene has six connection vectors, furan four,
19For example, according to [51], the first ten most frequent cyclic fragments in the
2005 version of the ZINC library are: benzene, chlorobenzene, toluene, fluorobenzene,
bromobenzene, nitrobenzene, pidirine, furane, thiophene, and 1,3-dichlorobenzene.
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and pyrrole five, one of which is discarded because of the involvement in
hydrogen bonding. Importantly, DAIM can fragment molecules and there-
fore provide GANDI with fragments and linkers whose particular annotated
vectors represent the heavy-atom→hydrogen vectors which were involved in
single bonds. This way, the problem of the synthetic feasibility of the de-
novo generated molecules can be mitigated. Additionally, GANDI contains
a list of prohibited bonds such as O-O, N-N, N-O, which are not chemi-
cally stable. The search for the best combination of linkers and fragments
is optimized with a complex, but highly customizable genetic algorithm.
The fitness function of each generated molecule for the genetic algorithm is
a linear combination of three terms:
Stotal = wffEff − w3DSim3D − w2DSim2D
where Stotal is the total fitness and the weights of the terms are expressed by
the w. Eff is the force-field calculated energy (see section 1.5), which is the
sum of the SEED interaction energy for the fragment and the CHARMM
non-bonded interaction energy for the linker. Sim3D and Sim2D are two
measures of similarity with respect to some important molecule, such as
a known binder, which have been introduced to drive the search towards
known molecular scaffold and pharmacophores. The minus signs for the
similarity terms are necessary because, during the minimization of Stotal,
Eff becomes more negative and the similarity becomes more positive and
closer to the unity (perfect similarity). According to the original paper, the
best results have been obtained with wff=0.02, w3D=1, and w2D=0 by trial
and error.
Last, GANDI can be used also in ligand (or lead) optimization, when a
particular fragment is known to bind, it is possible to instruct the program
to generate molecules that always contain this fragment. In this way, many
congeneric compounds are produced and the most interesting ones can be
synthesized and tested for activity.
1.9 Molecular Dynamics simulations
The first molecular dynamics simulation of a macromolecule of biological
interest dates back to 1977[60] and it started a revolution in thinking of
macromolecules, replacing the view of proteins as rigid structures. Never-
theless, already in 1963, Richard Feynman wrote in the Feynman's Lectures
on Physics the now over-quoted: Certainly no subject or field is making
more progress on so many fronts at the present moment than biology, and
if we were to name the most powerful assumption of all, which leads one on
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Figure 1.13: Framework of GANDI. Predocked fragments from
SEED are linked by linkers from a library. While the position of the
fragments is fixed, the linkers are optimized. Reproduced from [19].
and on in an attempt to understand life, it is that all things are made of
atoms, and that everything that living things do can be understood in terms
of the jigglings and wigglings of atoms. Now, molecular dynamics simula-
tions is a very appropriate tool for studying the jigglings and wigglings of
atoms.
In structure-based drug design, molecular dynamics simulations can be
very useful for elucidating the relationship between structure and function
of a protein and for providing alternative conformations of the receptor for
docking.
A very interesting review of the role of molecular dynamics simulations
in biology is by Karplus and McCammon[48] and a detailed review of molec-
ular dynamics techniques is by Van Gunsteren[37] and Nilsson[65].
CHARMM[7, 6] was used in my research for molecular dynamics simu-
lations performed by classical mechanics, that is they involve the numerical
integration of Newton's equations of motion for all the atoms a suitably
prepared system. The total energy of the system is empirically expressed
as the sum of bonded and non-bonded interactions as a force field in the
form
E = Ebonds + Eangles + Edihedrals + Eimpropers︸ ︷︷ ︸
bonded interactions
+ EvdW + Ecoulomb︸ ︷︷ ︸
non-bonded interactions
and depends on the bond lengths (Ebonds), the bond angles (Eangles),
the proper and improper20 torsion (dihedral) angles angles (Edihedrals and
20The improper torsion angle term was introduced to maintain chirality about a tetra-
hedral extended heavy atom and to maintain planarity about certain planar atoms, such
27
1. Introduction
Eimpropers, respectively), the van der Waals and the coulombic energy (see
section 1.5.1 for their analytical expression).
Molecular dynamics simulations can be performed in an explicit or im-
plicit solvent. In an explicit solvent simulation, the protein is immersed
in a appropriate water filled box, while, in an implicit solvent simulation,
the effects of the solvent are averaged and present as an additional term
in the empirical energy function. The water model used by CHARMM is
called TIP3P[47], and consists of three interaction sites corresponding to
the three atoms of the water molecule. Explicit solvent simulations are more
accurate than implicit solvent ones, but also very demanding in terms of
computational power, because it is not so uncommon that the protein atoms
represent less than 10% of the total atoms of the simulated systems and the
time required for the simulation is roughly proportional to the square of the
number of atoms.
With the term minimization or energy minimization it is meant a
progressive modification of the coordinates of the system, so that the total
energy at the end of the procedure is minimized (i.e. reduced, more fa-
vorable). During a minimization, some atomic coordinates can be fixed or
biased (by applying a restraint) to a certain position. For example, fixing
protein atoms is routinely used in docking, while minimizing a docked pose
in the rigid binding pocket, or while optimizing the positions of hydrogens
only, for the preparation of a suitable receptor structure.
1.9.1 Preparation of a protein for molecular dynamics
simulations
The preparation of a protein for molecular dynamics simulations is not a
completely trivial task. Besides simple technical problems arising from the
data manipulations of structures obtained from the Protein Data Bank,
such as different naming and numbering conventions of CHARMM, many
steps require the active participation of the user. For example, crystal struc-
tures might have an alternate location for some residues, meaning that
in the crystal lattice a particular residue assumed two or more conforma-
tions. It's then up to the user to decide which position is better, usually
the most populated one. If the population of the two states is the same and
this residue is supposed to be important for the outcome of the simulation,
one possibility would be starting simulations from two protein structures,
as carbons in benzene. Extended heavy atoms are a reduced representation of a molecule,
in which non-polar hydrogens are included in the carbon atom. For example, the methy-
lene group, CH2, is reduced to a single carbon atom with higher mass and van der
Waals radius. With this approximation, the complexity of the system decreases.
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each one containing a different rotamer. Additionally, as explained in sec-
tion 1.3, the crystal structure might contain errors in the positioning of
the asparagine and glutamine side-chains, and of the imidazole ring of his-
tidine. Those errors can be found and corrected automatically, but the
intervention of the user is always recommended. Moreover, the protonation
state of many titrable residues has to be defined, especially if a particular
residue is important for the simulated system, and disulphide bridges have
to be specified. Hydrogen atoms have to be added, and, while non polar
hydrogens are easier to insert (at the equilibrium bond and dihedral angle,
and at the equilibrium distance), polar hydrogens are more complicated.
In fact, hydrogens belonging to waters or hydroxyl groups can assume dif-
ferent conformations according to the environment. CHARMM copes with
this problem by optimizing their initial position with an iterative method
which searches for the conformation with the most favorable energy (hbuild
command).
If some residues are missing in the crystal structure, be they the N- or
the C-termini or a flexible loop whose electron density is not observed, to
prevent the presence of unwanted, unrealistic charges at the N- or C-termini
where the polypeptide chain is interrupted, two solutions are commonly
accepted. First, the termini at the missing parts of the protein can be
patched with capping groups, such as an acetyl group at the N-terminal part
or N-methyl-aminyl group at the C-terminal part, to remove the positive
and the negative charge, respectively (see figure 1.14). This is the simplest
solution, and it is generally well accepted for the N- and C-termini. Second,
the missing segments can be re-introduced by homology modelling. This
solution is particularly suitable in case of a missing loop, whose absence can
generate an unrealistic system. It is advisable to check the movability of the
introduced loop during the simulation, assuming that no electron density
of it was determined because of its high flexibility. In fact, if the homology
model presents an element of secondary structure in the generated loop
which is not present in the real structure in solution, the flexibility of the
loop can be lower than the expected one. Therefore, the behaviour of the
simulated protein structure could strongly differ from the real supposed
one in solution.
Once the protein structure is prepared, the system has to be minimized
(usually in an implicit solvent) until an energy minimum is reached, that is
when the sum of all forces acting on every atom is zero. This is due to the
fact that in a crystal structure it is very plausible that some atoms have
been placed with bond lengths which are a little stretched with respect to
the equilibrium value of the force field or that some atoms slightly overlap.
If no minimization were carried out and a simulation were started from
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Figure 1.14: Common patches for N- and C-termini. The acetyl
group and the N-methyl-aminyl group are two common patches for re-
moving the charge from the N- and the C-terminus, respectively.
a structure whose energy is distant from a minimum, the aforementioned
atoms would be subject to large forces and they would accelerate to veloc-
ities that could not be handled by CHARMM. To prevent big movements
of the protein backbone upon minimization, gentle constraints are placed
upon backbone atoms, so that their position will not be modified too much,
but allowing an energy minimum to be reached.
Crystallization waters and ions which appear in the crystal structure
should be retained if they are buried[68], or if they are known to be bio-
chemically important. For example, in figure 1.15 are shown the effects of
the removal of buried water. After minimization, two arginine residues orig-
inally making hydrogen bonds with cocrystallized water (magenta) change
their position (blue), filling the void left by missing water molecules. Con-
sequently, the algorithm which inserts the protein in a water box will not
be able to place water in the previously occupied positions.
1.9.2 Setting up an explicit solvent molecular
dynamics simulation
In explicit solvent molecular dynamics simulations, after the preparation
of the receptor structure, the protein is immersed in a box of water. Salts
(NaCl or KCl) are added to the system for neutralizing the net charge of
the protein and for reaching the the physiological ionic strength (0.2M).
In fact, long range electrostatics effects might influence the stability of the
protein if ions are not present[43].
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Figure 1.15: The effect of the removal of buried water. After
minimization, two arginine residues originally making hydrogen bonds
with cocrystallized water (magenta) change their position (blue), filling
the void left by missing water molecules.
To prevent finite size problems due to the interface between the box of
water and the vacuum, periodic boundary conditions are employed, which
eliminate interface problems by surrounding the simulated systems by im-
ages of itself. The easiest way to accomplish this task is to have cubical
symmetry21 and surrounding a cubic water box with other 26 images in the
x, y, and z directions (see figure 1.16 for a 2D example). According to this
method, boundaries are no more present and atoms close to the borders of
the box interact with others from the image but the number of interactions
that have to be calculated increases. To prevent that the protein interacts
with itself from an image (thus simulating a crystal), the water box size
has to be big enough. Usually, the size of the box is so that a minimum
distance of 1316 Å is left from every atom of the protein to the borders.
After a fully solvated system is prepared, the position of water molecules
is deeply minimized, usually fixing the heavy atoms of the protein in place,
to optimize the hydrogen bonding network.
Implicit solvent molecular dynamics simulations do not need any solvent
or counter ion, just the choice and the setup of the most suitable implicit
solvent. For example some implicit solvents are more appropriate for small
peptides and some others implement routines for the emulation of mem-
21Other symmetries are supported by CHARMM such as rhomobohedra, rhombic
dodecahedra, truncated octahedra, and hexagonal prisms.
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Figure 1.16: Periodic boundary conditions. To prevent finite size
problems of a a protein immersed in a box of water surrounded by empty
space, periodic boundary conditions are employed. The atoms in the cen-
tral box interact with identical images of themselves along all directions.
Moreover, if a particle exits the simulation box from a side, it reenters
from the opposite side, as shown in the figure by arrows.
branes. Simulations in implicit solvents are faster but less accurate than
simulations in explicit solvents.
1.9.3 Running a molecular dynamics simulation
A simplified flowchart of a molecular dynamics simulation is presented in
figure 1.17. According to it, a molecular dynamics simulation can be di-
vided in different phases. First, the setup of the system, the choice of an
integration step ∆t (explained later), and assignment of the initial random
velocities. Importantly, the two systems evolve differently, if two simula-
tions are started with different initial velocities. Second, the calculation of
the forces acting on the atoms and therefore the accelerations of the atoms,
by numerical integration of the Newton's law in the differential form. The
simulation time step is the length of the integration step. For each integra-
tion step, at least one energy calculation is required. Third, the movement
of the atoms according to the calculated accelerations and the chosen time
step. Fourth, the simulation time is increased. Then the point 24 are
iterated many times until a particular simulation length is reached.
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Figure 1.17: A simplified flowchart of a MD simulation.
A very important parameter is therefore the integration time step. For
sampling the system correctly22, the time step should be smaller than the
highest vibration frequency (that is the smallest period) of the system,
which is the C-H bond stretch for biopolymers. The problem is that the
simulation time is practically directly proportional to the integration step:
if one needs to collect 1 ps simulation time and the integration step is 0.5
or 2 fs, he has to run the simulation for 2000 or 500 steps, respectively. One
very common approximation for increasing the integration step is to keep
the bond length of hydrogen atoms fixed, therefore allowing integration
steps of 1 or 2 fs.
22Just imagine that you want to sample the position of the sun in the sky. You can
determine it too frequently, such as every second, or too rarely, such as every day. In
the first case, the system is ideally sampled correctly, because the observation frequency
is much higher then the frequency of the event. In the second case, the system is not
correctly sampled, because its frequency is much higher then the observation frequency,
and therefore the sun would seem (almost) not to move in the sky.
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Figure 1.18: The effect of a too large integration time step. If
the integration time step is too large, atoms can interpenetrate their van
der Waals radius generating high potential energy, which is transformed
into kinetic energy, provoking a violent repulsion.
A problem that can arise if the integration step is too large is the kinetic
energy instability of the simulation (see figure 1.18). If the time step is
too large, two atoms can be displaced too much and therefore they can
interpenetrate (third step of figure 1.17). As a consequence, a very high
potential energy will be generated, which will result in a high acceleration
and thus high kinetic energy. The accelerated atoms will very probably
clash with some other atoms and the system will be soon unstable23.
Heating, equilibration and production phases
A molecular dynamics simulations consists of three phases.
During the heating phase, the temperature of the system is gradually in-
creased from 0 K to the desired one for the production phase, usually 300
or 310 K. The temperature of a system made up by N atoms is related to
the kinetic energy, calculated from the atomic velocities, by the equation:
3
2
NkT =
N∑
i=1
miv
2
i
2
The initial random velocities are randomly assigned according to a gaussian
distribution whose mean is the desired temperature. During heating, tem-
perature rises by progressive reassignments of the velocities and the whole
heating process lasts 0.250.5 ns. Usually, the protein atoms are either kept
fixed during heating or a constrain on their position is applied.
The equilibration phase starts when the desired temperature is reached.
During equilibration, velocities are frequently rescaled (not reassigned) to
maintain the average temperature close to the wanted one. The constraints
23When a system becomes unstable, it is informally said that it explodes.
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on the protein atoms are first gently released and then completely removed
for a certain length of the equilibration phase. The equilibration process
lasts 0.51.0 ns.
During the production phase all the constrains on the atom positions are
removed and the system evolves in absence of velocity adjustments.
To run a molecular dynamics simulation, whose result can be compared
to experiments, a NpT (isothermal-isobaric) ensemble should be generated.
In this ensemble, the number of particles of the system is fixed, and the pres-
sure and the temperature are maintained by a barostat and a thermostat,
respectively.
The duration of the production phase depends on the observed phe-
nomenon. For example, the analysis of local motions such as atomic fluc-
tuations, side chain motions, and loop movements requires less simulation
time than the analysis of large scale motions such as folding/unfolding and
dissociation/association of proteins. The necessary simulation length can
not always be determined in advance, unless, for example, the time scale of
a phenomenon (nanoseconds, microseconds, milliseconds...) is known from
experiments.
The positions of the atoms of the system, recorded at regular intervals
(usually 12 ps), generated a trajectory.
1.9.4 Properties easily calculated from molecular
dynamics simulations
From the trajectory of a molecular dynamics simulation, several properties
can be easily calculated.
Average energy
The average energy of a trajectory of N frames is
〈E〉 = 1
N
N∑
i=1
Ei
The average energy can be useful to compare different simulations.
In the LIE method for the calculation of the binding energy of a ligand to
the protein (see section 1.5), the interaction energy of the ligand is average
calculated along the molecular dynamics trajectory.
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RMSD between two structures
The Root Mean Squared Distance between two structures such as the X-ray
structure and a simulation frame, or a docked pose and a native pose is
RMSD =
√√√√ 1
N
N∑
i=1
(xi − xi,ref )2 + (yi − yi,ref )2 + (zi − zi,ref )2
where N is the number of atoms; xi, yi, zi are the coordinates of the atom i
after best superposition on a reference structure; xi,ref , yi,ref , zi,ref are the
coordinates of the atom i in the reference structure.
RMSD expresses how different is an object with respect to another after
the best superposition of the two. A RMSD value of zero means perfect
superposition. It can be used for inferring the stability of a simulation if
RMSD between the simulation and the minimized structure which entered
in the dynamics is usually lower than 34 Å.
RMSF and B-Factor
The Root Mean Squared Fluctuation of an atom i in a trajectory segment
of Nf frames is
RMSFi =
√√√√ 1
Nf
Nf∑
i=1
(xi − x˜)2 + (yi − y˜)2 + (zi − z˜)2
The coordinates x˜, y˜, and z˜ refer to the average structure calculated along
small trajectory segments (1 or 2 ns) after superposition.
RMSF is a measure of local atomic flexibility (due to the averaging along
short trajectory segments) and it can be related to the crystallographic B-
factor by
Bi =
8pi2
3
(RMSFi)2
An example of RMSD and RMSF calculations is shown in figure 1.19.
Finally, often, it could be informative to calculate the residence time of
water molecules in the active site, because their position could be a hot-
spot and therefore their position might retained for docking purposes[38].
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Figure 1.19: RMSF as a function of residue number and RMSD
as a function of simulation time. Cα atoms were used and a trajec-
tory of 30 ns with averaging every 2 ns for the RMSF. High values of
RMSF indicate structural flexibility for the corresponding amino acids
and high values of RMSD for a frame indicate structural distance from
the template of the conformation of the protein in this frame.
1.9.5 An application of molecular dynamics
simulation for virtual screening
An interesting paper by Ekonomiuk and Caflisch[21] presents an application
of molecular dynamics simulation for the selection of an appropriate new
conformation of an enzyme for docking. They ran a 1 ns molecular dynamics
simulation of the West Nile virus nonstructural 3 protease and extracted
100 equispaced snapshots.
To choose the most appropriate non-native snapshot for docking, they
docked to every snapshot three small fragments with SEED and chose the
snapshot in which the binding energy of all three fragments was most fa-
vorable (see figure 1.21). In a sense, it was not the protein to select the
binder, but the binders (although not known for binding) to select the
protein. The three fragments were benzene, methylguanidinium, and 2-
phenylimidazoline (see figure 1.20).
Benzene was chosen because it is the most frequent fragment in known
drugs. Methylguanidinium and 2-phenylimidazoline were employed because
the active site of the protein displays many negatively charged residues and
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Figure 1.20: Fragment for the choice of the snapshot. Benzene,
methylguanidinium, and 2-phenylimidazoline were docked with SEED.
Benzene is the most common fragment in known drugs; methylguani-
dinium, and 2-phenylimidazoline were employed because the active site
of the protein displays many negatively charged residues and hydrogen
bond donors.
Figure 1.21: Choice of a snapshot from a simulation. A 1 ns
molecular dynamics was run and 100 snapshot extracted. The most
suitable snapshot for docking is the one in which the binding energy of
three fragments (benzene, methylguanidinium, and 2-phenylimidazoline)
is the most favorable (snapshot 29). The horizontal lines represent the
binding energy in the X-ray structure. Reproduced from [21].
hydrogen bond donors. Of course, fragments can come from other sources,
such as natural ligands, known inhibitors, and preferred pharmacophores of
the protein. Importantly, the first two sources can introduce a bias for the
selection of the snapshot.
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Figure 1.22: The two inhibitors of West Nile virus. The methyl-
guanidinium and the benzamidine fragments are shown in red.
Interestingly, the two inhibitors they found using this strategy would not
bind to the native X-ray conformation, confirming again the importance
of induced fit or conformational selection (see section 1.3.5) problems in
docking.
The choice of methylguanidinium and 2-phenylimidazoline, for selecting
the most appropriate protein conformation, was also reasonable, because
one of the two inhibitors identified in [21] contains methylguanidinium
and the other benzamidine, the latter being structurally very close to 2-
phenylimidazoline (see figure 1.22). It is remarkable that the docked library
was not biased towards any of the fragments used for selecting the snap-
shots, but, probably, the protein conformation was biased towards the
three aforementioned fragments.
In a follow-up paper[20] on longer molecular dynamics simulations of
the same protein used for docking, Ekonomiuk and Caflisch advanced the
hypothesis, supported by computational evidence, that conformational se-
lection and not induced fit drives the binding of ligands to the West Nile
virus protease.
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Chapter 2
Allosteric modifiers of
Cathepsin K
This work, a collaboration with Dr. Marco Novinec, PostDoc in the group
of Prof. Antonio Baici at the UZH, represents a recent (and still in early
stages) example of virtual screening applied to the search for allosteric ef-
fectors of a peptidase. The main challenge of this project is the absence of a
known allosteric binding pocket of cathepsin K, and therefore the reasonable
definition of a putative one.
2.1 Allostery
Allostery can be defined as the change in ligand affinity or catalytic effi-
ciency of a protein triggered by the binding of a ligand to a site distant
from the active site, often called exosite. The current view of allostery is
that proteins exist as a population of many dynamically linked states and
that the ligand binding shifts the equilibrium towards a particular state.
Three good reviews about protein allostery are [50, 35, 73].
Allostery is very interesting for drug design. One benefit of targeting an
allosteric site would be specificity. For example, inhibitors of some protein
families, such as kinases, are not very specific because of the high conser-
vation of the active site pocket which binds ATP. Another benefit would
be that an allosteric inhibitor would very probably behave as a hyperbolic
inhibitor. Hyperbolic inhibitors reduce the enzymatic activity without abol-
ishing it completely at saturating conditions and therefore they have a very
important pharmacological potential of maintaining the level of enzyme
which is necessary for the normal physiological activity of the organism.
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2.2 Cathepsin K
Cathepsin K is a cysteine peptidase of the papain family and it is interesting
from therapeutic point of view because it is involved in bone turnover. A
mature cathepsin K consists of a single polypeptide chain of 215 residues.
Inhibitors of cathepsin K have been developed for the treatment of osteo-
porosis. A lot of effort has been spent at designing specific and efficient
inhibitors of cysteine peptidases in general, and most of them target the
active site of the enzymes.
In a very recent paper, Marko Novinec and colleagues showed that
cathepsin K fluctuates between multiple conformations that are differently
susceptible to macromolecular inhibitors and can be manipulated by vary-
ing the ionic strength of the medium[66]. Moreover, they found that gly-
cosaminoglycans, such as chondroitin sulfate and dermatan sulfate, which
are long unbranched negatively charged polysaccharides, are natural al-
losteric modifiers of cathepsin K in enzymatic assays performed with low-
molecular weight substrates such as short peptides.
2.3 Binding pocket definition
The goal of the project is to find an allosteric modifier of cathepsin K,
therefore the active site of the enzyme can not be targeted. The binding
pocket definition was carried out first by the statistical coupling analysis
(SCA) method and then independently confirmed by normal mode analysis
and principal component analysis.
2.3.1 SCA method
The putative allosteric binding pocket of cathepsin K was determined by Dr.
Marko Novinec analyzing the family of papain-like cysteine peptidases with
the SCA method, developed by Ranganathan and coworkers[57, 72, 36]. It
consists of the analysis of the sequence conservation of amino acids among
a protein family. Instead of analyzing the evolutionary conservation of a
single amino acid, they study pair-wise and even higher order coupling of
conserved amino acids, because protein structure and function also depend
on the cooperative action of amino acids. Indeed, such analyzes of correla-
tion have contributed to the confirmation and the identification of allosteric
mechanisms in proteins.
For example, Ranganathan and coworkers found a conserved networks of
residues connecting the binding site of a PDZ domain to a distant patch on
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Figure 2.1: Network of conserved residues in a PDZ domain.
The network of conserved residues connecting the binding site of the
PDZ domain to a distant patch found by SCA (left) and NMR (right).
Reproduced from [73].
the surface of the protein[57]. The same patch and the network of residues
was then found by a NMR comparison of the side-chains dynamics of the
same PDZ domain in the bound and unbound states[28]. The binding of
the polypeptide to the PDZ domain has an effect at a site which is distant
from the active site. Figure 2.1 shows the network of interacting residues
as found by SCA and NMR.
The principal outcome of the SCA performed by Dr. Marko Novinec
was a pathway of aminoacids connecting the active site of cathepsin K to
two distal sites on the protein surface (see figure 2.2). One site corresponds
to a small pocket and therefore was targeted for virtual screening studies,
hypothesizing that an interaction of a molecule with this site might have a
consequence on the active site.
The other site corresponds to the binding pocket of glycosaminoglycans,
natural allosteric effectors of cathepsin K. A structure of cathepsin K in
complex with chondroitin sulfate is available (PDB accession code: 3H7D)
but the enzyme surface where the polysaccharide binds was not used for
docking because it is shallow and its binding is driven by many salt bridges
between negatively charged sulfate and carboxy groups of disaccharide units
and lysine and arginine residues of cathepsin K (see figure 2.3). Interest-
ingly, this binding surface was also identified by SCA before the structure
was released.
2.3.2 Normal mode analysis
The vibrations of a molecule are determined by its normal modes and they
are calculated by normal mode analysis (NMA). As an example, the vibra-
43
2. Allosteric modifiers of Cathepsin K
Figure 2.2: Network of conserved residues of cathepsin K found
by SCA. The network of conserved residues is in yellow, the cysteine of
active site of the enzyme is in red.
Figure 2.3: Binding mode of glycosaminoglycans. The represen-
tation from the back is obtained by a 180 degrees rotation around the
axis of the α-helix which contains the cysteine of the active site. Chon-
droitin sulfate is in green and one allosteric effector found by docking is
in blue. The two polypeptide segments indicated in figure 2.7, namely
residues 55-70 and 85-105, are in magenta and cyan, respectively.
tions of a small linear molecule such as carbon dioxide are described by four
normal modes: the symmetric stretch, the asymmetric stretch, and the two
bends (see figure 2.4). The two bending modes, which differ only by their
direction, have the same energy. In general linear molecules have 3N-5 nor-
mal modes, where N is the number of atoms, and non-linear molecules have
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Figure 2.4: Normal modes of a linear molecule.
3N-6 normal modes. The normal modes of simple molecules can be used
for the interpretation of IR spectra because the simplest IR bands appear
from the normal modes of molecules.
The -5 and -6 subtractive terms for the calculation of the normal modes
are due to the fact that 5 modes for linear molecules and 6 modes for non-
linear molecules are trivial, that is they are pure only rotational or trans-
lational movements of the whole molecule and therefore they do change
the energy of the molecule. The classical treatment of molecular vibration
approximates each mode as a simple harmonic oscillator, that is that the
oscillation is subject to the Hooke's law (F=−kx). It is possible to extend
the calculation of the normal modes to big macromolecules such as biopoly-
mers, but it is necessary to employ an implicit solvent. The requirement
of the implicit solvent might therefore introduce a further approximation.
Moreover, the method is strongly depending on the force-field and the im-
plicit solvent, if any, used for the calculations and the results may vary for
different setups. Nevertheless, NMA is very useful for biological systems
and a very comprehensive review on the usage of normal modes analysis for
biomolecular systems is from Bahar and colleagues[2].
Importantly, low frequency normal modes are linked to long time scale
movements of macromolecules, such as loop motions and domain motions,
and therefore conformational changes involved in allostery can be predicted
by normal modes analysis because many allosteric proteins are constructed
from several subunits linked by hinges that can move relative to each other.
For example, the cumulative sum of the first 15 modes of Myosin V can
describe the 71% of the rigor to post-rigor transition in either directions[13].
The binding pocket found by the SCA method was also involved in the
first (lowest frequency) normal modes (see figure 2.5). To obtain a struc-
ture which is perturbed according to the direction of the normal modes,
normal modes have to be projected. In the projection of the two first
normal modes there is an almost rigid rotation of the two lobes of the pro-
tein (right and left lobe with respect to the α-helix where the cysteine of
the active site lies), so that the helix indicated by A in figure 2.5 occludes
the active site. The occlusion of the active site might have effects on sub-
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Figure 2.5: Projection of the first two normal modes of cathep-
sin K. The starting X-ray structure is in green and the structure ob-
tained by the projection of the first normal mode is in red. The active
site cysteine is in yellow CPK representation. In the first two normal
modes, the helix A occludes the active site of the protein. Green and
red beads show the Cα atoms of the binding pocket residues.
strate binding and therefore on the activity of the enzyme. Interestingly,
the movement of the helix A is coupled with the deformation of a polypep-
tide loop which is part of one of the two binding pockets identified by SCA.
Assuming that the harmonic approximation in the NMA holds, it can be
hypothesized that the interaction of a small drug-like molecule with the
protein in the surface of the exosite might influence the movement of the
aforementioned helix and therefore could have an effect on the activity of
the enzyme.
2.3.3 Principal component analysis
Principal component analysis (PCA), also called essential dynamics, is a
mathematical procedure that allows to separate essential motions from
non-essential ones of a molecular dynamics trajectory and therefore can
identify collective motions of the trajectory. It is based on the diagonaliza-
tion of the covariance matrix of the atomic fluctuations during a molecular
dynamics simulation. The covariance of the atomic fluctuation is calculated
with respect to an average structure obtained from the trajectory. A set
of eigenvalues and eigenvectors are generated by the the diagonalization
procedure. The eigenvectors describe the concerted motions of atoms in
the Cartesian space, and the eigenvalues are the amplitude of the motion.
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Figure 2.6: Projection of the first eigenvector of the PCA on
cathepsin K. The starting X-ray structure is in green and the structure
obtained by the projection of the first eigenvector is in red. The active
site cysteine is in yellow CPK representation. In the projection, the helix
A occludes the active site of the protein. Green and red beads show the
Cα atoms of the binding pocket residues.
The main hypothesis of PCA is that the motions of the atoms along eigen-
vectors with large eigenvalues are meaningful for describing the significant
motions of a protein. A new trajectory which describes the motion along
an eigenvector can be obtained by projecting the molecular dynamics tra-
jectory onto that eigenvector. Contrary to normal mode analysis, the PCA
method does require that the motions of the atoms are completely harmonic
because it is performed on MD trajectories. Second, the PCA method is
also model agnostic, because it does not require any other information
than the position of the atoms in the trajectory. However, a trajectory has
to be obtained from a system which is modeled with a particular force-field.
Explicit solvent MD simulations, which are more accurate than implicit sol-
vent ones, can be analyzed by PCA, but not by NMA.
PCA was applied on a 300 K 114-ns trajectory of an explicit water MD
simulation (data not shown) of the apo-structure of cathepsin K (started
from PDB structure 1ATK). The projection of the first eigenvector is very
similar to the outcome of the projection of the first two normal modes (see
figure 2.6).
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2.3.4 Comparison of the three methods
Three very different analysis methods identified the same surface of the
enzyme. This finding is remarkable, considering that very different approx-
imations are used: no structural information used in SCA, harmonic approx-
imation in NMA, and a possibly inadequate simulation sampling for PCA
(if the simulation time is too short for studying a particular phenomenon).
Importantly, the effect of the binding of a molecule to the exosite found
by the SCA method can not be predicted. Moreover, kinetic assays can
identify a binder only if the compound not only binds to the protein, but
also changes the reaction rate.
2.3.5 RMSF analysis
RMSF analysis allows the calculation of the macromolecule flexibility during
a MD simulation and B-Factor can be estimated from the RMSF values
(see section 1.9.4). Cα RMSF was calculated for the 114-ns explicit water
MD simulation on 55 short contiguous segments of the trajectory (2 ns
each, discarding the first and the last one) and compared with the B-Factor
extracted from the 1ATK PDB structure (see figure 2.7).
The calculated B-Factor of two polypeptide segments have a remarkable
difference with respect to the experimental values (residues 55-70 and 85-
105, colored in magenta and cyan in figure 2.3, respectively). In the 1ATK
crystal, where the asymmetric unit contains only one macromolecule, the
two aforementioned polypeptide segments are involved in crystal contacts
and therefore their lower experimental B-Factor could be an artifact. No-
tably, the exosite used for docking includes several residues of the 85-105
polypeptide segment (see the mainchain colored in cyan of figure 2.3). An
important caveat of this virtual screening procedure is that the conforma-
tions of the exosite present in solution could be very different from the one
of the X-ray structure, possibly similar to the projected structures of NMA
and PCA. Nevertheless, if the X-ray conformation is also present in solu-
tion, a small molecule could dock the protein in this particular exosite and
therefore stabilize the X-ray conformation.
2.3.6 RMSD analysis
RMSD analysis shows the conformational stability of the protein during the
MD simulation (see section 1.9.4). Cα RMSD was calculated for the 114-ns
explicit water MD simulation (see figure 2.8).
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Figure 2.7: B-Factor comparison plot of cathepsin K. The Cα B-
Factors extracted from the 1ATK PDB structure are in black, while the
calculated B-Factor from the MD simulation are in red. The B-Factors
calculated from the simulation are similar to the experimental ones. Only
two polypeptide segments (residues 55-70 and 85-105, colored in magenta
and cyan in figure 2.3, respectively) show a strong difference (higher B-
Factor) with respect to the experimental ones. The aforementioned two
segments are involved in crystal contacts and therefore their B-Factor
could be artificially lower.
2.4 Virtual Screening
For docking to the Cathepsin K, two different programs suites were used:
the in-house DAIM/SEED/FFLD (see section 1.7) and the commercial
FRED (OpenEye Scientific Software).
DAIM/SEED/FFLD
Default parameters were used for DAIM/SEED/FFLD, except for the di-
electric constant used in SEED was 2.0.
FRED
FRED is a software from OpenEye Scientific Software and is was shown
to be among the best docking programs in an exhaustive study of virtual
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Figure 2.8: Conformational stability of cathepsin K. Cathepsin
K is conformationally stable in the 114-ns MD simulation because the
RMSD is in a 1.82.0 Å range, with respect to the energy-minimized
conformation that entered in the simulation. If the two very flexible
polypeptide segments identified with RMSF analysis (see figure 2.7) are
not considered in the calculations, the RMSD decreases and is stable in
a 1.01.3 Å range.
screening[61]. FRED exhaustively and rigidly docks previously generated
ligand conformations into the active site of a protein. The ligand conforma-
tions are generated by OMEGA (OpenEye), which is very effective at repro-
ducing bioactive conformations, and partial charges assigned by QuacPac
(OpenEye). The docking is exhaustive, meaning that all the possible rigid
rotations and traslations of a conformer are tried. The main differences of
FRED with respect to the in-house procedure is that FRED considers the
ligands rigid during docking and the flexibility of the ligand is introduced
by pre-generating several conformations; moreover, FRED docks the entire
ligand and does not require at least three fragmens as FFLD.
Default parameters were used for docking: the exhaustive search is per-
formed with the scoring function ChemGauss3 (OpenEye) and all the poses
are then ranked by consensus scoring with three different empirical scor-
ing function: PLP[78], ChemGauss3 and OEchemscore (a slightly modified
version of ChemScore[22]).
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2.5 Preparation of the compound library
Given the small size of the putative binding pocket, a library of small
molecules was selected for docking. It is indeed ambitious to search for
low molecular weight binders, for they would very likely have a binding
constant in the µM to mM range.
The ZINC database[44] subset clean-fragments was downloaded from
the ZINC webpage1. This subset follows the so called rule of three[10]
(molecular weight less than 250 Da, five or less rotatable bonds, calculated
water/octanol partition coefficient less or equal to 2.5) and it is devoid of
reactive and not desirable compounds, such as halides, acid anhydrides,
peroxides, iso(thio)cyanates, sulphate esthers, nitrogroups, epoxides, N-O
and N-N bonds and Michael acceptors2.
CHARMm atom types[62] and partial charges were successfully assigned
to 153884 of 170968 compounds (86027 neutral and 84941 charged) of the
subset by the program Witnotp (A. Widmer, Novartis Pharma, unpub-
lished). The remaining 17084 compounds, for which Witnotp failed to as-
sign the atom types, were discarded for further calculations. A 10% failure
ratio for the atom type assignment is in the average of our docking projects.
Only 114425 compounds, that after fragmentation with DAIM had three or
more fragments, were docked with the in-house procedure.
A total of 39459 compounds, with less than three fragments, were clus-
tered for similarity with DAIM (leader algorithm) and the 1351 cluster rep-
resentatives were docked with SEED. Since SEED rigidly docks molecules to
the receptor, several different conformations were generated for every com-
pound by an ad hoc procedure, mainly built on the software CORINA3, to
provide some degrees of flexibility. CORINA is a commercial software that
generates 3D structures from a 2D representation in a automatic, reliable
and robust way. The procedure follows these steps:
• Ten conformers are generated by CORINA from SMILES representa-
tions
• The CORINA generated conformers are minimized and redundant
conformations are discarded (RMSD <= 0.5 Angstrom or GSEAL
3D similarity >= 0.95)
1http://zinc.docking.org
2The full list of the SMILES based rules for the definition of reactive compounds are
listed in http://blaster.docking.org/filtering/rules_yuck.txt
3http://www.molecular-networks.com
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• For every remaining conformer, ten additional conformers are gener-
ated by randomly changing torsional angles with the program obro-
tamer of the OpenBabel suite (http://openbabel.org)
• All the generated conformers are then minimized with the CHARMm
and the TAFF force field[15] and redundant poses discarded. The
minimization with two different force fields provides more variability
in the minimized conformations.
An average of 5.18±3.16 conformers were generated for the 1351 clus-
ter representatives mentioned above (minimum=1; maximum=15; mode=2;
median=4; 1st quartil=3; 3rd quartil=7).
2.5.1 Docking to the Cathepsin K
A total of 114425 molecules with three or more fragments were docked with
the classical SEED/FFLD procedure, while smaller molecules with less than
three fragments were docked with SEED only.
Docking with SEED only
The normal docking procedure discards the informations about the position
of all the fragments in favor of their geometrical centers, while the dock-
ing with SEED only keeps all the docked positions. For every one of the
1351 molecules docked by SEED, multiple conformers were docked and the
representatives of the five energetically most favorable clusters were mini-
mized with CHARMM and the CHARMm force field[62], using a dielectric
constant of 2r.
2.5.2 Scoring
A total of 14729 poses (i.e., about 11 poses per compound) were generated
by the docking with SEED only, and 1152983 poses (i.e., about 10 poses
per compound) were generated by SEED/FFLD.
Cut-offs
Prior to scoring, some cut-offs on van der Waals energy and Coulombic
energy were applied to weed out molecules which are unlikely to bind. The
value of the cut-offs was based on the mode of the energy distribution (see
figure 2.9), and poses with a van der Waals energy and a Coulombic energy
more favorable than -18 kcal/mole (-2 kcal/mole for the compounds docked
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Figure 2.9: Distribution of the binding energies. The red dashed
lines show the value of the cut-offs on van der Waals and Coulombic
energies.
with SEED only) and -4 kcal/mole (0 kcal/mole for the compounds docked
with SEED only), respectively, were kept. Additionally, only poses with
two or more hydrogen bonds to the receptor were considered for scoring.
The number of hydrogen bonds was calculated with CHARMM employing
a cut-off distance between the heavy atoms of the donor and the acceptor
of 2.6 Å and a cut-off angle (donorH· · · acceptor) of 90 degrees.
A set diagram showing the yield after applying the cut-offs is shown in
figure 2.10. A total of 36904 poses of the SEED/FFLD procedure and 1111
poses of the SEED only procedure survived all the cut-offs.
SEED/FFLD
The scoring of the docking with SEED/FFLD was based on the van der
Waals and coulombic interaction energies calculated by CHARMm after
minimization. A novel procedure was used for separating molecules before
scoring. Compounds were initially divided into two main groups, charged
and neutral molecules, and subsequently into several subgroups depending
on the number of rotatable bonds (from one to five) and charged molecules
were also divided into smaller groups depending on their net formal charge
(from plus one to plus three). The grouping were established to compare
molecules with similar properties like charge and rotatable bonds. It's im-
portant to notice that the number of rotatable bonds correlates with the
molecular weight (a molecule needs to be big to accommodate many rotat-
able bonds), but molecular weight was not considered for grouping because
it is a continuous variable and therefore any grouping division would have
been completely arbitrary. Moreover, the number of rotatable bonds intu-
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Figure 2.10: Only the 3% of the poses survives all cut-offs. The
plot refers to the cut-offs applied to the results of the SEED/FFLD cal-
culations. The surfaces of the sets (the cut-off on coulombic energy, van
der Waals energy and the number H-bonds made) and of the universal
set (all the minimized poses) are proportional to the number of poses,
while intersections are only approximatively proportional.
itively correlates with the entropy which is lost upon binding, therefore the
entropy loss contribution was implicitly taken into account by comparing
molecules with the same number of rotatable bonds. For every one of the
aforementioned groups, two descriptors were calculated: the total interac-
tion energy (defined as the sum of van der Waals and coulombic interaction
energies), and the ligand efficiency[39], computed as the total interaction
energy divided by the molecular weight. Poses in every group were ranked
according to the two descriptors and, for each applied descriptor, the most
favourable twenty poses and the most favourable twenty compounds were
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Figure 2.11: Docking acts like a filter. Docking applied to vir-
tual screening can be considered as a filter for weeding out compounds
which are unlikely to bind to the target. Applied to the Cathepsin K ex-
osite, docking allowed to discard 170879 compounds from a library and
retaining only 89 compounds, 11 of them experimentally tested.
visual inspected4. After visual inspection, 89 compounds were proposed for
buying.
4In some rankings, more than one pose per compound was present in the first twenty
positions.
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FRED
The scoring of FRED is by default a consensus scoring based on three differ-
ent scoring function: PLP[78], ChemGauss3 and OEchemscore (a slightly
modified version of [22]).
2.6 Experimental procedures
The activity of Cathepsin K in the presence or absence of 1 mM compound
was measured using the substrate Z-Phe-Arg-AMC (Bachem) at a final
concentration of 20 µM. All experiments were performed in 50 mM HEPES
buffer pH 7.4 containing 150 mM NaCl, 1 mM EDTA and 2.5 mM DTT at
25 oC. Reactions were started by adding the enzyme (final concentration 0.1
nM) into the reaction mixture containing all other components and reaction
progress monitored continuously at λexcitation 383 nm and λemission 455 nm
in an Aminco SPF-500 fluorimeter.
2.7 Results
A first virtual screening was performed with SEED/FFLD on a library of
114425 compounds and with SEED only on a library of 1318 compounds.
After scoring, 89 compounds were selected and 11 were experimentally
tested.
One of them (ZINC16955291, figure 2.12, left), a deoxythymidine analogue,
slightly activated Cathepsin K. Its binding mode showed one hydrogen bond
between an hydroxy group and the carboxy group of D94; and a second
hydrogen bond between the NH group the thymine and the carbonyl of
the backbone of M97 (see figure 2.14, left, and figure 2.13). Interestingly,
docking of the active compound with FRED showed a more reasonable al-
ternative binding mode (see figure 2.14, middle). This binding mode was
not obtained by SEED/FFLD (compare figure 2.14, left and middle, and
figure 2.13, right).
A substructure search in the previously used database was performed with
DAIM using a 2,6-dioxopiperidine scaffold (see figure 2.12) and yielded 716
compounds similar to the first binder. They were docked with FRED, which
was preferred to SEED/FFLD because it lacks the limitation of the three
fragments, and therefore it is more suitable for docking small molecules than
SEED/FFLD. A total of 55 poses were selected from the docking results,
6 were experimentally tested and all of them activated Cathepsin K. The
most active of them them was ZINC13282342 (see figure 2.12).
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2.8 Crystal contacts, ligand binding, and
cocrystallization
As mentioned in paragraph 2.3.5, the exosite is involved in crystal contacts
in the crystal structure 1ATK, where the asymmetric unit contains only one
monomer. Besides the aforementioned considerations on the existence of the
exosite in solution, a problem might arise if the cocrystal of Cathepsin K
and the second binder is obtained by soaking a previously obtained crystal
of Cathepsin K in a solution of the second binder. In fact, if the binding
surface of the exosite is buried by the other macromolecule in the crystal
contact, the binder would never be able to diffuse and bind to the exosite.
Fortunately the surface of the exosite is not completely buried and the
binder should be able to bind to it (see figure 2.16, right).
In the 3HD7 structure (Cathepsin K complexed by Glycosaminogly-
cans), where the asymmetric unit contains two monomers, a crystal con-
tact in the asymmetric unit is observed, involving the same exosite surface.
Also in this structure, the volume between the macromolecules is enough
to host the activator. Moreover, the aforementioned volume between the
two macromolecules is occupied by several crystallization waters.
Figure 2.12: Binders found through virtual screening. A first
binder (ZINC16955291, left) was found by docking with SEED/FFLD
(see figure 2.14, left). Redocking this compound with FRED produced an
alternative binding mode (see figure 2.14, middle). Docking with FRED
a subset of similar structures resulted in a second binder (ZINC13282342,
left and see figure 2.14, right).
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Figure 2.13: Poses of the first binder generated by FFLD and
effects of the minimization. The first binder (ZINC16955291, left)
was found by virtual screening with SEED/FFLD. Left. A total of 17
poses were generated. After minimization with CHARMM, the mini-
mized poses were compared for similarity and 3 of them were discarded,
because they fell in the same energy minimum of others and therefore
their coordinates were the same of other poses. Right. The pose of the
first binder, that has been accepted by visual inspection and proposed
for buying, generated by FFLD (red) and subsequently minimized by
CHARMM, is shown. The heavy-atom RMSD between the pose gen-
erated by FFLD and the minimized one is only 0.840 Å, therefore the
genetic algorithm of FFLD performed well at finding a conformational
and positional energy minimum.
2.9 Conclusions
Virtual screening targeting a putative allosteric pocket of Cathepsin K pro-
duced a series of compounds that bind the protein and behave as activators.
A preferred thymine scaffold was found and compounds derived from it also
activated Cathepsin K. The physiological role of nitrogenous bases and nu-
cleosides in the regolation of the activity of Cathepsin K and other cysteine
peptidases, such as Cathepsin B, V and L, is not known and has still to be
investigated. The determination of the X-ray structure of the complex be-
tween Cathepsin K and the second binder (ZINC13282342) is also planned.
A possible explanation for the activation of the enzyme by the two binders
is that the movements predicted by NMA and observed in the PCA, which
are thought to interfere with the active site conformation and therefore with
substrate binding, are hindered.
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Figure 2.14: Binding modes of the two binders. The first binder
(ZINC16955291, left) was found by virtual screening with SEED/FFLD.
Interestingly, redocking it with FRED proposed an alternative binding
mode (middle). Therefore a small subset of similar molecules was docked
with FRED and a second binder was found (ZINC13282342, right).
Figure 2.15: Progress curves. Progress curve of the first binder (left)
and of the second binder (right). The substrate used in kinetic measure-
ments is fluorogenic dipeptide which contains a quencher. Upon the
cleavage of the peptide bond, the quencher is released and fluorescence
is measured.
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Figure 2.16: The crystal contact does not completely bury the
exosite surface. The surface of the exosite is involved in crystal con-
tacts (left). The solvent accessible surface of the original protein is in
green and the one of the interaction partner obtained from the crystal
lattice is in red. Fortunately, the exosite surface is not completely buried,
therefore the binder (yellow surface) could diffuse and bind to it (right).
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Abstract
Most synthetic inhibitors of peptidases have been targeted to the active site for inhibiting catalysis through
reversible competition with the substrate or by covalent modification of catalytic groups. Cathepsin B is
unique among the cysteine peptidase for the presence of a flexible segment, known as the occluding loop,
which can block the primed subsites of the substrate binding cleft. With the occluding loop in the open
conformation cathepsin B acts as an endopeptidase, and it acts as an exopeptidase when the loop is closed.
We have targeted the occluding loop of human cathepsin B at its surface, outside the catalytic center, using a
high-throughput docking procedure. The aim was to identify inhibitors that would interact with the occluding
loop thereby modulating enzyme activity without the help of chemical warheads against catalytic residues.
From a large library of compounds, the in silico approach identified [2-[2-(2,4-dioxo-1,3-thiazolidin-3-
yl)ethylamino]-2-oxoethyl] 2-(furan-2-carbonylamino) acetate, which fulfills the working hypothesis. This
molecule possesses two distinct binding moieties and behaves as a reversible, double-headed competitive
inhibitor of cathepsin B by excluding synthetic and protein substrates from the active center. The kinetic
mechanism of inhibition suggests that the occluding loop is stabilized in its closed conformation, mainly by
hydrogen bonds with the inhibitor, thus decreasing endoproteolytic activity of the enzyme. Furthermore, the
dioxothiazolidine head of the compound sterically hinders binding of the C-terminal residue of substrates
resulting in inhibition of the exopeptidase activity of cathepsin B in a physiopathologically relevant pH range.
Keywords: cysteine peptidases; inhibition; enzyme kinetics; occluding loop; docking; endopeptidase;
exopeptidase
Supplemental material: see www.proteinscience.org
Cathepsin B, a cysteine peptidase of the papain family
(EC 3.4.22.1, identifier C01.060 in the Merops database)
(Rawlings et al. 2004), has been classically ranked among
the lysosomal enzymes and implicated in intracellular
protein digestion. Physiologically, cathepsin B is also
involved in antigen processing (Matsunaga et al. 1993), in
the activation of thyroglobulin, the precursor of thyroid
hormones (Friedrichs et al. 2003), and in the maturation
of beta-galactosidase (Okamura-Oho et al. 1997). From a
pathological point of view, cathepsin B activates trypsin-
ogen in hereditary pancreatitis (Kukor et al. 2002) and
participates in apoptosis (Bro¨ker et al. 2005), tumor pro-
gression and malignancy (Yan and Sloane 2003; Mohamed
and Sloane 2006), and rheumatic diseases (Lenarcic et al.
1988; Baici et al. 1995a,b). Particular extralysosomal
functions of cathepsin B are due to altered expression at
the gene level and/or atypical trafficking (Mu¨ntener et al.
2003, 2004; Zwicky et al. 2003; Baici et al. 2006).
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Cathepsin B is capable of endopeptidase (Mort 2004),
peptidyl-dipeptidase (Aronson Jr. and Barrett 1978; Bond
and Barrett 1980), and carboxypeptidase activities (Takahashi
et al. 1986; Rowan et al. 1993). Among the cysteine pep-
tidases, it owns a unique structural element, called an
occluding loop, which comprises residues Ile105–Pro126
(Fig. 1; Musil et al. 1991). At low pH, two salt bridges,
His110–Asp22 and Arg116–Asp224, hold the loop in a closed
position over the primed subsites of the substrate binding
cleft, thus preventing extended binding of polypeptides and
endoproteolytic activity. The closed conformation, through
the engagement of His111 in a hydrogen bond with the C-
terminal carboxylate of the substrate and the loose specificity
in P29, is responsible for the peptidyl-dipeptidase activity of
cathepsin B (Illy et al. 1997; Quraishi et al. 1999; Krupa et al.
2002). As mutations of the amino acids His110 and Asp22 have
shown, removal of the salt bridges induces endopeptidase
activity, attributed to increased flexibility of the loop (Na¨gler
et al. 1997). This concept agrees with higher endopeptidase
activity and with the competition between the occluding loop
and the propeptide following deprotonation of His110 chang-
ing the pH from 4.0 to 6.0 (Quraishi et al. 1999). The
flexibility of the loop was further demonstrated by the fact
that cystatins A and C were able to displace the loop
(Nycander et al. 1998; Pavlova et al. 2000), and deletion of
residues 108–119 abolished the exopeptidase activity of
cathepsin B (Illy et al. 1997).
A large number of synthetic compounds behave as
inhibitors of cathepsin B. Most of them are either
reversible or irreversible competitive inhibitors acting
‘‘inside the active center’’ (Otto and Schirmeister 1997;
Michaud and Gour 1998; Frlan and Gobec 2006). The
practical use of these inhibitors is in most cases difficult
for reasons analyzed elsewhere (Baici 1998). In the
present study we target cathepsin B ‘‘from the outside,’’
i.e., at the surface of the molecule excluding any direct
interference with catalysis. Our strategy aims at proving
the concept that latching the occluding loop in its closed
conformation may possibly hinder the endo- and/or
exopeptidase activities of the enzyme. The approach
consists of computational analysis by docking a large
number of compounds to the surface of cathepsin B in the
occluding loop region. From 40 compounds matching the
working hypothesis, 29 are commercially available and
one of them inhibits at low micromolar concentration the
endo- and exoproteolytic activities of cathepsin B. We
analyze the kinetic mechanism of inhibition, from which
we propose a model for the interaction between the
compound and the enzyme.
Results
Kinetic mechanism of inhibition with synthetic substrates
Z-RRYAMC and Abz-GIVRYAK(Dnp)-OH were used as
substrates for monitoring the endo- and exoproteolytic
activity of cathepsin B, respectively. Arrows in the
substrate acronyms indicate the scissile bonds. Forty of
47,878 compounds screened in the docking approach
were selected as candidate binders of human cathepsin
B. Twenty-nine of them were commercially available and
were tested as modifiers of enzyme activity, and one of
them, DOFA (Fig. 2), behaved as a true inhibitor. Two
compounds out of 29 were scarcely soluble in DMSO
(Zinc-2005 codes 1271923 and 2990182; Supplemental
Table 1). Five of them were soluble in DMSO but were
prone to aggregation under the assay conditions for
cathepsin B giving rise to modest and inconsistent
inhibition between different assays. We considered these
five compounds (958753, 1837733, 1871954, 3247330,
and 1581881) as promiscuous inhibitors (Shoichet 2006).
None of the compounds tested was a covalent inactivator
of cathepsin B. DOFA did not inhibit human cathepsin L,
and papain was only partially inhibited at millimolar con-
centrations (assays with Z-FRYAMC; data not shown). A
Figure 1. The occluding loop of human cathepsin B. (A) Closed
conformation (red) in the mature enzyme (Musil et al. 1991), where a
hydrogen bond is made between His110 and Asp22. The conformation seen
in procathepsin B with the occluding loop lifted (green) to accommodate
the propeptide, which is not shown for clarity (Turk et al. 1996). Image
generated with PyMOL software (http://www.pymol.org). (B) Scheme of
the occluding loop with hydrogen bonds present in the closed confor-
mation. The symbol Glyc attached to Asn113 indicates the N-linked
oligosaccharide.
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previous report of high-throughput screening classified
DOFA inactive against cathepsin B (http://pubchem.ncbi.
nlm.nih.gov/, CID 2078629, AID 453). Reasons can be
sought in either too strict criteria or in the occasional failure
of high-throughput screening methods in detecting hits
(Buxser and Vroegop 2005). DOFA behaved as a reversible
inhibitor of cathepsin B and manifested neither tight-binding
nor slow-binding inhibition behavior. Reaction traces
were linear from the very beginning of the reaction, i.e.,
from 3–4 ms onward, as measured with a stopped-flow
apparatus. Therefore, initial velocities at variable sub-
strate and modifier concentrations were treated as steady-
state rates. In control experiments we checked the possi-
bility that any inhibitory effect of DOFA was not due to
aggregation of the compound. For this purpose 0.01%
Triton X-100 was added to buffers and the DTT concen-
tration was increased to 5 mM. In comparison with buffer
not containing detergent and with DTT ¼ 2 mM, the basal
activity of cathepsin B was higher by ;40%. However,
inhibition profiles for increasing DOFA concentration,
percentages of inhibition, and inhibition constants were
the same.
The kinetic results in this study refer to those obtained
with the enzyme purified from human liver. Nevertheless,
we confirmed inhibition mechanisms and kinetic param-
eters also with recombinant cathepsin B. The reason was
to ascertain any influence of glycosylation at N113, which
is located at the tip of the occluding loop, on the binding
of potential inhibitors. Both kinetic and modeling results
discussed below suggest that N113 glycosylation possibly
occurring in the wild-type enzyme does not affect
inhibition of cathepsin B by DOFA.
The kinetic mechanism was analyzed by a combination
of graphical and regression methods to discriminate
between models of enzyme–modifier interaction (Fig. 3).
With the Abz-GIVRYAK(Dnp)-OH exoproteolytic sub-
strate at pH 4.5, the best fitting model for cathepsin B
inhibition by DOFA was linear competitive inhibition with
I90/10¼ 81 andKi¼ 6.7mM (Fig. 4A). The specific velocity
plot, typical for this mechanism, is shown in the inset of
Figure 4A. With this substrate, data at pH 6.0 could not be
obtained because of its scarce solubility. DOFA inhibited
the endoproteolytic cathepsin B activity (Z-RRYAMC
as substrate) at pH 4.5 and 6.0. The specific velocity plot
(not shown) established the linear nature of the inhibition
Figure 2. Structure of the inhibitor. The IUPAC name of the compound is
[2-[2-(2,4-dioxo-1,3-thiazolidin-3-yl)ethylamino]-2-oxoethyl] 2-(furan-2-
carbonylamino)acetate (abbreviated DOFA; Zinc-2005 code: 2616818).
Numbering and lettering used as aid for the description in the main text.
Figure 3. Kinetic models for the inhibition of cathepsin B. vi and v0 represent reaction rates in the presence and in the absence of
inhibitor, respectively. s ¼ [S]/Km; I90/10 ¼ ratio of the inhibitor concentrations, which give 90% and 10% inhibition. The double-
headed inhibitor possesses two distinct binding moieties that sequentially bind the enzyme.
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process, i.e., enzyme activity was driven to zero at saturat-
ing inhibitor concentration, and diagnosed competitive-
type inhibition. However, the specific velocity plot would
not be able to discriminate between Models 1–3 in Figure 3.
The activity profiles obtained at a fixed substrate concen-
tration and variable inhibitor concentrations revealed the
I90/10 ratio to be less than 81, which can be estimated by
inspection to be around 60 at pH 4.5 and around 40 at pH 6.0
(Fig. 4B). This suggests that the inhibition mechanism was
not of the classical competitive type, for which I90/10 ¼ 81
(Model 1 in Fig. 3). On the other hand, Models 2 and 3 in the
same figure predict I90/10 values less than 81. For discrim-
inating between models with Z-RRYAMC as substrate, we
set its concentration equal to Km so that s¼ [S]/Km ¼ 1 in
the activity profiles in Figure 4B (thereby it was imperative
to carefully measure the substrate concentration and Km).
In Models 2 and 3, when the factor a ¼ 1, I90/10 depends
only on s, whereas for a 6¼ 1 the I90/10 ratio depends both on
a and s (Fig. 5A,B). Model 2 was ruled out as redundant,
and Model 3 was preferred on the basis of the following
quantitative and logical observations. In Model 2, two
inhibitor molecules should bind to different places at the
surface of the cathepsin B molecule with almost the same
affinity, i.e., with the a value between 1 and 2, as shown in
Figure 5A. The double-headed competitive inhibitor
(Model 3 in Fig. 3) was superior also on the basis of the
following quantitative observations. For Model 3, the
squared symbol with dashed arrows in Figure 5B indicates
the best-fit value for a ¼ 6 at pH 6.0, which corresponds to
I90/10¼ 37 andKi¼ 11.3mM (Fig. 4B). Similarly, at pH 4.5,
Model 3, with a ¼ 34 (the black circle in Fig. 5B), I90/10 ¼
59, and Ki ¼ 4.8 mM, produced a better fit to experimental
data (Fig. 4B) than Model 2.
Inhibition of endo- and exoproteolysis
using protein substrates
While low molecular mass oligopeptides are indispens-
able tools for determining inhibition mechanisms, they do
not represent typical substrates for evaluating true endo-
and exoproteolytic activities. Therefore, inhibition of
cathepsin B endo- and exoproteolysis by DOFAwas further
Figure 4. Inhibition profiles of human cathepsin B by DOFA. Main
conditions and best-fit kinetic parameters are shown. (A) Inhibition profile
using the FRET substrate Abz-GIVRYAK(Dnp)-OH (pH 4.5), [S] ¼ Km ¼
9.7 mM; data were obtained fluorimetrically with lex/lem at 320/420 nm.
The inset shows the specific velocity plot at four substrate and four
inhibitor concentrations. (B) Inhibition profiles with Z-RRYAMC as
substrate; [S] ¼ Km ¼ 0.47 mM at pH 6.0 (black circles) and [S] ¼ Km ¼
1.54 mM at pH 4.5 (black squares). Data at pH 6.0 were collected
photometrically at 360 nm and those at pH 4.5 were obtained fluorimetrically
with lex/lem at 383/455 nm. Fluorescence readings in A and B were
corrected for the inner filter effect.
Figure 5. Ratios of inhibitor concentrations that give 90% and 10%
inhibition. For Models 2 and 3 in Figure 3 the I90/10 ratio depends on a and
s ¼ [S]/Km. Curves were generated with Equations 4 and 6 shown in
Figure 3. (A) Curves for Model 2; (B) curves for Model 3. The black
squares in panels A and B correspond to the best-fit value of the coefficient
a, which coincides with the value obtained by inspection of the inhibition
profiles at pH 6.0 in Figure 4B. The black circle in panel B shows the best-
fit value of the coefficient a (34), close to the value obtained by inspection
of the inhibition profiles at pH 4.5 in Figure 4B.
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investigated with two protein substrates: rabbit muscle
aldolase and the oxidized b-chain of bovine insulin.
Peptide-bond hydrolysis on both proteins at pH 6.0 was
inhibited in a concentration-dependent manner by DOFA
(Fig. 6) and was almost complete at saturating inhibitor
concentration. As commonly observed when switching
from oligopeptide to polypeptide substrates, the modifier
concentrations needed for achieving inhibition were higher.
Cathepsin B has been previously reported to sequentially
remove up to nine dipeptide units from the C terminus of
aldolase with peptidyl-dipeptidase activity (Bond and
Barrett 1980). Aldolase incubated with cathepsin B in the
presence or absence of DOFA was subjected to SDS-PAGE
under reducing conditions. The bands excised after electro-
phoretic separation were N-terminally sequenced and the
masses of the polypeptides determined by mass spectrom-
etry. The SDS gels shown in Figure 7 were purposely over-
loaded to reveal the less prominent bands numbered 2, 3, and 4.
The N-terminal sequence of the polypeptides in bands 1 and 2
was PHSHPAL, which corresponds to positions 2–8 of
aldolase. Mass analysis of the whole broad band 1 revealed
the presence, besides intact aldolase with amino acids 2–364
and a mass of 39,216 Da, C-terminally degraded fragments
corresponding to sequences 2–362, 2–360, and other masses
down to 2–352 that were generated by the sequential removal
of six dipeptide units from the C terminus. The significant
presence of the 2–351 peptide indicates that aldolase degra-
dation also comprises carboxypeptidase activity of cathepsin
B. The tiny band 2 contained the polypeptide 2–347, which
was the smallest fragment obtained under the described
conditions and corresponded to the removal of 17 amino
acids from the C terminus, i.e., 8 dipeptide units (peptidyl–
dipeptidase activity) plus one amino acid (carboxypeptidase
activity). Bands 3 and 4 had the common N terminus
SIGTENT (positions 46–52), suggesting their generation
by a minor (but very useful for the purposes of this test)
endoproteolytic cleavage between Gln45 and Ser46. Band 3
corresponded to the 46–364 sequence and band 4 corre-
sponded to sequence 46–347. Comparison of the relative
intensities of bands 3 and 4 in lanes B and C (Fig. 7) suggests
that DOFA inhibited the exopeptidase activity of cathepsin B
on the macromolecular substrate aldolase, while the inhibitor
was less or not active against the endoproteolytic activity of
cathepsin B, as shown by the persistence of band 3 in lane C.
The bovine insulin b-chain is a helpful substrate for
exploring the specificity of peptide-bond cleavage by
peptidases, including human cathepsin B (McKay et al.
1983). The cleavage at multiple sites of the insulin b-chain
by cathepsin B was almost completely inhibited by a sat-
urating concentration of DOFA at pH 6.0 (Fig. 6). Samples
of insulin b-chain incubated with cathepsin B in the
presence and absence of DOFA were separated by liquid
chromatography, and the eluted peaks were analyzed by
mass spectrometry. We confirmed most of the cathepsin B
cleavages previously described (McKay et al. 1983). Addi-
tional cleavages, which depended on the incubation time
and the relative enzyme to substrate concentrations, were
identified. Each of the chromatographic peaks in Figure 8
contained only one (e.g., peptides 1–13, 1–14, and 6–28) or
more proteolytic fragments (e.g., peptides 20–30 plus 1–
11). Only a few of them will be discussed to demonstrate
the inhibitory activity of DOFA. The generation of peptides
1–11 and 20–30 by endoproteolysis was inhibited by
Figure 6. Inhibition of cleavage of rabbit muscle fructose 1,6-bisphos-
phate aldolase and of the bovine insulin b-chain by cathepsin B.
Concentration-dependent inhibition by DOFA at pH 6.0. Released peptides
were quantified fluorimetrically by the fluorescamine method.
Figure 7. Proteolysis of rabbit muscle fructose 1,6-bisphosphate aldolase
by cathepsin B. Aldolase was incubated 4 h at 25°C with cathepsin B at pH
6.0, and products were separated by SDS-PAGE. (Lane A) Aldolase alone
run in parallel as control; (lane B) aldolase plus cathepsin B; (lane C)
aldolase with cathepsin B and DOFA. The N- and C-terminal parts of the
rabbit aldolase sequence, with numbered amino acid residues, are shown at
the top of the figure. Thin arrows indicate sequential peptidyl-dipeptidase
cleavages by cathepsin B. The two open thick arrows show carboxypepti-
dase cleavages. The black thick arrow indicates a minor endoproteolytic
attack site. Numbers on the left side indicate the molecular masses of
markers in kilodaltons. Numbers 1–4 with long pointing arrows are
assigned to the bands for referencing in the main text, and the peptides
identified within the bands are shown next to the band numbers. Peptides
were identified in the excised bands by N-terminal sequencing and
MALDI analysis.
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DOFA. Fragment 1–13 was a product of carboxypeptidase
activity on peptide 1–14: While DOFA completely
inhibited this exoproteolytic event, endoproteolytic cleav-
age between residues 14 and 15 was unaffected, as shown
by comparing the chromatographic profiles in the absence
(Fig. 8, profile A) and in the presence of DOFA (Fig. 8,
profile B). Fragment 18–29, generated by endoproteolysis
at position 17–18 and exoproteolysis at position 29–30, was
strongly decreased in the presence of DOFA. Comparison
of the areas of fragments 18–29 and 18–30 after inhibition
shows that both the exo- and the endoproteolytic events
concerned with them were affected by the inhibitor. Carboxy-
peptidase activity inhibition is also shown by comparing the
disappearance of fragment 16–29 and the appearance of
fragment 16–30. Finally, the peptidyl–dipeptidase cleavage
shown by fragment 6–28 disappeared in the presence of
DOFA. Since the 6–30 peptide in Figure 8, profile B could
not be unambiguously assigned, inhibition could be as-
cribed to endoproteolytic cleavage at positions 5–6, peptidyl–
dipeptidase inhibition at position 28–29, or both.
Discussion
The docking approach used in this study aimed at
identifying compounds that bind to the occluding loop
of human cathepsin B and thereby modulate its enzymatic
activity. Considering that no other means are available for
selecting small molecules for a rather flexible protein
segment, the most diverse compound library was used.
There is a fundamental difference between our method-
ology and previous approaches to inhibitors that might
interact with parts of the occluding loop of cathepsin B
(Murata et al. 1991; Michaud and Gour 1998; Cathers
et al. 2002). These studies exploited the properties of the
fungal inhibitor E-64 (Hanada et al. 1978) and the crystal
structure of cathepsin B (Musil et al. 1991). New
inhibitors, such as CA-074, were designed by modifica-
tion of the E-64 structure to create interactions with the
primed sites of the substrate binding cleft and thus with
the occluding loop (Murata et al. 1991). In this approach
the epoxy moiety of the modifiers acted as a warhead
against the active site cysteine to produce potent irrever-
sible inhibition (Matsumoto et al. 1999). Conversely, we
did not target the active site, and the molecules selected
by docking were devoid of chemically active warheads.
The finding of only one active compound out of 29
substances is in line with previous studies, which showed
that candidate inhibitors predicted by docking algorithms
are not necessarily active in vitro (Huang et al. 2005).
In agreement with published data (Illy et al. 1997; Na¨gler
et al. 1997; Quraishi et al. 1999; Krupa et al. 2002) our
results support the notion that the occluding loop of cathepsin
B is a highly flexible segment. Short episodes of opening and
closing govern endo- and exoproteolysis, which thus occur
intermittently in the pH range 4.5–6.0. The compound
identified by docking, DOFA, behaves as a reversible
competitive inhibitor of the exo- and endopeptidase activ-
ities of cathepsin B with no involvement of a substrate-like
binding mode in the active center of the enzyme. It can
inhibit endoproteolysis most likely by forcing the loop in the
closed conformation, and exoproteolysis by disturbing the
accommodation of the C terminus of polypeptides in the
primed side of the binding cleft. Docking calculations suggest
that the dioxothiazolidine moiety of DOFA is located in the
binding pocket of the side chain of the substrate C-terminal
residue when the loop is closed. It makes a hydrogen bond with
Nd1 of His110 and sterically hinders substrate binding for
exoproteolytic activity (Fig. 9A,B). In this figure, the struc-
tures of DOFA and the four amino acids VRAK, which are part
of the FRET substrate used for measuring exoproteolytic
activity, were modeled on the known structure of human
cathepsin B merely to show their spatial relationship. In fact,
such a ternary ESI complex does not exist according to the
kinetic mechanism; only the ES and EI complexes exist. This
structural arrangement is consistent with the kinetic mecha-
nism of inhibition: At pH 4.5 the exoproteolytic activity of
cathepsin B is inhibited in a linear competitive manner by
virtue of the dioxothiazolidine ring. Docking suggests that
DOFA binds at the surface of the occluding loop and is
involved in three hydrogen bonds with the enzyme (Fig. 9A).
Of particular interest is that the carbonyl oxygen involved in a
hydrogen bond with the amide of His111 occupies the place of
the oxygen of a conserved water molecule present in the crystal
structures of human cathepsin B. This position is shown as a
red sphere in Figure 9B. Together with the favorable van der
Waals interactions, three hydrogen bonds stabilize the loop in
Figure 8. Proteolysis of the bovine insulin b-chain by cathepsin B.
Incubation at pH 5.5 and 25°C in the absence (A) and in the presence
(B) of DOFA. Peptides released by enzymatic digestion were characterized
by LC/MALDI/MS. The sequence at the top of the figure shows the
sequence of bovine insulin, b-chain with amino acid numbering. Boxed
numbers, e.g., 6–28, indicate peptides released by the endo- and exopro-
teolytic action of cathepsin B.
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the closed conformation (Fig. 9B). These structural properties
are reflected in the kinetic mechanism observed with Z-
RRYAMC. Despite not being a complete model for endopro-
teolysis, the dipeptide is unquestionably cleaved by cathepsin
B in the endo-, not in the exoproteolytic mode. The double-
headed competitive kinetic mechanism diagnosed for DOFA
on Z-RRYAMC, and the changes in the kinetic parameters
observed when going from pH 4.5 to 6.0, insinuate cooperation
between the furan and the dioxothiazolidine moieties. Kinetic
measurements alone would be unable to identify which
element makes the stronger contribution to binding energy.
However, with the support of structural information from
modeling discussed above, we suggest that the dioxothiazoli-
dine moiety takes the leader function. In the double-headed
mechanism at pH 4.5, theKi value of 4.8mM is thus ascribed
to the dioxothiazolidine part of the molecule and Ki  160
mM to the furan part (factor a ¼ 34 in Model 3, Fig. 3). The
increase of pH to 6.0 disfavors theKi of the dioxothiazolidine
portion, which becomes 11.3 mM and favors binding of the
furan moiety, decreasing its Ki to 68 mM.
The measurements with protein substrates, aldolase and
the insulin b-chain, confirm the results just discussed with
synthetic substrates, as well as the previously recorded
ability of cathepsin B to exert peptidyl–dipeptidase and
carboxypeptidase activity in the pH range 5.5–6.0 (Mort
et al. 1998). While efficiently inhibiting these two exopro-
teolytic activities, DOFA was not able to inhibit all endo-
proteolytic events. For instance, the minor endoproteolytic
action at position 45–46 of rabbit muscle aldolase was only
moderately or not affected by DOFA, as was not position
14–15 of the insulin b-chain. Yet, other endoproteolytic
attacks on the insulin b-chain were efficiently inhibited.
The pooled experimental evidence from the above
described properties of DOFA inhibition strengthens the
notion that not only pH dependent, intermittent closing
and opening of the occluding loop, but also substrate
structure determine together the susceptibility of partic-
ular peptide bonds. The binding affinity of DOFA is
possibly not high enough to compete with a substrate, which
optimally binds at both unprimed and primed sites. It appears
that the occluding loop of cathepsin B can be assisted in
assuming its closed or open conformation by particular
polypeptides with an induced fit mechanism that promotes
either exo- or endoproteolysis. This observation forms the
basis of cathepsin B inhibition by its own propeptide
(Quraishi et al. 1999) and its resistance to cystatin A and
C inhibition (Nycander et al. 1998; Pavlova et al. 2000).
The above results draw attention to the physiopatho-
logical role of cathepsin B, which exerts its action in a
relatively broad range of pH values, with exoproteolysis
in the range 5–6 and endoproteolysis in the range 5–7.4.
The pH in early endosomes is ;6.2 and drops to 5.0–5.5
in late endosomes and lysosomes (Gu and Gruenberg 2000).
Extracellularly, the pH can vary from relatively acidic, e.g.,
at the periphery of solid tumors (Rofstad et al. 2006), to 7.4
in blood. Contrary to commonplace textbook information,
proteolysis within phagolysosomes does not quite occur in a
very acidic environment. For instance, 5 min after initiation of
Figure 9. Stereoview of inhibitor and substrate within the structure of
human cathepsin B. (A) The protein surface is shown with the occluding
loop in red, His110 and His111 in orange, and the catalytic Cys29 in yellow.
The substrate (carbon atoms in purple) is shown as residues VRYAK,
which is part of the FRET substrate used in this study to monitor peptidyl–
dipeptidase activity. The Dnp group, which is exposed to the solvent, was
omitted for clarity. The pose of DOFA obtained by docking (carbon atoms
in gray) is visible in the upper part with the furan moiety in the occluding
loop and the dioxothiazolidine ring sterically interfering with the lysine side
chain of the substrate. (B) Details of the presumed interactions between
DOFA and cathepsin B residues (carbon atoms in green). The inhibitor
makes three hydrogen bonds with residues of the occluding loop: carbonyl
group labeled ‘‘a’’ in Figure 2 with amide nitrogen of Cys119, carbonyl
group labeled ‘‘b’’ in Figure 2 with amide nitrogen of His111, and 2-oxo
group of the dioxothiazolidine ring with Nd1 of His110. The hydrogen
bonds of the occluding loop in the closed conformation, His110–Asp22 and
His111 with the C-terminal carbonyl of the substrate, are also shown. The
red sphere indicates the position of a water molecule in the cathepsin B
crystal structure. Images generated with PyMOL software (see Fig. 1).
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phagocytosis in human polymorphonuclear leukocytes, the
relatively acidic milieu of the lysosomes (pH 5) increases in
the phagocytic vacuoles to a value of 7.8. It falls then to 7.4
after 15 min, to 6.4 after 30 min, and 5.7 after 60 min (rounded
values from Cech and Lehrer [1984]). Various hydrolases are
expected to find their optimal conditions of action during this
forth and back excursion of pH (Baici et al. 1996).
It has been suggested that ‘‘targeting of the occluding loop
of cathepsin B may be a poor inhibitor design strategy if the
enzyme environment has a pH greater than 5.5’’ (Cathers
et al. 2002). This statement refers to the above discussed
approach ‘‘from inside.’’ Since endo- and exoproteolysis
by cathepsin B occurs in the physiologically and patholog-
ically relevant pH range of 5–6, our approach of targeting
the occluding loop from the enzyme surface may represent
an alternative starting point for the development of clin-
ically active compounds.
Materials and Methods
Materials and general methods
Recombinant human cathepsin B was prepared from Escherichia
coli inclusion bodies (Kuhelj et al. 1995). Wild-type cathepsin B
from human liver was obtained from Calbiochem. The synthetic
substrates Z-FRYAMC2 and Z-RRYAMC were purchased from
Bachem and the internally quenched fluorogenic substrate Abz-
GIVRYAK(Dnp)OH from Merck. Rabbit muscle fructose-1,6-
bisphosphate aldolase (EC 4.1.2.13) and fluorescamine were from
Sigma-Aldrich Chemie and the oxidized bovine insulin b-chain
from Serva Feinbiochemica. The putative binders/modifiers of
cathepsin B activity determined by docking analysis and their
sources are listed in Supplemental Table 1. The compound studied
in detail, [2-[2-(2,4-dioxo-1,3-thiazolidin-3-yl)ethylamino]-2-
oxoethyl] 2-(furan-2-carbonylamino)acetate (IUPAC name, here
abbreviated DOFA; Fig. 2), Zinc-2005 code 2616818 (Irwin and
Shoichet 2005) was obtained from Enamine. The compounds were
dissolved as concentrated stock solutions in dimethyl sulphoxide,
stored at 4°C, and diluted into the appropriate buffer at the
moment of the assay. Photometric measurements were carried out
with a Cary50 UV-visible spectrophotometer, and fluorescence
was measured with an Aminco SPF-500 fluorimeter operating in
the ratio mode. Reversed phase HPLC was performed in a Hewlett
Packard Series 1100 apparatus with a Nucleosil 120-5 C18
column (4.0 3 250 mm). Matrix-assisted laser desorption/ioniza-
tion mass spectrometry (MALDI-MS) and liquid chromatography
followed by mass analysis, LC-MALDI/MS, was performed at the
Functional Genomics Center in Zurich.
Docking
The A and B chains of the human cathepsin B structure, entry
1HUC in the Brookhaven database, were considered and all
water molecules were removed. Hydrogens were added to side
chains and termini of the protein to simulate conditions at pH 6–
7. Cys29 was in the reduced form, and His110 was protonated at
both imidazole nitrogen atoms. CHARMm atom types and force
field parameters were assigned and used for both protein and
ligands (Momany and Rone 1992), and hydrogens were mini-
mized with the program CHARMM (Brooks et al. 1983). The
search for a putative binding site focused on the occluding loop
of the enzyme, for which no inhibitor has been reported to date.
A benzene molecule was used as a probe with the program
SEED (Solvation Energy for Exhaustive Docking) to identify
possible binding pockets whose main interaction component is
supposed to be hydrophobicity (Majeux et al. 1999). The surface
tested by SEED consists of cathepsin B residues within a 9 A˚
distance from His110, which locks the occluding loop in a closed
position. The benzenes with the most favorable free energy of
binding, excluding those in the catalytic site, were used to
define the binding site for docking, which included all the 42
residues of the protein that had >50% of their atoms within 5 A˚
from the optimal poses of benzenes.
About 3 million compounds in the ZINC 2005 library (Irwin
and Shoichet 2005) were clustered using a 17-field fingerprint
by Decomposition and Identification of Molecules (Kolb and
Caflisch 2006). Molecules with more than nine rotatable bonds
were neglected. The resulting 48,026 cluster representatives
were docked as in previous in silico campaigns (Huang et al.
2005, 2006; Kolb et al. 2008). For each molecule docked by the
program FFLD (Fragment-based Flexible Ligand Docking)
(Budin et al. 2001; Cecchini et al. 2004), the 300 most favorable
poses were clustered with the leader algorithm yielding 764,776
poses (;17 poses per compound, 44,527 compounds). The
cluster representatives were minimized in the rigid protein using
CHARMM.
It is necessary to weed out unlikely poses to prevent a high
number of false positives (Kolb et al. 2008). Suitable filters are
cutoffs in the total van der Waals interaction energy and in the
van der Waals efficiency (defined as the ratio between van der
Waals energy and molecular mass). A cutoff of 30 kcal/mol
for intermolecular van der Waals energy was selected by
plotting a histogram of the van der Waals energies (Supplemen-
tal Fig. 1). Analogously, a cutoff of 0.09 kcal/g was chosen for
the van der Waals efficiency (Supplemental Fig. 2). A total of
106,502 poses of 10,709 compounds survived both filters. Poses
closer than 4 A˚ to Cys29 of the catalytic site and those with no
hydrogen bond to the protein were neglected, yielding 25,178
remaining poses (5678 compounds).
The electrostatic contribution to the binding free energy was
evaluated by the finite difference Poisson approach (module
PBEQ of CHARMM) (Im et al. 1998). Poses were ranked for
visual inspection according to most favorable van der Waals
energy, van der Waals efficiency, electrostatics, and sum of van
der Waals and electrostatic energy. Poses with high ranking in
two lists or more were selected and visually inspected. Forty
poses belonging to 40 different compounds were selected in this
way. According to the predicted binding modes, three regions of
the protein were exploited for binding: one on the occluding
loop and one each on immediately adjacent regions. Twenty-
nine out of the 40 candidate compounds were commercially
available.
Kinetics
The peptide Z-RRYAMC with 7-amino-4-methlycoumarin
(AMC) as leaving group is a handy substrate for measuring
the endopeptidase activity of cathepsin B (Barrett 1980), in
which the two arginine residues correspond to the P1 and P2
positions (Schechter and Berger 1967). We preferred this
substrate over Z-FRYAMC for its slower hydrolysis that allowed
long measuring times with low substrate consumption. The buffer
for measurements at pH 6.00 was 50 mM sodium phosphate
Schenker et al.
2152 Protein Science, vol. 17
JOBNAME: PROSCI 17#12 2008 PAGE: 8 OUTPUT: Sunday November 2 03:24:39 2008
csh/PROSCI/170217/ps037341
 Cold Spring Harbor Laboratory Press on November 21, 2008 - Published by www.proteinscience.orgDownloaded from 
containing 2 mM EDTA and 2 mM dithiothreitol (DTT), hereafter
referred to as pH 6.0 buffer. For measurements at pH 4.50, 0.1 M
sodium acetate, 0.2 M NaCl, 2 mM EDTA, and 2.5 mM DTT were
used (hereafter referred to as pH 4.5 buffer). In control experi-
ments aimed at ascertaining any aggregation phenomena on the
part of the putative inhibitors, the DTT concentration was
increased to 5 mM and the buffer included 0.01% (v/v) of
hydrogenated Triton X-100, which does not absorb light in the
ultraviolet range and is not fluorescent. The buffers were prepared
and used at the same temperature of the kinetic assays, 25 6 1°C.
The final concentration of dimethyl sulphoxide, used for preparing
stock solutions of the compounds, was 0.2% (v/v) in experiments
with synthetic substrates and 1% (v/v) in those with protein
substrates. Reaction progress with Z-RRYAMC at pH 4.5 and 6.0
was followed by either measuring the change in absorbance at 360
nm, with De ¼ 11,400 M1cm1 as the difference absorption
coefficient between free and bound AMC or fluorimetrically with
excitation and emission wavelengths, lex and lem, set at 383 and
455 nm, respectively. Exopeptidase activity was continuously
monitored fluorimetrically with the Fo¨rster resonance energy
transfer (FRET) labeled substrate Abz-GIVRYAK(Dnp)-OH
(Cotrin et al. 2004). Appropriate corrections for inner filter effects
were taken into account in fluorescence measurements consider-
ing the absorbencies of the substrates and of the tested compounds
at lex and lem (Palmier and Van Doren 2007). With the AMC-
based substrate, lex at 383 nm allowed high substrate concen-
trations to be used with small inner filter corrections. Since with
the FRET substrate inner filter effects were more pronounced, lex
and lem were selected according to the compound being tested.
The combination lex/lem 320/420 nm, often used in assays with
this type of substrate, could not be utilized for the strong
absorbance at 320 nm of one of the compounds (ZINC-2005 code
1797383), which simulated strong enzyme inhibition, whereas the
combination lex/lem 370/430 nm revealed no inhibition. Any
modifier-independent contribution to enzyme activity loss by
denaturation, adherence to the vessel walls, or other causes was
monitored in time-course assays by the Selwyn method (Selwyn
1965). Screening and primary analysis of the kinetic inhibition
mechanism of the compounds was performed on initial velocity
data obtained at various concentrations of substrate and com-
pounds. The specific velocity plot, a sensitive tool for detecting
mixed-type and/or hyperbolic mechanisms was routinely used in
this phase (Baici 1981). The kinetic inhibition models considered
and their related rate equations are shown in Figure 3. In Models 2
and 3, a is a coefficient, which is equal to 1 when the first binding
process does not influence the second one. If the equilibrium
constant of the vacant site is influenced after binding to the first
site, a 6¼ 1. Kinetic analysis was performed by fitting the equations
in Figure 3 to experimental data using GraphPad Prism version
5.00 for Windows. The runs test and analysis of residuals were
performed to monitor deviations from a model, and discrimination
between mechanisms was made by analysis of variance of the
difference between the sum of squares (extra sum-of-squares test)
and calculation of F ratios and p values. According to Occam’s
razor principle, the simplest mechanism describing experimental
data was considered superior to a more complex (redundant)
mechanism. Additionally, a powerful and decisive tool for model
discrimination was the I90/10 ratio, i.e., the ratio of inhibitor
concentration necessary to achieve 90% and 10% inhibition. This
parameter was determined experimentally and compared with
values calculated from Equations 4 and 6 in Figure 3.
Protein substrates
The activity of cathepsin B on rabbit muscle aldolase was quantified
by measuring primary amino groups derived from peptide-bond
hydrolysis with fluorescamine (Schwabe 1975). Aldolase was
dissolved in pH 6.0 buffer without DTT, incubated 3 h at 37°C
with cathepsin B, which was pre-activated with DTT, and DOFA
under vigorous shaking to prevent precipitation. Final concentrations
were: aldolase ¼ 3.5 mg/mL ¼ 21.7 mM, cathepsin B ¼ 2.3 mM,
DOFA ¼ 0.5, 1.0, 1.5, and 2.0 mM. The reaction was stopped with
trichloroacetic acid, 5% (w/v) final concentration, and centrifuged.
We added 0.1 mL of the clear supernatant to 2.0 mL 0.2 M sodium
borate buffer (pH 8.50), and 1.0 mL of fluorescamine solution (15
mg/100 mL acetone). The fluorescence of labeled peptides was
measured with lex/lem ¼ 390/480 nm. Blanks were subtracted and
controls compared with the samples containing the compounds.
Measurements with the oxidized b-chain of bovine insulin as
substrate were performed in pH 6.0 buffer using the same procedure.
Final concentrations were: insulin b-chain ¼ 72 mg/mL ¼ 20.6 mM,
cathepsin B ¼ 2.3 mM, DOFA ¼ 0.5, 1.0, 1.5, and 2.0 mM.
Endo- and exoproteolysis of protein substrates
Reaction products resulting from incubation of aldolase with
cathepsin B and DOFA were also assessed by denaturing gel
electrophoresis. Final concentrations in incubation mixtures at
25°C under continuous shaking for 4 h were: aldolase 3.5 mg/
mL (21.7 mM) in pH 6.0 buffer without DTT, 2.3 mM of
preactivated cathepsin B, and 1.0 mM DOFA. After centrifuga-
tion, the clear supernatant was analyzed by sodium dodecyl
sulphated, polyacrylamide gel electrophoresis (SDS-PAGE)
under reducing conditions with 12.5% polyacrylamide and silver
stained. For N-terminal sequencing by Edman degradation, the
bands were transferred to a polyvinylidene fluoride membrane.
Peptides in the excised bands were also identified by MALDI
analysis.
The oxidized b-chain of bovine insulin was incubated at a
final concentration of 1.0 mg/mL (286 mM) in 0.1 M sodium
acetate buffer containing 0.2 mM NaCl, 2 mM EDTA, and 2.5
mM DTT (pH 5.50) with 1.2 mM cathepsin B (control) or
cathepsin B plus 1.0 mM DOFA. After 20 h at 25°C under
shaking, solutions were centrifuged and the solvent removed in
a Speed Vac concentrator. The residue was resuspended in 60
mL of deionized water containing 0.1% trifluoroacetic acid and
centrifuged before analysis by LC/MALDI/MS.
Electronic supplemental material
Supplemental Table 1 shows the identification codes and the
sources of the cathepsin B inhibitors. Supplemental Figure 1
presents the van der Waals interaction energies distribution used
in the docking procedure and shows the cutoff of 30 kcal/mol
for intermolecular van der Waals energy. Analogously, Supple-
mental Figure 2 shows the van der Waals interaction energy
efficiencies distribution.
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Supplemental Table S1. Identification codes and source of 29 putative inhibitors of 
human cathepsin B. The ZINC-codes are those of the database 2005 [Irwin, J. J., and 
Shoichet, B. K. (2005) J. Chem. Inf. Model. 45, 177-182]. [2-(2,4-dioxothiazolidin-3-yl) 
ethylcarbamoylmethyl 2-(furan-2-carbonylamino) acetate (DOFA) is shown in boldface. 
 
Source ZINC 2005-codes 
ChemDiv (San Diego, USA) 33816, 978038, 2487954, 2560859 
Ambinter (Paris, France) 1271923, 1414169 
ChemBridge (San Diego, USA) 958753, 2904166, 2973678, 2990182 
Pharmerks (Moscow, Russia) 989395, 1755678, 1837733, 1871954 
Life Chemicals (Burlington, Canada) 1797383 
Enamine (Kiev, Ukraine) 
2616818, 2667966, 3247330, 3333255, 3340535, 
3417832, 3439551, 3451184 
IBScreen (Moscow, Russia) 1419203, 2128374, 2131752 
National Cancer Institute, U.S.A. 1581881, 1628238, 1682930 
 
  
 
 
Supplemental Figure S1. Van der Waals interaction energies distribution. The 
histogram represents the distribution of van der Waals interaction energies before and 
after the efficiency cutoff. The vertical line marks the cutoff on van der Waals energy. 
  
 
Supplemental Figure S2. Van der Waals interaction energy efficiencies distribution. 
The histogram represents the distribution of van der Waals interaction energy efficiencies 
before and after the energy cutoff. The vertical line represents the cutoff of van der Waals 
efficiency. 
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Abstract
Polycomb group (PcG) proteins are essential to maintain gene expression patterns during development. Transcriptional
repression by PcG proteins involves trimethylation of H3K27 (H3K27me3) by Polycomb Repressive Complex 2 (PRC2) in
animals and plants. PRC1 binds to H3K27me3 and is required for transcriptional repression in animals, but in plants PRC1-
like activities have remained elusive. One candidate protein that could be involved in PRC1-like functions in plants is LIKE
HETEROCHROMATIN PROTEIN 1 (LHP1), because LHP1 associates with genes marked by H3K27me3 in vivo and has a
chromodomain that binds H3K27me3 in vitro. Here, we show that disruption of the chromodomain of Arabidopsis thaliana
LHP1 abolishes H3K27me3 recognition, releases gene silencing and causes similar phenotypic alterations as transcriptional
lhp1 null mutants. Therefore, binding to H3K27me3 is essential for LHP1 protein function.
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Introduction
Polycomb group (PcG) proteins maintain gene expression
patterns during development in animals and plants by establishing
a cellular memory system for transcriptional repression [1].
Although many functional details of PcG proteins remain
unknown, current models suggest that repression involves
trimethylation of histone H3 lysine 27 (H3K27me3) by Polycomb
repressive complex 2 (PRC2). In insects and mammals,
H3K27me3 assists in the recruitment of PRC1 [2]. Binding of
PRC1 to H3K27me3 is mediated by the chromodomain of the
PRC1 subunit Polycomb (Pc) [3]. Metazoan PRC1 complexes
catalyze H2A monoubiquitylation via their RING-domain
subunits and are needed for stable repression of PcG target genes
[2]. Although the PcG system is present in plants and PRC2
homologs have similar functions, no clear plant PRC1 homologs
have been identified [1]. Proteins that may have PRC1-like
functions in plants include EMBRYONIC FLOWER 1, VER-
NALIZATION 1, LIKE HETEROCHROMATIN PROTEIN 1
(LHP1) and RAWUL-proteins [4–7].
The gene for Arabidopsis thaliana LHP1 was first found in screens
for mutants with altered leaf glucosinolate levels and named TU8
[8,9] as well as in screens for inflorescence meristem function and
named TERMINAL FLOWER 2 [10,11]. In addition, LHP1 was
identified as a homolog of metazoan HETEROCHROMATIN
PROTEIN1 (HP1) [12]. Similar to HP1, LHP1 contains a
chromodomain and a chromo shadow domain [11,12]. Unlike
HP1, however, LHP1 is usually localized in euchromatin and is
needed for maintenance of gene silencing in euchromatin but not
in heterochromatin [13,14]. Finally, LHP1 can bind to
H3K27me3 in vitro and associates with genes marked by
H3K27me3 in vivo [15,16]. Homologs of the animal PRC1 core
component RING1 have recently been identified in Arabidopsis,
and binding of AtRING1A to LHP1 suggests similar structure and
function of plant and animals PRC1 complexes [17].
Together, the model has emerged that LHP1 binds to PcG
target loci that have been trimethylated at H3K27 by PRC2 to
establish persistent transcriptional repression. We tested this
hypothesis using a LHP1 mutant with a defective chromodomain.
In agreement with predictions from structural homology-based
modeling, LHP1 with the mutated chromodomain had strongly
reduced binding to H3K27me3 in vitro. Furthermore, recruitment
to target genes and intra-nuclear localization of mutated LHP1
was greatly impaired in vivo. Because the phenotype of this new
lhp1 allele is very similar to an lhp1 null allele, we conclude that
chromodomain-mediated binding of LHP1 to H3K27me3 is
essential for LHP1 function. These results support the model that
LHP1 has a PRC1-like function in plants.
Results
An LHP1 mutant protein with a defective chromodomain
The new lhp1-7 allele was discovered in a suppressor screen of a
late flowering transgenic line with reduced MSI1 function (msi1-
tap1; [18]). For details of the mutant screen see Materials and
Methods. Sequencing of the LHP1 locus and the LHP1 cDNA
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revealed a newly created splice site that led to the presence of nine
additional nucleotides at the junction of exons two and three in the
processed lhp1-7 transcript (Fig. 1A, B). This results in three
additional amino acids (Cys-Glu-Arg) in the chromodomain
adjacent to the conserved tryptophan 129, which is changed into
a cysteine (Fig. 1C). The lhp1-7 allele was introduced into the
Columbia wild-type by backcrossing, and all further experiments
were performed with lhp1-7 in the wild-type background unless
otherwise specified. We compared lhp1-7 to the lhp1-6 null allele,
which we isolated previously from the SALK T-DNA insertion
collection (line SALK_011762). While no LHP1 transcript was
detected in the lhp1-6 T-DNA insertion mutant (Fig. 1D, E), LHP1
transcript levels in lhp1-7 were similar to those in wild-type
(Fig. 1F). However, in lhp1-7 only the mutant but not the wild-type
splice variant was detected (Fig. 1F), suggesting that lhp1-7
produces no or only very little wild-type protein. We discovered
lhp1-7 in a screen for suppressors of reduced MSI1 function, but
the potential link between LHP1 and the histone binding WD40
repeat protein MSI1 will be discussed elsewhere (for a review
about MSI1-like proteins see [19]). Here, we used the new lhp1-7
allele to probe LHP1 function in vitro and in vivo.
The HP1 and Pc chromodomains have binding cavities formed
by three aromatic residues to accommodate methylated lysines of
H3 histone tails [3,20,21]. Homology-based modeling revealed
that similar to HP1 and Pc, the chromodomain of LHP1 has the
potential to form a binding cage containing three aromatic
residues (Fig. 2A). Because one of the three aromatic residues,
tryptophan 129, was changed to a cysteine in the chromodomain
of lhp1-7, it is likely that this protein cannot form the typical
binding cage and will be called LHP1-CD* (Fig. 2B). To more
easily distinguish between the lhp1-6 null allele and the lhp1-7
mutant, we will refer to these alleles as lhp1-6 (null) and lhp1-7
(CD*). Calculation of interaction energies suggested that LHP1-
CD* has reduced affinity to trimethylated and unmethylated lysine
residues (Table 1).
Next, we tested whether binding to H3K27me3 was indeed
affected by the lhp1-7 (CD*) mutation. Similar to previously
reported results, wild-type LHP1 bound strongly to the
H3K27me3 peptide in vitro, but LHP1-CD* binding to
H3K27me3 was significantly reduced and similar to the binding
to unmethylated H3K27 (Fig. 2C). The reduced binding affinity to
H3K27me3 in vitro suggests that LHP1-CD* could have
compromised activity in vivo.
The LHP1 chromodomain is required for correct sub-
nuclear localization and binding to target genes
To analyze the in vivo activity of LHP1-CD*, we introduced
LHP1-GFP and LHP1-CD*-GFP fusion proteins into lhp1-7(CD*).
We found several lines in which the LHP1-GFP fusion protein
could complement lhp1-7(CD*), demonstrating that LHP1-GFP is
fully functional (Fig. 3A, B). In contrast, the LHP1-CD*-GFP
fusion protein was expressed (Fig. 3G, H) but unable to
complement the mutant, suggesting that LHP1-CD*-GFP cannot
substitute for wild-type LHP1.
Microscopic inspection of the LHP1-GFP and LHP1-CD*-GFP
lines revealed that both wild-type and the mutant fusion proteins
were targeted to the nucleus. The LHP1-GFP fusion protein
showed a speckled pattern throughout the nucleus in most lines
(Fig. 3C–F), similar to published data [13]. In contrast, the mutant
LHP1-CD* was more uniformly distributed in the nucleus, often
with additional strong accumulation in the nucleolus (Fig. 3G–K).
Accumulation of mutant LHP1 versions in the nucleolus has been
reported before [13,22], but the relevance of this abnormal
targeting is unknown.
Figure 1. A novel lhp1 allele. (A) Part of the genomic sequence of wild-type LHP1; exons are marked in bold. The EMS allele lhp1-7 has a G to A
transition in the second intron (position marked in red). (B) The point mutation in lhp1-7 creates a new splice site. The critical region of the alignment
of wild-type and mutant LHP1 cDNAs is shown. (C) The lhp1-7 mutant protein has a defect in the chromodomain. The critical region of the alignment
of the wild-type and mutant LHP1 proteins is shown. The chromodomain is shown in bold; the aromatic cage residues are marked in green and the
cysteine that substitutes one of them in the mutant protein is marked in red. (D) The structure of wild-type and mutant LHP1 transcripts and primers
for PCR amplicons. Black boxes, grey boxes and lines represent exons, untranslated regions and introns, respectively. The asterisk marks the position
of the point mutation in lhp1-7 and the additional exon inclusion is shown in dark grey. The arrow marks the position of the T-DNA insertion in lhp1-6.
Note that amplicon 1 is not specific for either splice variant while amplicons 2 and 3 are specific for the wild-type and mutant splice variants,
respectively. For primer sequences see Table 3. (E) lhp1-6 is a transcriptional null mutant. (F) lhp1-7 expresses the mutant splice variant at the same
level as the wild-type expresses LHP1. RNA in (E, F) was isolated from seedlings grown under long day conditions for 9d or 16d.
doi:10.1371/journal.pone.0005335.g001
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Altered in vitro binding and sub-nuclear distribution of LHP1-
CD* could also affect binding to individual target loci. We used
the GFP fusion lines to test binding of LHP1 to AGAMOUS (AG)
and SEPALATA3 (SEP3), which are well-established PcG and
LHP1 targets [14–16,23]. After chromatin immunoprecipitation
we found that LHP1-GFP, but not LHP1-CD*-GFP, bound
efficiently to both loci (Fig. 3L). Together, these results show that
LHP1-CD* lost specificity for H3K27me3 in vitro and that LHP1-
CD*-GFP cannot bind to at least some LHP1 targets in vivo, which
may explain its altered sub-nuclear localization.
Development is altered in lhp1-7(CD*) mutants
We compared the lhp1-7(CD*) mutant to wild-type and lhp1-
6(null) mutant plants to establish which aspects of LHP1 function
depend on chromodomain binding to H3K27me3. Analysis of
flowering time revealed that both lhp1-7(CD*) and lhp1-6(null)
plants flowered at similar times but much earlier than wild-type
under long and short day conditions (Fig. 4). Early flowering was
characterized by shortened juvenile and adult phases concomitant
with strong FT upregulation (Fig. 4B, D). Epidermal cells of lhp1
mutant rosette leaves were much smaller, although they
maintained the characteristic jigsaw like shape (Fig. 5). Leaf cell
number and expansion were reduced in both lhp1 alleles, causing a
strongly decreased rosette leaf size (Fig. 5).
Figure 2. lhp1-7(CD*) encodes an LHP1 mutant protein with a defective chromodomain. (A) Structural model of the LHP1 chromodomain
based on homology modeling using the coordinates of the Drosophila Pc chromodomain complexed with an H3K27me3 peptide [3]. (B) Structural
model of the LHP1-CD* chromodomain, which is encoded by lhp1-7(CD*). The arrow indicates the mutated region in LHP1-CD*. The position of the
trimethylated lysine side chain (arrow heads) in (A) and (B) was derived from the template crystal structure. (C) Peptide-binding pull-down assay for
wild-type LHP1 and LHP1-CD* (left) and quantification (right).
doi:10.1371/journal.pone.0005335.g002
Table 1. Intermolecular energy values in Kcal/mol calculated
by CHARMM upon minimization using a distance dependent
dielectric function.
Van der Waals Electrostatic Total
LHP1-CD/H3K27me3 225.0 23.9 228.9
LHP1-CD*/H3K27me3 222.5 23.0 225.5
LHP1-CD/H3K27 219.5 23.3 222.8
LHP1-CD*/H3K27 215.9 22.5 218.4
doi:10.1371/journal.pone.0005335.t001
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Arabidopsis LHP1 was initially identified genetically for its
terminal flower phenotype [10]. Both lhp1-6(null) and lhp1-7(CD*)
have the terminal flower phenotype, but lhp1-7(CD*) formed the
terminal flower later than lhp1-6(null) (Fig. 6A). Consistently,
primary stem growth ceased much earlier in lhp1 mutants than in
wild-type plants, but later in lhp1-7(CD*) than in lhp1-6(null)
(Fig. 6B, C). In both lhp1 alleles, not only duration of primary stem
growth but also growth rates were reduced (Fig. 6D). Together,
lhp1-7(CD*) is phenotypically similar to lhp1-6(null) during early
plant development, but has a slightly milder phenotype late in
development.
Silencing of PcG target genes is lost in lhp1-7(CD*)
mutants
Flowers produced late during lhp1-6 and lhp1-7(CD*) develop-
ment often have supernumerary, missing or deformed organs
(Fig. 7A–C), which may be caused by deregulation of floral
homeotic genes. AG and SEP3 were ectopically expressed in lhp1-
6(null) and lhp1-7(CD*) rosette leaves (Fig. 7D). Similarly, MEDEA
and AGL19, two PcG targets [24,25], were de-repressed in both
lhp1 alleles (Fig. 7D and data not shown). The observation that
there was no reactivation of transposons or pseudogenes
(At4g03760, MU1, TA2) or of targets of the RNA-dependent
DNA-methylation pathway (IG/LINE, IG2, IG5, RPL18) (Fig. 7E
and data not shown) confirmed that loss of LHP1 does not affect
silencing in heterochromatin [13,14].
Together, our results show that similar to lhp1-6(null) major
developmental regulatory genes (e.g., FT, AG and SEP3) are not
repressed in lhp1-7(CD*) at times when they should be silent. Thus,
we conclude that specific binding of LHP1 to H3K27me3 is
essential to maintain repression of PcG target genes.
Discussion
In animals, PRC2 complexes set H3K27me3 marks, which
assist to recruit PRC1 to mediate stable silencing [2]. Plant LHP1
proteins are similar to metazoan HP1, but could have PRC1
functions. Phylogenetic analysis suggests that the LHP1 and HP1
protein subfamilies have strongly diverged (Fig. 8). In addition to
Arabidopsis, genes for LHP1 homologues were previously
described for multiple mono- and dicotyledonous plant species
Figure 3. Altered sub-nuclear localization of LHP1-CD*-GFP. (A) Wild-type (Col, left) and lhp1-7(CD*) (right) after five weeks of growth under
long day photoperiod. (B) LHP1 35S::LHP1-GFP (left) and lhp1-7(CD*) 35S::LHP1-GFP (right) plants. Plants are in the msi1-tap1 background. (C-K)
35S::LHP1-GFP (C-F) and 35S::lhp1-7(CD*)-GFP plants (G-K) were used to analyze protein localization in leaf nuclei. Protein localization was detected by
confocal laser scanning microscopy of GFP-fluorescence (C, G) or by immuno-localization (D, H). (E, I) DAPI-staining of the nuclei in D and H; merged
images of D and E (F) and of H and I (K). (L) ChIP assays for binding of LHP1-GFP and LHP1-CD*-GFP to the AG and SEP3 loci. Top: Genomic structure of
AG and SEP3. Lines represent introns, narrow bars 39 and 59 UTRs and wide bars represent coding exons. Black lines represent regions probed by
qPCR. Values are recovery as percent of input; IgG served as negative control.
doi:10.1371/journal.pone.0005335.g003
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such as apple, rape seed, carrot, tomato, rice and maize
[11,12,26]. We found LHP1 homologues also in the genomes of
poplar (Populus trichocarpa), of a lycophyte (Selaginella moellendorffii),
an ancient vascular plant lineage, and of a moss (Physcomitrella
patens). In contrast, we failed to identify LHP1 or HP1 homologs in
the genomes of the chlorophyte algae Volvox carteri and Chlamydo-
monas reinhardtii, suggesting that the presence of LHP1 is linked to
multicellular development in the plant kingdom. Because chro-
matin immunoprecipitation has shown that LHP1 binding
overlaps with H3K27me3 and LHP1 can bind H3K27me3 in
Figure 4. Early flowering of lhp1 mutants. (A) Rosette leaves produced until bolting in long days (LD). (B) Phase transition in LD. (C) Rosette
leaves formed until bolting in SD. Values in (A-C) are mean6S.E. (n$7). (D) FT expression at ZT = 4h (ZT, zeitgeber time; ZT = 0 is lights on) in 12 days
old seedlings from LD and at ZT = 6h in 14 days old seedlings from SD. Samples were taken at times when FT expression in wild-type is low [43].
Values in D are mean6S.E. (n = 4). Note that expression values for LD and SD were independently normalized to the corresponding wild-type. For all
panels: White, grey, and dark-grey bars represent wild-type, lhp1-6(null) and lhp1-7(CD*), respectively.
doi:10.1371/journal.pone.0005335.g004
Figure 5. Altered leaf development in lhp1 mutants. (A-C) Adaxial epidermis of Col (A), lhp1-6(null) (B) and lhp1-7(CD*) (C) leaves. (D) Area of
first and second rosette leaf after bolting (n$11). (E) Cell size in the adaxial epidermis of the first and second rosette leaves (n$244). (F) Estimated cell
number in the adaxial epidermis of the first and second rosette leaf. For all panels: White, grey, and dark-grey bars represent wild-type, lhp1-6(null)
and lhp1-7(CD*), respectively. Values in (D-F) are mean6S.E.
doi:10.1371/journal.pone.0005335.g005
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vitro, it was suggested that the chromodomain-protein LHP1 is a
PRC1 equivalent of plants [15,16]. In contrast to animals,
however, where PRC1 is needed for spreading of H3K27me3
over extended regions, in plants loss of LHP1 does not affect
genomic H3K27me3 distribution [15].
Three aromatic residues form the binding cavity for methylated
lysines of H3 in the chromodomain of animal HP1 and Pc
[3,20,21,27]. Based on protein homology modeling, the chromo-
domain of plant LHP1 forms a similar binding pocket. Therefore
we suggest that the novel lhp1 allele lhp1-7(CD*) has a defective
binding pocket for the quaternary ammonium group because the
preference of LHP1 for H3K27me3 over H3K27 was lost for
LHP1-CD*. Energy calculations using CHARMM [28] and the
CHARMm [29] force field are in qualitative agreement with the
relative affinities measured by the pull-down assay. A quantitative
agreement is not expected because of approximations inherent to
the force field and the qualitative nature of the pull-down assays.
An LHP1-CD*-GFP fusion did not efficiently bind to target gene
chromatin and had lost its correct sub-nuclear distribution,
suggesting that chromodomain-mediated binding to H3K27me3
is essential for LHP1 targeting in vivo. In contrast, the
chromodomain might not be necessary for targeting of animal
HP1 in vivo [30–32].
Mutations in Arabidopsis LHP1 strongly affect development
[10,12]. The phenotype of the lhp1-7(CD*) allele was very similar
to that of an lhp1 null allele, suggesting that LHP1 function
requires an intact chromodomain. Because only LHP1-GFP but
not LHP1-CD*-GFP could rescue lhp1 mutants, LHP1-CD* has
no or strongly reduced biological activity. Residual binding of
LHP1-CD* to H3K27me3 could explain the phenotypic differ-
ences between lhp-7(CD*) and lhp1-6(null) plants.
Loss of LHP1 or PRC2 share many similar developmental and
molecular effects. Our experimental results, supported by
homology modeling and previous reports, have revealed that
LHP1 contributes to PRC1-like functions in plants and that
chromodomain-mediated binding to H3K27me3 is required for
this activity.
Materials and Methods
Plant material and growth conditions
All mutants used are in the Columbia (Col) wild-type accession
of Arabidopsis thaliana. The ddm1-2 allele was described before [33].
A new lhp1 allele, lhp1-6, was identified in the SALK T-DNA
Figure 6. Altered shoot development in lhp1 mutants. (A) The
total number of reproductive organs (siliques, flowers and flower buds)
on the primary shoots of five weeks old plants from LD. Values are
mean6S.E. (n$8). (B) Example of the growth curve of a wild-type
plant’s primary shoot. (C) Length of linear growth phase. (D) Growth
rates during linear growth phase of primary shoots. Values in (C, D) are
averages over two experiments with n$9 per experiment. For all
panels: White, grey, and dark-grey bars represent wild-type, lhp1-6(null)
and lhp1-7(CD*), respectively.
doi:10.1371/journal.pone.0005335.g006
Figure 7. Loss of silencing at PcG targets and maintenance of silencing at heterochromatic loci in lhp1 mutants. (A–C) Flowers of wild-
type Col (A), lhp1-6(null) (B) and lhp1-7(CD*) (C) produced late during development. (D) Expression of PcG targets in seedlings at ZT = 5h after 16 days
in LD. (E) Expression of heterochromatic loci in rosette leaves at ZT = 5h after 25 days in LD. RNA from ddm1-2 was used as positive control.
doi:10.1371/journal.pone.0005335.g007
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insertion mutant collection (SALK_011762). LHP1 and lhp1-7
cDNAs were cloned into vector pK7FWG2 [34], which was used
to transform plants by floral dip with Agrobacterium tumefaciens (strain
GV3101). Seeds were germinated on sterile basal salts Murashige
and Skoog (MS) medium (Duchefa, Brussels, Belgium), and plants
were analyzed on plates or transferred to soil 10 days after
germination. Alternatively, seeds were directly sown on soil. Plants
were kept in Conviron growth chambers with mixed cold
Figure 8. Sequence alignment and phylogenetic tree of LHP1 and HP1 homologues. (A) Segment of the alignment that contains the
chromodomain. The arrow heads highlight the aromatic cage residues that form the binding cavity for histone methyl groups. (B) Phylogenetic tree
of 15 LHP1 and HP1 homologs (Arabidopsis thaliana: At_LHP1 GI:15625407. Populus trichocarpa: Pt_LHP1A, estExt_Genewise1_v1.C_LG_XIX1329;
Pt_LHP1B, eugene3.00130688. Oryza sativa: Os_LHP1, GI:110810411. Zea mays: Zm_LHP1 GI:22135459. Physcomitrella patens: Pp_LHP1,
jgi|Phypa1_1|169812|estExt_fgenesh1_pg.C_2200058. Selaginella moellendorffii: Sm_LHP1, jgi|Selmo1|407083|fgenesh2_pg.C_scaffold_6000334.
Homo sapiens: Hs_HP1alpha, GI:6912292; Hs_HP1beta, GI:48428808; Hs_HP1gamma, GI:5732187. Drosophila melanogaster: Dm_HP1a, GI:17136528;
Dm_HP1b, GI:24640713. Caenorhabditis elegans: Ce_HP1-1, GI:17568757; Ce_HP1-2, GI:71987888. Schizosaccharomyces pombe: Sp_SWI6, GI:510930.).
The evolutionary history was inferred using the Maximum Parsimony method; the most parsimonious tree with length= 2089 is shown. Support for
each node, assessed with bootstrap analysis (1000 replicates) is given when higher than 60%. Note that the tree is displayed as circular cladogram
with all branches of the same length.
doi:10.1371/journal.pone.0005335.g008
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fluorescent and incandescent light (110 to 140 mmol m22 s21,
2162uC) under long day (LD, 16h light) or short day (SD, 8h light)
photoperiods or were alternatively raised in green houses.
Isolation of the new lhp1-7(CD*) allele
For a suppressor screen, seeds of the late flowering msi1-tap1
transgenic line [18] were mutagenised with ethyl methane sulfonate
(EMS). Approximately one thousand F2 families were screened for
suppression of the delayed floral transition of msi1-tap1. One family
(0.3 362) segregated plants with a conspicuous early flowering
phenotype. These early flowering plants were smaller, had reduced
fertility and segregated in a 1:3 ratio (data not shown), suggesting
recessive Mendelian inheritance. Molecular mapping located the
mutation between the markers CER456657 (BAC MPI7) and
CER457604 (BAC MXE10) on the top arm of chromosome V.
Within the same region lies the gene At5g17690, which encodes
LHP1. Because of similarities between the phenotypes of 0.3 362
plants and lhp1 mutants, the At5g17690 locus in 0.3 362 was
sequenced and a single G to A transition was discovered.
To confirm that the mutation in the LHP1 gene is indeed
responsible for the observed phenotype, an allelism test between
0.3 362 and the lhp1-6 null allele was performed. The analyzed F1
and F2 generations displayed a homogenous appearance with
small rosette size and were early flowering (data not shown), while
genotyping revealed the expected ratios of plants homozygous,
heterozygous or negative for the presence of the lhp1-6 T-DNA
insertion (data not shown), confirming that 0.3 362 was allelic to
lhp1-6. The newly identified lhp1 allele was henceforth called lhp1-
7.
Flowering time and growth kinetics
Flowering time was defined as the time needed by the plants
(n.7) to form a 5 mm high primary shoot. In addition, the
numbers of juvenile and adult rosette leaves were determined
based on the presence of abaxial trichomes as indicators for phase
identity [35]. For growth kinetics, the height of the primary shoot
was measured daily. The end of the linear growth phase was
determined manually for individual plants from height vs. time
after bolting diagrams. Primary shoots of wild-type plants grew
linearly for nearly two weeks after bolting before growth ceased
gradually (Fig. 6B).
In vitro transcription/translation and pull down assays
LHP1 and lhp1-7 cDNAs were cloned into vector pRSET-A
(Invitrogen) for in vitro transcription/translation reactions (TNTH
T7 Quick Coupled Transcription/Translation System, Promega,
Madison, WI) supplemented with L-[35S]methionine. Equal
amounts of wild-type and mutant protein were incubated with
H3K27 or H3K27me3 peptides (LATKAARKSAPATGGC)
coupled to SulfoLink Coupling Gel (Pierce Perbio, Lausanne,
Switzerland). Samples were resolved by SDS-PAGE, exposed to a
storage phosphor screen (Amersham Biosciences, Otelfingen,
Switzerland) and visualized using a Molecular Imager FX Pro
Plus System (BioRad, Reinach, Switzerland).
RNA isolation, RT-PCR and Real Time PCR
RNA isolation and RT-PCR was performed as previously
described [36]. For Q-PCR analysis, the Universal Probe Library
system (Roche Diagnostics, Rotkreuz, Switzerland) was used on a
7500 Fast Real-Time PCR instrument (Applied Biosystems,
Lincoln, CA). PP2A was used as reference gene [37]. Q-PCR
was performed with three to four replicates, and results were
analyzed as described [38]. For details of the assays see Table 2.
Immuno-localisation
Immuno-localization of GFP fusion proteins was performed as
described previously [39] using nuclei isolated from rosette and
cauline leaves and a rabbit anti-GFP antibody (A11122, Molecular
Probes Invitrogen, Basle, Switzerland). For detection, Alexa
FluorH 488 goat anti-rabbit IgG (A11008; Molecular Probes
Invitrogen, Basle, Switzerland) was used. The preparations were
analyzed by either epifluorescence microscopy (Zeiss Axioplan 2)
or by confocal laser microscopy (Leica TCS SP1). For confocal
laser microscopy, Alexa fluorophores were excited with a 488 nm
laser; the emission signal was collected in a wavelength window
between 502 nm and 543 nm. DAPI fluorescence was collected in
a window from 438–485 nm
Structure determination by homology modeling
Wild-type and mutant sequences were processed by the
SwissModel server [40] in automatic mode, fixing as a template
the A chain of 1PDQ (Drosophila Polycomb chromodomain
complexed with the histone H3 tail containing trimethyl lysine 27
[3]). CHARMm atom types and force field parameters [29] were
assigned for all structures. Hydrogen atoms were added and
minimized with the program CHARMM [28]. Trimethylated and
unmethylated lysine residues were blocked with acetyl and N-
methyl-aminyl groups. They were then minimized in the rigid
protein using CHARMM and a distance-dependent dielectric
Table 2. Assays used for qPCR.
Gene Forward primer Reverse primer Universal Probe Library probe
FT GGTGGAGAAGACCTCAGGAA GGTTGCTAGGACTTGGAACATC #138 (Arabidopsis)
PP2A GGAGAGTGACTTGGTTGAGCA CATTCACCAGCTGAAAGTCG #82 (Arabidopsis)
AG CTAATCAAATTTTGCCCTAAACG TCCTAGCTCCGATTGGTACG #132 (Arabidopsis)
SEP3 ATTGATCTTGTTCTCTATCCTCTTCAA AGAGAGAGAGATTGAGATATCTTTTGG #103 (Arabidopsis)
doi:10.1371/journal.pone.0005335.t002
Table 3. Primer sequences.
Primer-ID Sequence
LH156 TGCATATTTGCGCTTCCGTTT
LH157 CGGTGGAAACAGTCGGAGAAA
LH369 GGAAGGCTAGAGTTGTTGAGAGAC
LH473 GGTTCAGTATCTAATTAAATGTTGTGAAAG
LH474 GGCAAGGTTCAGTATCTAATTAAATGG
doi:10.1371/journal.pone.0005335.t003
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function (e= 4r). During minimization, harmonic constraints with
a force constant of 2.5 Kcal/mol/A˚2 were added to the blocking
groups. The starting position of the trymethylated lysine residue
was obtained by superimposing 1PDQ to each model. The
interaction energy between the protein and the trymethylated/
unmethylated lysine residue was calculated by INTE command of
CHARMM. Given the approximations inherent to the force field
and the homology models, only a qualitative agreement with
experimental data is expected.
Chromatin Immunoprecipitation
Chromatin isolation was performed as described previously [24]
using 15d-old seedlings. Chromatin immunoprecipitation was
done using the LowCell# ChIP kit (Diagenode, Lie`ge, Belgium)
according to manufacturer’s instructions. The following antibodies
were used: Polyclonal anti-H3 antibody (#01-690, Upstate,
Charlottesville, VA), polyclonal anti-GFP antibody (#A11122,
Molecular Probes Invitrogen, Basle, Switzerland) and non-immun
IgG (Diagenode). Presence of AG and SEP3 fragments was
determined by qPCR using the Universal Probe system (Roche).
Sequence alignment and phylogenetic analysis
Protein sequences of HP1 and LHP1 proteins were selected
based on previous publications [16,26] and on BLAST searches
with the Arabidopsis LHP1 sequence using the DOE Joint
Genome Institute data base (http://genome.jgi-psf.org/). Final
sequence alignments of the selected sequences were generated with
CLUSTALX 1.81 (protein weight matrix was Gonnet 250, gap
opening penalty was 10.0, and gap extension penalty was 0.2). The
evolutionary history was inferred using the flat-weighted Maxi-
mum Parsimony method. The MP tree of amino acid sequences
was obtained using the Close-Neighbor-Interchange algorithm
with search level 3 in which the initial trees were obtained with the
random addition of sequences (10 replicates). All alignment gaps
were treated as missing data. There were a total of 985 positions in
the final dataset, out of which 292 were parsimony informative.
Phylogenetic analyses were conducted in MEGA4 [41]. The
presentation of the phylogenic tree was prepared using Dendro-
scope [42].
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SUMMARY 
 
Plants use different classes of photoreceptors to collect information about their 
light environment. Cryptochromes are blue light photoreceptors that control 
deetiolation, entrain the circadian clock and are involved in flowering time control. 
Here, we describe the cry1-L407F allele, which encodes a hypersensitive 
cryptochrome 1 protein. Plants carrying the cry1-L407F point mutation have elevated 
expression of CO and FT under short day conditions leading to very early flowering. 
These results demonstrate that not only the well-studied cryptochrome 2 with an 
unequivocal role in flowering promotion but also cryptochrome 1 can function as an 
activator of the floral transition. The cry1-L407F mutants are also hypersensitive 
towards blue, red and far-red light in hypocotyl growth inhibition. In addition, cry1-
L407F seeds are hypersensitive to germination-inducing red-light pulses, but the far-
red reversibility of this response is not compromised. This demonstrates that the cry1-
L407F photoreceptor can increase the sensitivity of phytochrome signaling cascades. 
Molecular dynamics simulation of wild-type and the mutant cry1 proteins indicated 
that the L407F mutation considerably reduces the structural flexibility of two solvent-
exposed regions of the protein, suggesting that the hypersensitivity might result from 
a reduced entropy penalty of binding events during downstream signal transduction. 
 
Key-words: Arabidopsis, CO, cryptochrome, FT, flowering time, phytochrome 
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INTRODUCTION 
 
Light determines the plant’s life, because light is the essential energy source 
for plant metabolism. The spatial, temporal and spectral variability of light provides 
cues about the time of day, the season and the presence of competitors for light. 
Sensitive and precise light perception is therefore essential to properly adjust plant 
development for maximal photosynthetic efficiency, to correlate vegetative and 
reproductive growth with favorable seasons and eventually to maximize fitness. To 
cope with this task plants have evolved several types of photoreceptors including the 
phytochromes and cryptochromes (for review see (Banerjee et al., 2005, Josse et al., 
2008, Muller et al., 2009). Phytochromes are red and far-red light receptors and 
regulate different aspects of plant development, such as hypocotyl elongation in red 
and far-red light and shade avoidance responses (Franklin et al., 2005). In addition, 
the two major phytochromes in Arabidopsis, phytochrome (phy) A and phyB are 
involved in flowering time control: phyA promotes flowering under short day (SD) 
and long day (LD) photoperiods (Johnson et al., 1994), while phyB acts as a floral 
inhibitor (Reed et al., 1993, Mockler et al., 1999). 
Cryptochromes (cry) are flavoproteins with two chromophores that sense blue 
and ultraviolet-A light in plants (Lin et al., 2005). The essential chromophore is a 
flavin adenine dinucleotide (FAD), the second chromophore is supposed to function 
in light harvesting and is a pterine (methenyltetrahydrofolate) (Muller et al., 2009). 
Cryptochromes have an amino-terminal photolyase related (PHR) domain that is 
similar to photolyases, but are distinguished from the latter by a variable carboxy-
terminal domain. Furthermore, crystallization of the photolyase-like domain of 
Arabidopsis cry1 has revealed additional structural differences between photolyase 
and cryptochrome that explain the lack of DNA-binding activity of the cryptochromes 
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(Brautigam et al., 2004). Moreover, the crystal structure confirmed the previously 
described ATP binding of cry1 (Bouly et al., 2003) by soaking cry1 crystals with the 
nonhydrolyzable ATP analog AMP-PNP and showing AMP-PNP located in the FAD 
access cavity (Brautigam et al., 2004). Despite the available protein structure, 
cryptochrome’s mode of action still remains to be determined. Interestingly, the 
carboxy terminus of plant cryptochromes as well as a carboxy terminal 80-residue 
motif (NC80) confer constitutive cryptochrome signaling when overexpressed in 
plants even in the absence of light (Yang et al., 2000, Yu et al., 2007). For plant 
cryptochromes, it has been proposed that the PHR domain and the carboxy terminus 
form a "closed" conformation to mask the NC80 motif in the absence of light. Blue 
light would trigger phosphorylation of the carboxy terminal tail and its electrostatical 
repulsion from the surface of the PHR domain to form an "open" conformation, 
exposing the NC80 motif and initiating signal transduction (Yu et al., 2007). 
The Arabidopsis thaliana genome harbors two cryptochrome genes: CRY1 and 
CRY2. A third member of this family, CRY3, belongs to the DASH-type subgroup 
with repair activity for cyclobutane pyrimidine dimer lesions in single-stranded DNA 
(Selby et al., 2006) and loop structures of duplex DNA (Pokorny et al., 2008), but 
with so far unproven photoreceptor function. Mutations in both CRY1 and CRY2 
interfere with inhibition of hypocotyl elongation under blue light conditions (Ahmad 
et al., 1993, Guo et al., 1998).  Current data suggest that cry1 is the major blue light 
receptor for seedling photomorphogenesis, while cry2 is more important for the 
control of flowering time (Guo et al., 1998, Mockler et al., 1999, El-Din El-Assal et 
al., 2003, Mockler et al., 2003, Endo et al., 2007). Nevertheless, several studies also 
reported cry1 as a floral regulator: some cry1 mutant alleles conferred late flowering 
under certain growth conditions (Bagnall et al., 1996, Blazquez et al., 2003), but 
others did not (Zagotta et al., 1996, Mockler et al., 1999). 
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Even though the functions of the different photoreceptors are assigned to 
specific segments of the spectrum of light, physiological and mutant analyses have 
revealed extensive cross-talk between blue and red light photoreceptors (Casal 2000): 
phyA and phyB display antagonistic and synergistic effects on the action of each 
other, depending on which responses are studied (Reed et al., 1994, Casal et al., 
1995), and several of the phytochromes functionally interact with the cryptochromes 
(Ahmad et al., 1997, Casal et al., 1998, Neff et al., 1998, Hennig et al., 1999, Mockler 
et al., 1999, Devlin et al., 2000). In addition, a physical interaction of phyA with cry1 
(Ahmad et al., 1998) and of phyB with cry2 (Mas et al., 2000) has been reported. 
While these cross-talks are of minor importance under controlled monochromatic 
light conditions, they are probably essential for fine tuning of developmental 
programs in natural environments. 
Here, we provide evidence that a hyperactive cry1 allele confers 
hypersensitivity not only to blue but also to red light and strongly shortens flowering 
time under SD.  
 
RESULTS 
 
Isolation of a new cry1 allele 
For a suppressor screen, seeds of the late flowering msi1-tap1 transgenic line 
(Bouveret et al., 2006) were mutagenised with ethyl methane sulfonate (EMS) (Exner 
et al., 2009). Flowering time was scored under LD photoperiods for 1045 M2 families. 
Among these, eleven families segregated plants that shortened the vegetative phase of 
msi1-tap1. For six of them we confirmed the phenotype in subsequent generations. 
One of these six contained a mutation in LHP1 (Exner et al., 2009); the others belong 
to at least 4 complementation groups (data not shown). All these mutants still react to 
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changes in day length, but exhibited different responses as tested by flowering time 
experiments under LD and SD (data not shown). The mutant with ID 0.3-457 was 
chosen for further characterization (Tab. 1). 
The mutation in 0.3-457 was localized between markers CER446440 (BAC 
T3H13) and CER460528 (BAC T3H13) on the lower arm of chromosome IV. This 
region contains 9 genes including CRY1. Sequencing of the CRY1 locus revealed a C 
to T transition in the third exon, 1469 bp after the ATG start codon (Fig. 1A), which 
caused a change of leucine 407 into a phenylalanine (Fig. 1B). Therefore, 0.3-457 is 
henceforth called cry1-L407F.  
Comparison of cryptochrome and photolyase sequences from different 
organisms revealed that leucine 407, which is located in the photolyase-like PHR 
domain, is conserved among nearly all plant cryptochromes. The only exception is 
Arabidopsis CRY2, which has an isoleucine instead of the leucine at this position 
(Fig. 1B). In contrast, photolyases and animal cryptochromes have amino acids with 
small side chains (alanine, serine, threonine or glycine) at this position but never a 
bulky hydrophobic residue such as leucine. Furthermore, leucine 407 is located in a 
block of 12 amino acids that are highly conserved in plant cryptochromes but not in 
photolyases and animal cryptochromes. A structure of the cry1 PHR domain has been 
reported (Brautigam et al., 2004), and according to this structure leucine 407 is buried 
inside the protein without solvent contact (Fig. 1C). 
 
cry1-L407F strongly accelerates flowering 
The cry1-L407F mutant did not only flower earlier in the msi1-tap1 
background but also when backcrossed into Col wild type both under long day (LD) 
and short day (SD) conditions (Fig. 2A, B). Under LD, the acceleration of flowering 
in cry1-L407F was caused by a shortened adult phase (0.8 vs. 2.6 leaves) while the 
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duration of the juvenile phase (5.3 leaves) was not affected. The early flowering 
phenotype was even more dramatic under SD. While wild-type plants produced 61 
leaves before bolting, cry1-L407F produced only 12 leaves. Tests for genetic 
interaction between cry1-L407F and msi1-tap1 revealed additivity of both mutants 
(Supplemental Fig. S1), suggesting that CRY1 and MSI1 function in separate genetic 
pathways in the control of flowering. Besides the early flowering phenotype, cry1-
L407F featured a small and compact rosette (Supplemental Fig. S1), which is partly 
caused by shortened petioles (data not shown). Such a reduction of petiole length has 
also been described for plants overexpressing cry1 (Lin et al., 1996). 
These results, together with the observation that cry1-L407F behaved 
semidominantly (data not shown), suggested that we identified a gain-of-function 
CRY1 allele. Because genetic complementation tests and transgenic complementation 
are difficult with hyper- and neomorphic alleles, the ability of cry1-L407F to 
accelerate flowering was tested by transgenic phenocopy experiments. When wild-
type cry1 was introduced and overexpressed in Col wild-type plants, the four tested 
transgenic lines all flowered as late or even slightly later than Col wild type under SD 
(Fig. 2C). Similarly, Lin et al. had previously reported that increased cry1 dosage 
caused slightly delayed flowering (Lin et al., 1996). In contrast, when the cry1-L407F 
mutant gene under control of the same CaMV 35S promoter was introduced into Col, 
the four tested transgenic lines all flowered earlier than Col wild type under SD (Fig. 
2C). 
Together, the results show that cry1-L407F is a gain-of-function CRY1 allele 
that strongly accelerates flowering. 
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cry1-L407F causes FT over-expression 
Cryptochromes can affect flowering in at least three different ways. First, 
cryptochromes control the phase of the circadian clock, which in turn controls diurnal 
expression patterns of CONSTANS (CO). Second, cryptochromes stabilize CO protein 
in the light, and CO then activates flowering by inducing expression of FLOWERING 
LOCUS T (FT), which encodes the mobile flowering signal FT (for review see 
(Kobayashi et al., 2007). Third, cry2 can directly induce FT expression (Liu et al., 
2008). To elucidate whether one of these mechanisms is involved in accelerated 
flowering of cry1-L407F, we measured gene expression of ELF4, GI, CO and FT 
under SD conditions. ELF4 and GI participate in signaling from the circadian clock to 
downstream processes such as CO expression (Park et al., 1999, Doyle et al., 2002). 
In SD, CO is usually expressed only after the end of the light phase, and because CO 
protein is rapidly degraded in the dark, FT remains inactive. We found that ELF4 
expression was not significantly affected in cry1-L407F maintaining its typical 
evening peak (Fig. 3), suggesting that the accelerated flowering was not caused by a 
malfunction of the circadian clock. Likewise, GI expression was very similar between 
wild type and cry1-L407F (Fig. 3). In contrast, expression of CO and FT was 
considerably increased in cry1-L407F (Fig. 3). However, FT expression was strongest 
during the light period (zeitgeber time (ZT) = 3h) while CO expression was strongest 
during the dark period (ZT = 14h), suggesting that cry1-L407F does not establish 
aberrant CO protein stabilization in the dark. 
Together, these results indicate that cry1-L407F causes untimely expression of 
CO during the light period and thus allows for the accumulation of CO under SD 
photoperiods. Increased CO levels then strongly activate FT and cause the very early 
flowering of wild-type plants and the suppression of msi1-tap1’s late flowering 
phenotype. 
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cry1-L407F causes hypersensitivity towards blue and red light 
The cry1 photoreceptor is known to control hypocotyl growth in response to 
blue light (Koornneef et al., 1980, Ahmad et al., 1993). To investigate the effects of 
the amino acid substitution on the function of cry1-L407F in further detail, seedlings 
were grown under different fluence rates of blue, red and far-red light and hypocotyl 
elongation was measured. Under blue light, inhibition of hypocotyl elongation was 
observed under much lower fluence rates in cry1-L407F than in wild type (Fig. 4). 
Thus, cry1-L407F is a hypersensitive blue-light photoreceptor, and cry1-L407F is a 
hypermorphic allele. The hypersensitivity of cry1-L407F towards blue light is a 
dominant trait. Heterozygous cry1-L407F seedlings uniformly displayed short 
hypocotyls when grown under low fluence rates of blue light (data not shown). 
Surprisingly, cry1-L407F seedlings were not only strongly hypersensitive to blue but 
also to red light (Fig. 4), which should not efficiently activate cry1 (Lin et al., 1995, 
Ahmad et al., 2002). It is unlikely that this phenotype was caused by a 
"contamination" of the red light by photons from the blue part of the spectrum, 
because there is extremely little if any blue light emitted the light source used in these 
experiments (Supplemental Fig. S2). Similar to the situation under red light, cry1-
L407F seedlings were also hypersensitive to far red light, which is believed to be 
predominately sensed by phyA. 
Repression of hypocotyl elongation under blue light is a normal function of 
wild-type Arabidopsis cry1 and cry2 (Koornneef et al., 1980, Ahmad et al., 1993, Lin 
et al., 1998). In order to test whether cry1-L407F does also affect red-light sensitivity 
of a process normally not controlled by cryptochromes, we compared light-dependent 
germination of wild type and cry1-L407F. It is commonly thought that germination of 
Arabidopsis seeds is exclusively controlled by phytochromes but not by 
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cryptochromes (Shinomura et al., 1996, Oh et al., 2007). Under continuous white 
light, both wild type and cry1-L407F show a similarly high frequency of germination, 
while in the dark or after a far red pulse almost no germination occurred (Fig. 5). 
Pulses of red or white light that caused a germination rate of about 30% in wild-type 
seeds caused a germination rate of 80% in cry1-L407F seeds. Thus, cry1-L407F 
strongly increased the sensitivity of red-light induced germination. Red light-induced 
germination is usually a function of  phyB. However, the results shown in Figure 5 
could indicate that cry1-L407F itself can induce germination. Because 
photoreversibility is a hallmark of phyB function, we tested whether the red light-
induced induction of germination could be reverted by a pulse of far red light. Indeed, 
a far red light pulse could completely prevent red light-induced germination in both 
wild type and cry1-L407F (Fig. 5). This strongly suggests that cry1-L407F can 
increase the sensitivity to red light or signaling of photoreversible phytochromes such 
as phyB in the low fluence repsonse. 
Phytochromes regulate transcription of many genes; EARLY LIGHT 
INDUCED 2 (ELIP2), for instance, is rapidly upregulated after exposure to red or far 
red light, and this upregulation requires phyB and phyA, respectively (Harari-
Steinberg et al., 2001). We tested whether the cry1-L407F mutation would affect the 
red light-induced expression of ELIP2. In darkness and during the investigated time 
course up to six hours after transfer to red light, ELIP2 expression was consistently 
higher in cry1-L407F than in wild type, but with very similar kinetics for both 
genotypes (Fig. 6). Thus, the effect of cry1-L407F on red light signaling is not 
restricted to germination and hypocotyl growth inhibition. 
Together these results show that cry1-L407F causes strong hypersensitivity to 
both blue and red light in a dominant manner. 
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The hypersensitivity of cry1-L407F is not caused by elevated cry1 levels 
Overexpression of CRY1 under the control of the constitutive 35S promoter 
results in hypersensitivity of the transgenic plants towards blue light (Lin et al., 1996). 
Thus, we reasoned that the observed hypersensitivity of the cry1-L407F mutant could 
be caused by increased cry1 protein levels, although flowering time was not affected 
in overexpressors of wild type cry1 (Fig. 2). Quantitative immunoblots revealed, 
however, unchanged cry1 levels in cry1-L407F mutants (Fig. 7 and data not shown). 
These results demonstrate that the blue and red light hypersensitivity and early 
flowering of cry1-L407F is not caused by increased expression of cry1 but most likely 
by increased activity of the cry1-L407F protein. This conclusion is supported by the 
observation that blue fluence rates of up to 50 µmol m-2 s-1 caused a stronger shift of 
the cry1 band in the cry1-L497F mutant than in wild type (Fig. 7). This blue light-
induced shift reflects phosphorylation of the cry1 protein that is associated with 
photoreceptor activation (Shalitin et al., 2002, Bouly et al., 2003, Shalitin et al., 
2003). We thus conclude that the L407F mutation in cry1 increases the fraction of 
active (phosphorylated) photoreceptor over a broad range of blue fluence rates but has 
no effect in darkness as seen from the absence of a shifted cry1 band in both, wild 
type and the cry1-L407F mutant (Fig. 7). 
 
The hypersensitivity of cry1-L407F could be caused by reduced structural 
flexibility of the photoreceptor 
To understand potential consequences of the L407F mutation on cry1 structure and 
function, we carried out three independent molecular dynamics simulations for each 
of the four following systems: wild-type protein and the L407F mutant, both with 
ATP and without ATP. The time series of RMSD are useful to visualize the spatial 
deviation of the structure during the simulation with respect to the energy-minimized 
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X-ray conformation (Supplemental Fig. S3). RMSD plots of the Cα atoms show that 
wild-type and mutant protein are stable in all the simulated systems (RMSD = 2 – 
3 Å). Generally, simulated RMSD were smaller for proteins with ATP than for 
proteins without ATP (Supplemental Fig. S3A). Interestingly, the crystallographic 
ATP binding mode was unstable in the simulations of both wild-type and mutant 
proteins. During the simulations of the wild-type and mutated proteins, the distance 
between the N6 atom of ATP and the Cγ of D409 was higher than the crystallographic 
distance of 3.5 Å (Supplemental Fig. S3B, top), indicating that this interaction is not 
maintained. Similarly, the RMSD plots of the adenine moiety of ATP showed 
instability of the ATP binding mode in the wild-type and mutant protein 
(Supplemental Fig. S3B, bottom, RMSD > 5 Å). To identify potential regions of 
altered structural flexibility, we plotted RMSF values of Cα atoms, which illustrate 
structural plasticity along the protein sequence. The RMSF plots of the wild-type 
protein show that ATP reduces the atomic fluctuations of three segments (Fig. 8A, 
top). The segments 1, 2 and 3 are spatially close to FAD and the adenine moiety of 
ATP, respectively (Fig. 1, left), but distant in sequence. A qualitative representation of 
the backbone flexibility where the thickness of the backbone is proportional to the 
RMSF is shown in Fig. 8B. The RMSF plots of the mutant protein show that ATP 
reduces the atomic fluctuations only of segment 1, because the L407F mutation has 
already a stabilizing influence on segments 2 and 3 (Fig. 8A).. To assess the effect of 
the mutation on the protein backbone flexibility, the residue-wise RMSF difference 
between the wild-type and mutant simulations without of ATP was calculated (Fig. 
8A, bottom). The 20 residues affected by the highest flexibility reduction include the 
mutation site; they are located in segments 2 and 3, and are close to the three 
conserved tryptophans (Fig. 1C, right).  
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Together the simulations indicate that ATP binding stabilizes three regions of 
wild-type cry1 and that the L407F mutation partially mimics the effect of ATP 
binding by stabilizing two of three ATP binding-responsive regions even in the 
absence of ATP. Therefore, the differences in flexibility suggest that the L407F 
mutation reduces the conformational entropy penalty of ATP binding and thus might 
promote ATP binding, autophosphorylation and eventually cry1 signaling. 
 
 
DISCUSSION 
 
Cry1 controls flowering time 
Blue light promotes flowering (Guo et al., 1998), and this effect was attributed 
mainly to cry2, as cry2 mutations delay flowering under long day conditions in a 
phyB dependent manner (Koornneef et al., 1991, Guo et al., 1998, Guo et al., 1999, 
El-Assal et al., 2001, El-Din El-Assal et al., 2003, Endo et al., 2007, Liu et al., 2008). 
Some studies had reported that cry1 functions in flowering time regulation as well, 
but others failed to find such evidence (Bagnall et al., 1996, Zagotta et al., 1996, 
Mockler et al., 1999, Blazquez et al., 2003). While cry2 mainly affects flowering time 
under long day conditions, the negative effects reported for certain cry1 alleles and 
the carboxy-terminal domain of cry1 were prominent under short day conditions 
(Bagnall et al., 1996, Yang et al., 2001). Since both, cry1 and cry2 are involved in 
blue-light mediated repression of hypocotyl elongation (Ahmad et al., 1993, Lin et al., 
1998), it is also possible that both act to some extent in flowering time control, but 
that the effect of cry1 on flowering time control is often masked by other floral 
regulators. In fact it was reported that cry1 cry2 double mutants flower significantly 
later than cry2 single mutants when grown under monochromatic blue light (Mockler 
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et al., 2003). Here, we describe the new CRY1 allele cry1-L407F, which supports 
previous findings showing that cry1 can act as a positive regulator of the floral 
transition. 
The cry1-L407F allele was isolated in a mutant screen for suppression of the 
late flowering phenotype of msi1-tap1 plants. Because cry1-L407F and msi1-tap1 
showed an additive genetic interaction (Supplemental Fig. S1), MSI1 and CRY1 
possibly function in independent genetic pathways of flower induction.  
 
cry1-L407F causes increased expression of CO and FT 
The cry1-L407F photoreceptor caused increased expression of FT (Fig. 3), and 
this can explain the observed early flowering phenotype. FT plays only a minor role in 
flowering time regulation under SD, but high levels of FT expression cause early 
flowering even in SD. FT expression is affected by light in several ways: First, light 
controls the phase of the circadian clock to establish the correct diurnal expression of 
CO. Second, light stabilizes CO and allows the accumulation of CO specifically under 
LD, when expression peak and light coincide. This coincidence of the diurnal CO 
expression peak and external light stimulus is what mainly causes photoperiodic 
acceleration of flowering by LD in Arabidopsis (Kobayashi et al., 2007). More 
recently, it was found that cry2 can also directly induce FT expression (Liu et al., 
2008). Because increased FT expression in cry1-L407F remained constrained to the 
light period, it is unlikely that stabilization of CO by cry1-L407F in the dark caused 
the increased FT expression. Instead, the increased FT expression is probably caused 
by expression of CO during the light period in cry1-L407F. It is not clear how cry1-
L407F caused increased CO expression during the light period. An indirect effect via 
altered function of the circadian clock seems unlikely given the unchanged expression 
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of ELF4 and GI (Fig. 3). It is however conceivable that cry1-L407F directly affects 
CO expression, a possibility we are currently testing. 
 
A conserved leucine is important for cry1 function 
Cryptochromes are flavoproteins with two chromophores and high sequence 
similarity to photolyases. However, cryptochromes lack several of the characteristics 
of the DNA-repairing photolyases, most prominently binding to DNA, which is 
explained by a negative electrostatic potential of the surface around the flavin-binding 
pocket of DNA-photolyase (Brautigam et al., 2004, Mees et al., 2004). In addition to 
the amino-terminal photolyase-like PHR domain, cryptochromes contain a 
characteristic carboxy-terminal domain, termed CCT, which is not present in the 
photolyases. Expression of the CCT domain in transgenic Arabidopsis led to 
constitutive photomorphogenesis and mimicked the phenotype of mutations in 
CONSTITUTIVE PHOTOMORPHOGENIC (COP) 1 (Yang et al., 2000). COP1 is 
involved in regulation of hypocotyl elongation, anthocyanin production and 
chloroplast development and binds to cry1 and cry2 via their CCT domains 
independent of light (Yang et al., 2000, Wang et al., 2001). It is possible that normally 
the CCT domain is kept inactive by an interaction with the PHR domain. Absorption 
of light would then cause conformational changes of the PHR domain leading to 
release of the CCT domain, which could eventually activate the signaling chain 
(reviewed by (Lin et al., 2005).  
Here, we reported the new cry1-L407F allele with increased light sensitivity. 
In addition, the cry1-L407F mutants have some defects in skotomorphogenesis 
(cotyledons partially unfold and the light-induced ELIP2 gene has a slightly increased 
basal expression in extended darkness), but there is no constitutive activation of 
photomorphogenesis in the dark, such as observed in plants overexpressing the CCT 
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domain. For example, there is no induction of cell division in the shoot apical 
meristem in the dark (data not shown). 
The L407F amino acid substitution is within a region of the protein that is 
conserved in all plant crytochromes, but not in photolyases or animal cryptochromes 
(Fig. 1). Despite the strong conservation of leucine 407, it is not immediately obvious 
why the change to phenylalanine, which is of similar size and hydrophobicity like 
leucine, would increase the light sensitivity of cry1. The mutated L407 is close to the 
phosphate residues of AMP-PNP sticking out of the flavin-binding pocket in the 
cocrystal structure of cry1 with AMP-PNP (Brautigam et al., 2004). To test whether 
the L407F mutation could modulate the ATP binding to cry1, molecular dynamics 
simulations of cry1 wild-type and the L407F mutant in complex with FAD and with 
or without ATP were run. ATP binding reduced the Cα flexibility of three sequence 
segments, which are distant in sequence (segment 1 – 2, >50 amino acids; segment 2 
– 3, >100 amino acids). In contrast to wild type, ATP binding did not reduce the 
flexibility of the segments 2 and 3 in the L407F mutant because their flexibility is 
already diminished by the single point mutation.  
To explain the hyperactivity of the cry1-L407F mutant, three non mutually 
exclusive hypotheses can be formulated. First, the reduced flexibility of cry1-L407F 
could favor binding to a signaling partner, because of a reduced conformational 
entropy penalty upon binding. Such an effect was recently observed for a mutant of a 
PDZ domain (Petit et al., 2009). Second, the novel phenylalanine of the mutant is 
close to three conserved tryptophans, which are involved in electron transport from 
the surface to the FAD at least in vitro as extensively studied in Escherichia coli 
photolyase (Park et al., 1995, Giovani et al., 2003, Banerjee et al., 2007). Thus, it is 
possible that cry1-L407F has altered photochemical properties. Third, partial pre-
stabilization of the ATP binding pocket in cry1-L407F could stabilize ATP-binding 
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extending the life time of the signaling state of cry1. This conclusion is at least 
consistent with the increased level of shifted and phosphorylated cry1-L407F 
compared to wild-type cry1 (Fig. 7). Discrimination between these possibilities will 
be addressed in future studies. 
 
Hypersensitivity of cry1-L407F to various light qualities reveals tight integration 
of several light signaling pathways 
The cry1-L407F allele was not only hypersensitive to blue but also to red and 
far-red light. Normally, red and far red light is not sensed by cryptochromes but by 
phytochromes. This raises the question which photoreceptor then is responsible for 
the increased sensitivity to red light. Because the hypersensitivity of cry1-L407F to 
red pulses could be fully reverted by far-red pulses, at least in this case it was clearly 
phytochrome signaling which was affected by the cry1-L407F allele. Interactions of 
red-light absorbing phytochrome and blue-light absorbing cryptochrome signaling 
cascades have been reported (Casal et al., 1995, Ahmad et al., 1997, Hennig et al., 
1999). Furthermore, nuclear import of phyB was initiated by blue light, but not by 
light of 695 nm, which establishes a similar phytochrome photoequilibrium as blue 
light (Gil et al., 2000). Finally, cryptochromes were found to be required for 
phytochrome signaling to the circadian clock (Devlin et al., 2000). On the molecular 
level, these effects could potentially be based on an interaction of the cry1 carboxy 
terminal domain with phyA (Ahmad et al., 1998) or of cry2 with phyB (Mas et al., 
2000). Further work will establish whether the L407F mutation in cry1 affects direct 
interactions with phytochrome or whether the photochemical properties of cry1-
L407F are changed. We propose that the increased sensitivity of cry1-L407F plants to 
blue, red and far-red light reveals the intimate cross-talk between cryptochrome and 
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phytochrome light signaling cascades, which has been suggested to be important for 
concerted plant development under natural light conditions (Casal 2000).  
 
MATERIALS AND METHODS 
 
Plant material and growth conditions 
Seeds of Columbia (Col) and Landsberg erecta (Ler) Arabidopsis thaliana 
wild-type accessions were obtained from the Nottingham Arabidopsis Seed Stock 
Centre. The line msi1-tap1 (accession Col) has been described before (Bouveret et al., 
2006). The EMS allele cry1-L407F (accession Col) was isolated from a mutant screen 
(this study). To construct plants that ectopically overexpress cry1 or cry1-L407F 
(35S::CRY1 and 35S::CRY1-L407F), the full-length coding sequences were inserted 
into the binary destination vector pK7WG2 (Karimi et al., 2002) downstream of the 
cauliflower mosaic virus (CaMV) 35S promoter. Constructs were transformed into 
Columbia wild-type plants. 
Seeds were usually germinated on sterile basal salts Murashige and Skoog 
(MS) medium (Duchefa, Brussels, Belgium) after two or three days stratification 
treatment of the imbibed seeds at 4 ºC, and plants were analyzed on plates or 
transferred to soil ("Einheitserde", H. Gilgen optima-Werke, Arlesheim, Switzerland) 
10 days after germination. Alternatively, seeds were directly sown on soil. Plants were 
kept in Conviron growth chambers with mixed cold fluorescent and incandescent light 
(110 to 140 µmol m-2 s-1, 21±2 ºC) under long day (LD, 16 h light) or short day (SD, 8 
h light) photoperiods or were alternatively raised in green houses (LD: 14 h light, 19 
ºC/10 h dark, 14 ºC; SD: 8 h light, 20 ºC/16 h dark, 20 ºC; if necessary, daylight was 
supplemented with mercury vapor lamps [Sylvania Lighting S.A., Meyrin, 
Switzerland] to a maximum of 150 µmol m-2 s-1). 
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For immunoblot analyses, seeds were plated on ½ MS plates and stratified at 
4°C for 4 days in darkness. Germination was induced by white light illumination for 4 
h. Plants were grown at 22 °C for 4 days, and seedling were harvested after treatment 
with blue light emitted from LEDs (λmax 471 nm, CLF Plant Climatics, Emersacker, 
Germany) for 30 min or 120 min with fluence rates indicated and measured with a P-
2000 optometer (Gigahertz-Optik, Puchheim, Germany). 
 
Flowering time analysis 
Flowering time was scored as the length of time between the end of 
stratification and the development of a primary shoot of 5 mm height (= bolting). The 
number of rosette leaves was determined at bolting. For phase transition, all formed 
rosette leaves were inspected for the presence of abaxial trichomes at bolting. 
 
RNA isolation, RT-PCR and quantitative PCR 
RNA was extracted from plant tissue as previously described (Hennig et al., 
2003). For RT-PCR analysis, 1 µg total RNA was treated with DNase I (Promega, 
Dübendorf, Switzerland). The DNA-free RNA was reverse-transcribed using a 
RevertAid First Strand cDNA Synthesis Kit (Fermentas, Nunningen, Switzerland) 
according to manufacturer’s instructions. For qPCR analysis, the Universal 
ProbeLibrary system (Roche Diagnostics, Rotkreuz, Switzerland) was used on a 7500 
Fast Real-Time PCR instrument (Applied Biosystems, Lincoln, CA). Quantitative 
PCR was performed with three replicates, and results were analyzed as described 
(Exner et al., 2009). Details of the assays used are given in supplemental Tab. S1. 
 
Analysis of hypocotyl length 
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Seeds were plated on two layers of water-soaked 3 MM chromatography paper 
(Whatman Schleicher & Schuell, GmbH, Dassel, Germany), which were placed into 
clear plastic boxes. A 48 h to 96 h dark treatment at 4 ºC was followed by induction of 
germination by white light for 10 h (24 h for far-red studies) at 23 ºC and further 
incubation of the seedlings under specific light conditions, which were as follows: 
blue light: Philips TLD 18W/18 Blue E003, continuous light, 21 ºC; red light: Philips 
TLD 18W/18 Red, continuous light, 21 ºC; far red light: as described (Sperling et al., 
1997), continuous light, 26 ºC. The hypocotyl length was measured by spreading the 
seedlings on millimetre paper and reading the length. 
 
Quantitative immunoblots 
Per sample approximately 50 seedlings were collected, frozen in liquid nitrogen and 
ground to a fine powder with a cell mill (MM200, Retsch, Haan, Germany). Protein 
was extracted by trichloracetic acid-acetone precipitation according to (Shultz et al., 
2005) with the following modifications: After the washing steps, samples were dried 
in a SpeedVac and then dissolved in SDS sample buffer (45 mM Tris-HCl, pH 6.8; 
10% glycerol; 1% SDS; 0.01% bromphenol blue; 50 mM DTT). Samples were 
incubated at 95 °C for 10 min followed by a centrifugation step (10 min, 20,000×g) to 
remove cell debris. For SDS-PAGE, 15 µg of total protein were loaded per lane on 
10% SDS-minigels (Shultz et al., 2005). PageRuler™ (Fermentas, St. Leon-Rot, 
Germany) was used as marker. Separated proteins were transferred to nitrocellulose 
membranes (porablot NCP, Macherey-Nagel, Düren, Germany). Membranes were 
blocked with 7% milk powder in TBS (20 mM Tris-HCl, pH 7.5; 150 mM NaCl). 
Incubation with the two primary antibodies was done stepwise with monoclonal 
antibody against α-tubulin (anti-α-tubulin, produced in mouse; Clone B-5-1-2, Sigma, 
Taufkirchen, Germany), then with anti-cry1 antibody (raised in rabbits and provided 
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by M. Ahmad, Universite Paris VI, France). Both antibodies were used in a 1:2000 
dilution in TBS-T (TBS with 0.1% (v/v) Tween-20). Fluorescence-labelled secondary 
antibodies against rabbit (donkey anti-rabbit IRDye®800CW, LI-COR Biosciences, 
Lincoln, Nebraska, USA) and mouse (donkey anti-mouse IRDye 700DX, Rockland, 
Gilbertsville, PA, USA) were incubated simultaneously for 1 h (each diluted 1:10000 
in TBS-T). The membranes were scanned and analyzed with the LI-COR Odyssey 
Infrared Imaging System (LI-COR Biosciences, Lincoln, Nebraska, USA). Bands 
detected in the 700 nm channel correspond to α-tubulin, bands detected in the 800 nm 
channel to cry1. The system was calibrated to ensure measurements in the linear range 
for both, α-tubulin and cry1. The cry1 signal was normalized against the α-tubulin 
signal. In addition, the percentage of shifted cry1 bands compared to the total cry1 
signal was determined. 
 
Sequence alignment 
The Arabidopsis CRY1 (At4g08920), CRY2 (At1g04400) and photolyase 
(At3g15620) protein sequences were obtained from TAIR 
(http://www.arabidopsis.org/) and blasted against the non-redundant protein data 
bases at NCBI (http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Search&db=pubmed) 
and at the DOE Joint Genome Institute (http://genome.jgi-psf.org/). The obtained 
sequences were aligned using ClustalX 2.0. The identifiers of the protein sequences 
included in this analysis are listed in supplemental Table S2. Nomenclature of 
phytochrome as well as cryptochrome photoreceptors and their genes is according to 
(Quail et al., 1994). 
 
Molecular Dynamics Simulations 
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The crystal structure of the PHR domain of Arabidopsis cry1 with AMPPNP 
bound (PDB accession code: 1U3D) was used for modeling and molecular dynamics 
simulations. The L407F mutation was introduced with PyMOL (The PyMOL 
Molecular Graphics System, Version 1.2r1, Schrödinger, LLC) and the most common 
rotamer was selected. To generate ATP from AMP-PNP, the nitrogen atom between 
phosphate groups of AMP-PNP was replaced by oxygen. Ions and crystallization 
water were kept for further calculations. All the simulations were carried out using 
CHARMM (Brooks et al., 1983) (version c35b2) and the PARAM22 force field 
(MacKerell et al., 1998, Mackerell, Jr. et al., 2004) with the TIP3P model of water 
(Jorgensen et al., 1983, MacKerell et al., 1998). To effectively compare simulations 
with experiments, pH of 7.4 was considered. The side chains of aspartates and 
glutamates were negatively charged, those of lysines and arginines were positively 
charged, histidines were considered neutral, the N-terminus was positively charged 
and the C-terminus negatively charged. First, structures were minimized in vacuo 
using a dielectric constant ε=4r (where r is the distance in Å between atoms/partial 
charges) to an energy gradient of 0.01 Kcal mol-1 Å-1. The minimized protein was 
then inserted into a water box where each atom of the protein had a distance of at least 
14 Å from the boundary. Water molecules within 2.8 Å from any atom of the protein 
were removed. Chloride and sodium ions were added to neutralize the total charge of 
the system at a concentration of 200 mM. The final system consisted of around 96000 
atoms, circa 7900 of which belong to the solute. To avoid finite-size effects, periodic 
boundary conditions were applied. Long-range electrostatic effects were taken into 
account by the Particle Mesh Ewald summation method (Darden et al., 1993). The 
temperature was kept constant at 300 K by the Nosé-Hoover thermostat (Nose 1984, 
Hoover 1985), while the pressure was held constant at 1 atm by applying the 
Langevin piston pressostat. Lookup tables (Nilsson 2009) for the calculation of water-
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water nonbonded interactions (van der Waals and Coulomb) were used to increase 
efficiency. SHAKE was applied to the hydrogens allowing an integration step of 2 fs. 
Different initial random velocities were assigned to every simulation. Four systems 
were simulated: the wild-type protein with only FAD bound; the wild-type protein 
with FAD and ATP bound; the mutant with only FAD bound; and the mutant with 
FAD and ATP bound. Three independent 30-ns long simulations were carried out for 
each system. 
 
Trajectory Analyses 
Root mean square deviations and root mean square fluctuations, RMSD and 
RMSF respectively, were calculated with CHARMM and their formula is: 
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where N is the number of atoms; xi, yi, zi are the coordinates of the atom i after best 
superposition on a reference structure; xi,ref, yi,ref, zi,ref are the coordinates of the atom i 
in the reference structure; the coordinates iii z,y,x refer to the average structure; Nf is 
the number of frames in the trajectory segment analyzed for RMSF calculations; the 
coordinates xi,ave, yi,ave, zi,ave refer to the average structure. The reference structure for 
RMSD analyses was the starting structure used in the dynamics, i.e. the energy-
minimized X-ray structure. The average structures and RMSF were calculated along 
2 ns segments of trajectory, skipping the first 2 ns and the last incomplete segment 
shorter than 2 ns. For the first 30 ns of simulation time, 13 values of RMSF were 
therefore calculated and then averaged. RMSD expresses how different an object is 
with respect to another after the best superposition of the two. A RMSD value of zero 
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means perfect superposition. RMSF is a measure of atomic flexibility and it can be 
related to the crystallographic B-factor, ( ) .3/8 22 RMSFπ=B  The distance between the 
N6 atom of ATP and the Cγ of D409 was calculated with the program Wordom 
(Seeber et al., 2007). Structures were plotted with PyMol. 
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TABLES 
 
Table 1. Flowering time of 03 457. 
Shown are mean ± S.E. (n ≥ 10). Note that 0.3 457 was in the msi1-tap1 background. 
 
genotype flowering time in LD (days) flowering time in SD (days) 
Col 23.9 ± 0.6 81.8 ± 1.8 
msi1-tap1 38.5 ± 1.2 117.9 ± 6.1 
0.3 457 28.4 ± 0.3 51.4 ± 1.7 
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FIGURE LEGENDS 
 
Figure 1. CRY1 sequence context of the conserved leucine 407. A: Structure of the 
Arabidopsis CRY1 gene. Boxes represent exons; positions of translational start and 
stop as well as of the L407F mutation are shown; grey boxes represent untranslated 
regions. B: Cryptochrome and photolyase protein sequences of several organisms 
were aligned, and a segment of the generated sequence alignment is shown; numbers 
at the end of each line indicate the amino acid position within the respective protein. 
The arrow head marks the leucine that is exchanged for a phenylalanine in CRY1-
L407F. Note that this leucine is usually conserved in plant cryptochromes, but not in 
photolyases. The arrows indicate conserved tryptophans involved in electron transfer 
to FAD. The grey box marks a plant cryptochrome-specific 12 amino acid motif, 
which includes L407. C: X-ray structure of the complex of cry1, FAD and AMP-PNP 
taken from (Brautigam et al., 2004) (Left). Conserved Trp residues are in black, and 
L407 is in magenta. The red, yellow and orange sequence regions (labeled 1, 2 and 3, 
respectively) correspond to the peaks in the RMSF plot (see main text). Structural 
model of L407F cry1 (Right). The mutation L407F is in magenta. The first 20 
residues, for which the reduction of flexibility caused by the L407F mutation is 
highest, are in yellow.  
 
Figure 2. cry1-L407F mediates early flowering. A: Juvenile-adult phase transition 
of Col wild-type (WT) and cry1-L407F plants under long day photoperiods. B: 
Flowering time of Col wild-type and cry1-L407F plants under long day (LD) and 
short day (SD) photoperiods. C: Flowering time of wild-type plants and four 
randomly selected transgenic cry1 or cry1-L407F overexpressing lines (OE) under 
short day photoperiods. Diagrams show means and standard errors (n ≥ 14). 
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Figure 3.  CO and FT transcript levels are increased in the cry1-L407F mutant. 
Quantitative RT-PCR was performed on cDNA from 15 day-old seedlings grown 
under short day conditions. Relative expression values are shown as mean and 
standard error (n ≥ 4). White and grey bars on top of the diagrams represent periods of 
light and darkness, respectively. Values were normalized to a PP2A gene 
(At1g13320). 
 
Figure 4. Inhibition of hypocotyl elongation in cry1-L407F mutant seedlings is 
hypersensitive to blue, red and far-red light. Fluence rate response curves of 
hypocotyl growth inhibition under continuous light treatments. Diagrams show means 
and standard errors of three replicates with at least 15 seedlings analyzed in each 
experiment. Wild type (WT), filled circles; cry1-L407F, open circles. 
 
Figure 5. Induction of germination in cry1-L407F mutants is hypersensitive to 
white and red light. Seeds were sown under green light, stratified for 2 days at 4°C 
and treated with light pulses. After 4 days in the dark, germination rates were 
determined. DD, no light treatment; pR, 30 min of red light (10.5 µmol m-2 s-1); pW, 
30 min of white light (130 µmol m-2 s-1); pFR, 30 min of far red light (110 µmol m-2 s-
1); pR-pFR, red pulse followed by far red pulse; cW, continuous white light for 4 days 
(130 µmol m-2 s-1). Shown are means and standard errors of 4 replicate experiments 
with three different seed batches. 
 
Figure 6. Induction of ELIP2 expression in cry1-L407F mutants is hypersensitive 
to red light. Seedlings were grown for 4 days in the dark before transferred to 
continuous red light (10.5 µmol m-2 s-1). Relative expression values based on RT-
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qPCR are shown as mean and standard error (n ≥ 3). Values were normalized to a 
PP2A gene (At1g13320). 
 
 
Figure 7. Cry1-L407 is stronger phosphorylated in blue light than wild-type 
cry1. Immunoblot analysis of wild-type cry1 (cry1-WT) and cry1-L407F protein 
levels (both in msi1-tap1 background). Seedlings were grown for 96 hours in 
complete darkness before transferred to monochromatic blue light (λmax 471 nm) of 
given fluence rates. A: Representative immunoblot of samples kept in darkness for 96 
hours (0) and then irradiated with blue light for 30 min or 120 min, or kept in 
darkness for another 120 min (120d). The blot shows samples from irradiation with 25 
µmol m-2 s-1 blue light. The cry1 and tubulin signals are indicated with arrows. Note 
the shifted cry1 bands appearing in the light-treated samples that correspond to 
phosphorylated forms of cry1. B: Ratios of shifted (phosphorylated) cry1 to total 
amount of cry1 in the respective genotypes. Seedlings were irradiated with the given 
fluence rates of blue light for 30 min. C: Same as B but seedlings were treated for 120 
min with blue light. Quantification of the bands was done with the LIC-COR Odyssey 
infra-red imaging system and software in the linear range of cry1 and tubulin signals. 
 
Figure 8. The L407F mutation reduces structural flexibility of cry1. A: 
Comparison of backbone flexibility. Each curve is the average of the RMSF 
calculated over three trajectories. The segments corresponding to the peaks labeled 1, 
2, and 3 are shown in Fig. 1. B: The tube-like rendering of the backbone flexibility of 
wild-type (left) and L407F cry1 (right) was generated using values from (A). 
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Supplement 
 
Supplementary Table S1. Primers used for quantitative RT PCR. 
 
Gene Forward primer Reverse primer Universal 
ProbeLibrary 
probe 
FT,  
At1g65480 
GGTGGAGAAGACCTCAGGAA GGTTGCTAGGACTTGGAACATC #138 (Arabidopsis) 
ELF4,  
At2G40080 
AGTTTCTCGTCGGGCTTTC GCTCTAGTTCCGGCAGCA #157 (Arabidopsis) 
GI, 
At1G22770 
TTTCCGATGGTGTAGTGGTG TTGAAGGCATCAGTTGAGGA #67 (Arabdopsis) 
CO, 
At5g15840 
GCCTACTTGTGCATGAGCTG GTTTATGGCGGGAAGCAAC #53 (Arabidopsis) 
ELIP2, 
At4G14690 
CCACCACAAATGCCACAG GCAAATCTCCAAACTTCGTACTC #101 (Arabidopsis) 
PP2A, 
At1g133201) 
GGAGAGTGACTTGGTTGAGCA CATTCACCAGCTGAAAGTCG #82 (Arabidopsis) 
 
1) Reference gene. 
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Supplementary Table S2. Protein sequences used for the alignment. 
 
Organism Label Identifier 
Arabidopsis thaliana At_CRY1 GI: 826470 
Arabidopsis thaliana At_CRY2 GI: 839529 
Arabidopsis thaliana At_Photolyase GI: 828632 
Danio rerio Dr_CRY1 GI:8698584 
Drosophila melanogaster Dm_CRY1 GI:3986298 
Physcomitrella patens Pp_CRY1 jgi|Phypa1_1|111603|e_gw1.2.5.1 
Physcomitrella patens Pp_Photolyase jgi|Phypa1_1|200971|estExt_gwp_gw1.C_4880009 
Populus trichocarpa Pt_CRY1 estExt_fgenesh4_pm.C_LG_II0442 
Populus trichocarpa Pt_CRY2 gw1.273.26.1 
Populus trichocarpa Pt_Photolyase fgenesh4_pg.C_LG_III000326 
Oryza sativa Os_CRY1 GI: 115458700 
Oryza sativa Os_CRY2 GI: 28372347 
Oryza sativa Os_Photolyase GI:125581224 
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Supplementary Figure S1. cry1-L407F and msi1-tap1 affect flowering time 
additively. 
cry1-L407F msi1-tap1 flowers later than cry1-L407F but earlier than msi1-tap1 under 
long and short day conditions. A: Rosette leaf number at bolting under long day 
conditions. B: Phase transition under long day experiments. Diagrams represent 
means and standard errors (n ≥ 10); asterisks indicate student’s t-test results: single 
asterisk = p<0.05, double asterisk = p<0.005, black: test against Col, grey: test against 
cry1-L407F, red: test against msi1-tap1. C: 45 days old plants grown under short day 
conditions; scale bar: 1 cm.  
 
 
Supplementary Figure S2. Emission spectrum of the red light source. 
 
 
Supplementary Figure S3. 
A: Structural stability of the PHR domain of cry1. The Cα atoms RMSD of 
residues 13-497 was calculated using the energy-minimized X-ray structure (PDB 
accession code 1U3D) as reference. Each color represents an independent MD run. 
B: Stability of the ATP binding mode. (Top) The dashed line shows the distance 
ATP/N6 – D409/Cγ in the X-ray structure (3.5 Å). (Bottom) The RMSD of the 
adenine heavy atoms was calculated upon optimal overlap of the Cα atoms of the 
PHR domain of cry1. Only in one wild type simulation (blue time series, bottom left), 
the position of ATP was almost conserved, but the interaction between D409 and the 
N6 atom of ATP was not established (blue time series in Fig. S3B, top left). 
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Additionally, in one mutant simulation (blue time series, top right and bottom right), 
the ATP assumed a different binding mode in which the adenine moiety and D409 
side chains were more exposed to solvent but at the same hydrogen bond distance as 
in the X-ray structure (see Fig. S4) of the N6 atom of ATP and the Cγ of D409.  
 
 
Supplementary Figure S4. Binding mode displacement of ATP. Energy-minimized 
X-ray structure (green) and last snapshot from the molecular dynamics (red). In one 
mutant simulation (blue time series in Fig. S3B, top right and bottom right), the ATP 
rebinds with a different orientation of the adenine and ribose groups after about 22 ns. 
The hydrogen bond between the N6 atom of ATP and the Cγ of D409 is preserved. 
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1 Introduction
Molecular recognition is a very important aspect of biology and it is involved in
many biological processes. There are several classes of protein binders that rec-
ognize peptides: protein domains such as SH2, PTB, PDZ, SH3, and WW; the
major histocompatibility complexes; antibodies; and repeat proteins. The latter
is very interesting because of the modular, repetitive nature of the proteins.
Repeat proteins are made up by several tandem repeats of α-helical struc-
tural unit, which create an extended superhelical structure. The superhelical
structure is very suited to generate an interface for the recognition of polypep-
tides in the extended conformation.
Armadillo repeat proteins are made up by 42 aminoacids-long repeats formed
by three α-helices, named H1, H2, and H3. H3 helix is the longest and consti-
tutes the binding surface for the polypeptide. Each repeat binds two peptides
in a context of a longer peptide. The peptide bonds of peptide backbone is con-
tacted by a conserved asparagine residue of each repeat, and other sidechains
on the binding surface provide the specificity of binding. Figure 1 shows an
importin α armadillo repeat protein (10 repeats) bound to a polypeptide. It is
important to notice that internal repeats have a solvent accessible surface and
two buried surfaces, where they contact neighboring flanking repeats. Only the
first and the last repeat, called N- and C-terminal caps, have only one buried
surface and they are shorter than the internal ones (see figure 2).
Parmeggiani and colleagues[12] designed artificial armadillo repeat proteins
optimizing the hydrophobic core derived from a consensus sequence with compu-
tational methods. The consensus sequence was obtained by multiple alignment
of single armadillo repeat modules to generate an unique stable internal module
sequence. The computational optimization of the hydrophobic core was needed
because the consensus sequence protein had molten globule properties. Inter-
estingly, they found that the quality of the NMR spectra was pH dependent,
probably due to ionizable side chains of lysine residues. Only after changing the
acidity of the solution from pH=7 to pH=11, most of the peaks in the 2D-NMR
spectrum appeared, although with low dispersion (see figure 3). Interestingly,
the mutation of two lysines to glutammines in every internal repeats generated
a mutant with better 2D-NMR spectrum at lower pH (see figure 4). Therefore
1
the pH-dependence of the quality of the NMR spectrum was attributed to the
lysines, which have a side chain pKa of 10.5 circa. A stable internal module
repeat was needed because it can be randomized in positions which provide
binding sites for amino acids side chains, and therefore screened for binding.
The mutated internal repeat are very likely to be less stable, and for this reason
a very stable internal repeat is needed.
The aim of this work was to improve the signal dispersion of NMR spectra
by reducing the flexibility of the computationally optimized protein with the
consensus sequence (YM4A). Since mutating the sequence of internal repeats
is experimentally time-demanding, we focussed on the optimization of the N-
and C-terminal caps. The absence of a crystal structure of YM4A prompted
us to design a progressive optimization method of homology models based on
consecutive cycles of molecular dynamics simulations and clustering analysis:
to sample the conformations of the protein and to choose the most favourable
conformations of repeat dimers, respectively. Subsequently, a new model is built
from the clustered dimers taking advantage of the modular nature of the pro-
tein as described farther in the methods. Each optimization cycle produced a
new generation of models having a previous generation model as input. The
flexibility of the protein was assessed from the simulation trajectories by root
mean square fluctuation (RMSF) analysis and by the calculation of the con-
figurational entropy. The optimization procedure was applied until when the
entropy difference between two consecutive generations was negligible.
Four mutations and a deletion, which in the simulations reduced the flexibil-
ity of the protein, were proposed and introduced in YM4A. The mutant showed
better 2D-NMR plots and also a better chemical and temperature denaturation
stability.
2
2 Methods
The consensus armadillo sequence is called YM4A elsewhere[12], Y refers to the
sequence of the N-terminal cap; M4 refers to the sequence of the four inter-
nal repeats; A refers to the sequence of the C-terminal cap. Here, the YM4A
sequence is called KK because of the presence of lysine at position 26 and 29
repeat-wise of the internal repeats, that are positions 60, 102, 144, 186 and 63,
105, 147, 189, respectively. The QQ mutant was derived from the KK model
with aforementioned lysines mutated to glutamines. Further studied mutations
are reported in table 2.
The following nomenclature is henceforth adopted: Ri stands for the i -th in-
ternal repeat; Ri -Rj stands for the dimer composed by the i -th and j -th repeats;
Ncap and Ccap are the N-terminal and the C-terminal caps, respectively.
2.1 Molecular dynamics simulations
Langevin dynamics simulations were performed at 300K using the program
CHARMM and the implicit solvent FACTS[5]. The protein was modeled ac-
cording to the united atom CHARMM PARAM19 force field. To effectively
compare simulations with experiments, the protein side chains were titrated at
pH=7.4, that is, the sidechains of aspartates and glutamates were negatively
charged, those of lysines and arginines were positively charged, histidines were
considered neutral, the N-terminus was positively charged and the C-terminus
negatively charged. SHAKE was applied to the hydrogens allowing an inte-
gration step of 2fs. Different initial random velocities were assigned to every
simulation.
Each simulation consisted of a 0.2ns heating phase, 0.4ns equilibration phase
and 30ns production phase, if not specified differently. About 10.5 hours on a
core of a XEON 5410 Quadcore CPU running at 2.33GHz are required for a 1ns
trajectory of the KK model (nearly 2220 atoms).
Explicit solvent molecular dynamics simulations were performed at 300K
using the program CHARMM. The protein was modeled according to the all-
hydrogen CHARMM force field (PARAM22 with CMAP correction)[9][8] and
TIP3P water model[7]. To effectively compare simulations with experiments,
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the protein sidechains were titrated at pH=7.4 (see above). The protein was
inserted into a a water box where each atom of the protein had at least 13 A˚
distance from the boundary. Chloride and sodium ions were added to neutralize
the total charge of the system at a concentration of 200mM. To avoid finite-size
effects, periodic boundary conditions were applied. Different initial random
velocities were assigned to every simulation. Long-range electrostatics effects
were taken into account by the Particle Mesh Ewald summation method[3].
The temperature was kept constant by the Nose´-Hoover thermostat[11][6] while
the pressure was held constant at 1 atm by applying the Langevin piston pres-
sostat. SHAKE was applied to the hydrogens allowing an integration step of
2fs. Lookup tables[10] for the calculation of pair wise nonbonded interactions
(van der Waals and Coulomb) were used to increase efficiency. Different initial
random velocities were assigned to every simulation.
2.2 Clustering Analysis
A clustering analysis was applied to the snapshots of simulations trajectories to
obtain the most populated conformers. Conformations were grouped together
according to their RMSD (see farther) distance. At the end of the clustering
procedure, several clusters were obtained and for every one the representative
was defined. The cluster representative is the structure that differs the least
from all the other conformations in the same cluster.
The first nanosecond of every production trajectory was removed from the
analysis and one tenth of the snapshots, that is every 20ps, was analyzed. Con-
formational clustering was performed using the program “Cluster” version 3.2 by
Michael Schaefer (Syngenta Crop Protection AG, unpublished work). We clus-
tered the conformations of contiguous repeat dimers: the N-terminal cap and
the first internal repeat (Ncap-R1); the last internal repeat and the C-terminal
cap (R4-Ccap); and all the internal repeats (Rn-Rn+1). The conformations of
the internal repeat dimers (R1-R2, R2-R3 and R3-R4) were collected together
to generate a single model of the internal repeat dimer, therefore the dimers
R1-R2, R2-R3 and R3-R4 are identical. All structures were clustered on all Cα
atoms, except the first two residues for Ncap and the last of Ccap, and a selec-
tion of Cγ atoms. Cγ atoms were included to cluster the sidechains orientation
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in the hydrophobic core. For this purpose, Cγ atoms of of lysine, glutammine,
asparagine, glutamate and arginine were not included. A cutoff of 1.5 A˚ was
chosen for clustering. This value, found by trial and error, is optimal to discern
between non homologous conformers. The clusters representatives of the most
populated cluster were used for modelling.
2.3 Trajectory analyses
Root mean square deviations and root mean square fluctuations of an atom j,
RMSD and RMSFj respectively, were calculated with CHARMM, and their
formula is:
RMSD =
√√√√ 1
N
N∑
i=1
(xi − xi,ref )2 + (yi − yi,ref )2 + (zi − zi,ref )2
RMSFj =
√√√√ 1
Nf
N∑
i=1
(xi − x˜i)2 + (yi − y˜i)2 + (zi − z˜i)2
whereN is the number of atoms andNf is the number of frames in the trajectory
segment where RMSF is calculated; xi, yi, zi are the coordinates of the atom i;
xi,ref , yi,ref , zi,ref are the coordinates of the atom i in the reference structure;
x˜i, y˜i, z˜i are the coordinates of the atom i in the average structure. The
reference structure for RMSD analyses was the starting structure used in the
dynamics. The average structures and RMSF were calculated for every 2ns
segments of trajectory. For 30ns of simulation time, 15 values of RMSF were
therefore calculated.
The quasiharmonic entropy was computed using the covariance matrix of
the atomic fluctuations[1] using the program Wordom[13]. The quasiharmonic
approximation was shown to yield an upper bound for the true entropy and is
calculated with the following equation:
Sho = k
3n−6∑
i
~ωi/kT
e~ωi/kT − 1 − ln(1 − e
~ωi/kT ),
where ωi are the quasiharmonic frequencies obtained from the eigenvalues λi.
λi are obtained from the diagonalized mass-weighted covariance matrix σ
′, which
is obtained directly from MD simulations.
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Global and local entropies were computed. Global entropies, calculated on
all Cα, were divided by the number of residues to compare models of different
lenghts (i.e. KK has 243 residues while ∆5 has 242 residues). Local entropies
were calculated for a subset of atoms spanning all repeat dimers (i.e. Ncap-R1,
R1-R2, R2-R3, R3-R4 and R4-Ccap).
2.4 Model generation
The first generation KK model was derived from three homology models built
with Insight II (Accelrys Inc.) by mapping the YM4A sequence on the crystallo-
graphic structure of three natural armadillo repeat proteins: yeast karyopherin
(importin α), mouse importin α and murine β-catenin (PDB accession numbers:
1EE4, 1Q1T, 2BCT, respectively). A single implicit solvent MD simulation was
run for each homology model, while, for further generations models, six molec-
ular dynamics simulations were run.
The models were constructed assembling together the most probable struc-
ture of the three repeat dimers obtained from MD simulations through cluster-
ing analysis: 8706 conformations of the dimer Ncap-R1 (6879 for the homology
models), 26118 conformations of the three internal repeat dimers (51579 for the
homology models, because they have a different number of internal repeats, see
table 1) and 8706 (6879 for the homology models) conformations of the R4-
Ccap dimer is used for clustering. The resulting representatives of the most
populated cluster of the dimers were assembled superimposing Cα atoms of the
common repeat (see figure 6). For istance, the dimers Ncap-R1 and R1-R2 are
superimposed on the common R1 monomer. The repeat R1 of the dimer R1-R2
is deleted to mantain the original interface between Ncap-R1. The procedure
is repeated to build the whole model. Finally, the pair R3-R4 was deleted to
mantain the interface between R4 and C. Missing peptide bonds between the
assembled dimers were generated by CHARMM.
The optimization of the initial position of hydrogens and subsequent energy
minimization were performed with the CHARMM[2] PARAM19[9] united atom
force-field with distance-dependent dielectric function. Loops connecting α-
helices were relaxed through four minimization cycles consisting of 100 iterations
of steepest descent and 200 steps of conjugate gradient algorithms with gradually
6
decreasing harmonic constraints on the Cα atoms of the helices (k=10, 5, 1 and
0.1 Kcal/mol/A˚2). The system was further optimized with the presence of the
implicit solvent FACTS without constraints by 100 steps of steepest descent
and 200 iterations of conjugate gradient, followed by an adopted basis Newton-
Raphson minimizer until an energy gradient of 0.02 Kcal/mol/A˚2 was reached.
The program WitnotP (Armin Widmer, Novartis Pharma, not published)
was used for the modelling.
2.5 Geometry analysis
Interrepeat twist angle (see figure 18C) was determined as the angle between
the axis of the helix 3 of two repeats (segment NM in figure 18B). Helix 3 is
the longest helix of a repeat. The axis of the helix has been calculated as the
vector sum of the vectors defined by the carbon and oxygen atoms of the peptide
bonds.
To determine the interrepeat bend angle, a plane on which the repeat lies
had to be defined. For this purpose, three points were marked (see figure 18B):
N and M, two point on the axis of the helix 3 and P, the center of gravity of
helix 1 and helix 2. The interrepeat bend angle (see figure 18C) was determined
as the angle between the surface normals (segment NQ in figure 18B) to the
planes of two repeats.
The Cα RMSD to the original crystal structures used for building the starting
model (1EE4, 1Q1T, 2BCT) was calculated with the program Witnotp, fitting
to the crystallographic reference structures with the command fit structal. The
core of the algorithm is from M.Gerstein and M.Levitt[4]. The main difference
is that, to obtain an initial alignment needed for the Gerstein-Levitt procedure,
the fit structal command uses a sequence alignment algorithm in which the
usual scoring matrix is replaced by a function which rewards the alignment
of Cα pairs with similar local backbone geometry. After the Gerstein-Levitt
alignment step, the list of aligned pairs is purged by removing pairs for which
the distance between the Cα in the aligned structure exceeds a given threshold.
The threshold used in this work was 3 A˚. This procedure allows, for example, a
better fit for structures with different loop orientations, because the variability
of the loops will not negatively influence the superposition.
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2.6 Protein biochemistry and production of 15N-labeled
proteins
Sorry, the protocols of the experiments are still missing!!!
Experimental conditions.
ANS binding: protein, 10 µM; ANS, 100 µM; buffer PBS 150, pH 7.4
CD spectra: protein, 10 µM; buffer PBS 150, pH 7.4
SEC: Superdex 75 column; buffer PBS 150, pH 7.4
Thermal denaturation: protein, 10 µM; buffer PBS 150, pH 7.4
Chemical denaturation: protein, 10 µM; buffer PBS 150, pH 7.4; samples incu-
bated overnight at 4 C
The repeat proteins YM3A, YM4A and their respective cap mutants (see
somewhere in Gauthams part) were expressed in the E. coli strain M15 in M9
minimal medium containing 15N-NH4Cl as the sole nitrogen source: 5 ml of
overnight culture (LB medium, 1% glucose, 100 mg/l ampicillin and 25 mg/l
kanamycin, 37 C) was used to inoculate 1 L cultures (M9 medium, 1% glucose,
150 µM thiamine, 30 mg/ml ampicillin and 25 mg/ml kanamycin, 37 C). At
OD600 = 0.6 (after 6 to 8 hours), the cultures were induced with 1 mM IPTG
and further incubated for 4 hours.
2.7 NMR Spectroscopy
NMR experiments were carried out using 250-500 µM solutions of YM3A,
YM4A, and mutants in 50 mM phosphate buffer, 150 mM NaCl, pH 7.4. All
NMR spectra were acquired at 310 K on Bruker Avance 600 or 700 MHz spec-
trometer equipped with cryoprobes. Experiments were selected from the Bruker
standard pulse sequence library. All spectra were processed in TOPSPIN 2.1
and spectra were evaluated using the program Topspin 2.1.
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3 Results
3.1 Initial homology models and KK models
Implicit solvent MD simulations were performed for every one of the homol-
ogy models derived from the YM4A consensus sequence (see table 1). RMSD
plots of the Cα atoms show deviations of about 7 to 10 A˚ from the starting
model, which indicate structural instability (see figure 8, top). Visual analysis
of the trajectories suggested that the protein structure undergoes a rigid body
rearrangement of the repeats. On the contrary, the simulations started from
the crystal structure of yeast importin α (1EE5) with its wild-type sequence
(see figure 8, middle) were structurally stable, being the RMSD less than 5 A˚.
These results provide evidence for the suitability of the simulation protocol and
indicate that the fold of the homology models is not optimal.
Therefore, the first generation KK model for NR4C was built from the ho-
mology models simulations as described in the methods part. The population of
the clusters of the N-R1 and internal repeat dimers, whose representative struc-
tures were used for building the model, belongs uniquely to the mouse importin
α simulation (1Q1T); while that of the dimer R4-C belongs uniquely to the
murine β-catenin simulation (2BCT). Remarkably, the KK model simulations
are more stable than those of the original homology model. The RMSD does
not exceed 4 A˚ for six independent simulations (see figure 8, bottom).
Furthermore, three short molecular dynamics simulations of the KK model
(6.5ns, 6.6ns and 4.9ns) were run in explicit solvent. Also in this case the fold
is stable, being the RMSD around 4 A˚(supplementary materials). Interestingly,
in one simulation, a water molecule permeated the interface R4-C close to a
buried glutamine (Q240) (see figure 9). In the crystal structure of β-catenin
(2BCT), this position is occupied by a methionine (M662), which is also buried.
The hydration of Q240 position was not noticed in implicit water simulations
because the implicit solvent is not able to reproduce the granular properties of
water. Nevertheless, the C-terminal cap showed more conformational instability
than the internal repeats also in the implicit solvent simulations. In fact, the
average RMSD of the N-terminal cap (2 A˚) is higher than that of the internal
repeat (1 A˚) (supplementary materials).
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A second generation KK model was built according to the clustering analysis
based on simulations started from the first generation KK model, and six MD
simulations were run. Third, fourth and fifth generation KK models were also
built following the same protocol.
3.2 QQ models and mutational study
It was previously observed from NMR experiments [12] that the KK protein
generates better resolved spectra only at pH higher than 10, while the QQ
mutant provides an increase in spectra quality already at pH 8.
Therefore, a QQ model was derived from the second generation generation
KK model and six molecular dynamics simulations were run. This model is
called “second generation QQ model”. Applying the same protocol, third, fourth
and fifth generation QQ models were subsequently built. It’s important to notice
that QQ models are completely independent from KK models from the third
generation (see figure 7).
The RMSF plot of the second generation KK model showed high flexibility
in the N-terminal and the C-terminal caps (see figure 10). To reduce the flexi-
bility of N-terminal cap, mutations on three residues were introduced in second
generation QQ models (see figure 19). The V24R mutation was introduced to
favour the interrepeat salt bridge with E64 and remove the solvent exposed V24;
while the serine at position 27 was replaced by an arginine to match the same
position in the internal repeats. Finally, R32 was deleted because it showed
high flexibility and to shorten the loop connecting the N-terminal cap and the
first repeat.
The following mutations of the last helix of the C-terminal cap were also
introduced: the buried Q240 was mutated into a leucine and the solvent exposed
F241 was mutated into glutamine. Those two mutations were suggested by the
aforementioned water molecule permeation and because of the high RMSF of
this repeat. For this project, mutations of the internal repeats were not analyzed
because of the higher synthetic feasibility of introducing mutations in the caps.
Third generation models of these mutants were produced since mutations
were introduced on the third generation QQ model. Rounds of optimization
were run up to the fifth generation. The complete list of mutations is reported
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in table 2.
To assess the effects of the mutations on the whole protein flexibility, the
quasiharmonic entropy of the fifth generation models was estimated (see figure
11). The quasiharmonic entropy is a measure of the configuration entropy.
A reduced value of this quantity corresponds to a reduction of the structure
flexibility and thus to an increase of fold stability. The plot shows that the
average value of the entropy of the QQ model is lower than that of the KK model,
but the decrease could not be significant because it lies within the error. The
∆5 model possesses a significant lower conformational entropy than any other
mutations, in accord with the 2D-NMR spectra. To investigate the local effect
of the mutations, the quasiharmonic entropy of the repeat dimers Ncap-R1, R1-
R2, R2-R3, R3-R4 and R4-Ccap was calculated (see figure 12). The trend of QQ
and ∆5 found for the total entropy is reproduced: the quasiharmonic entropy
of ∆5 is lower than QQ for all the repeat pairs. Interestingly, the results of the
N-cap and of Q240L mutants simulations are suggesting that the contribution to
the entropy reduction is mainly located in the repeat dimer that the mutations
affect, without affecting the internal repeats. Only for ∆5, where both caps are
mutated, there is an overall decrease of whole and partial entropy.
The same conclusions can also be drawn from the analysis of the RMSF
differences plot calculated on fifth generation models (see figure 13). In this
plot, the KK model RMSF are used as a baseline to calculate the difference with
respect to the other models. The red lines on the plot represent the position of
the residues for the KK to QQ mutation (see table 2); the green ones the position
of the residues mutated in the N-terminal cap; and the cyan and the orange
lines show the mutations at the C-terminal cap. Mutations in the N-terminal
cap (green lines) and in the C-terminal cap (cyan and orange lines) reduce the
flexibility of the backbone around the mutated aminoacids. Moreover, the QQ
mutation reduces the flexibility of the N-cap even if no mutation is introduced
in this segment. The effect is reproducible, the QQ and Q240L models, which
have no mutations in the N-cap, show a very similar flexibility reduction with
respect to the KK model. The N-cap and ∆5 models, with the same mutations
in the N-cap, show a very similar flexibility reduction, which is higher than for
the QQ and Q240L models. These observations support the robustness of the
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method.
3.3 Explicit water simulations
To further study and validate the results of the implicit solvent simulations,
three long, independent explicit solvent MD simulations were run for each one
of the KK, QQ and ∆5 models. The starting conformations of the simulations
were the most visited conformations of the implicit solvent simulations, obtained
by clustering on all the Cα atoms. The same analyses carried out on the implicit
solvent simulations were performed on more than 80 ns of simulation time for
every simulation. Therefore, implicit solvent and explicit solvent simulations
are compared and analogies and differences are shown.
To assess the conformational flexibility, global and local entropy were calcu-
lated. Similarly to the implicit water simulations, the global entropy plot (see
figure 14) shows that ∆5 is less flexible than QQ and KK. The partial entropy
plot trend (see figure 15) is similar to the one of the implicit solvent simulations
(see figure 15), but it shows that the average conformational flexibility of the
KK model simulations in the Ncap-R1 dimer is lower than ∆5. This result is in
disagreement with the implicit solvent simulations, where the flexibility of the
Ncap-R1 dimer of KK is higher than the one of ∆5, and this discrepancy could
be due to the reduced sampling (langevin dynamics vs. explicit solvent) and
the reduced number of run simulations (6 for the implicit solvend and 3 for the
explicit solvent simulations). For the other repeat dimers, KK is more flexible
than QQ, and QQ is more flexible than ∆5, and this is in agreement with the
implicit solvent simulations.
The RMSF difference plot (see figure 16) shows a trend which is similar
to the implicit solvent simulations, but, in contrast, in the QQ and ∆5 model
simulations, an increase of flexibility in the Ncap-R1 dimer with respect to the
KK model is observed. The increase with respect to the KK model simulations
is mainly involving the Ncap only (residues 23 to 33), where the mutations
of the ∆5 model were introduced, and not the R1. Therefore, the mutations
introduced in the Ncap (green lines in figure 16) and ∆5 reduce the flexibility of
the aforementioned sequence segment in the implicit solvent simulations, while
they increase the flexibility in the explicit solvent simulations. Interestingly, an
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increase of flexibility in this segment is also observed in the QQ model, which has
the same sequence of the KK model in this segment, and therefore its flexibility
should be very similar to KK. One possible explanation is that the lysine to
glutammine mutations of the internal repeats (see table 2)introduced in the QQ
and ∆5 models can influence the N-cap. In fact, the mutated positions 60 and
63 are close to the N-cap (see figure 19) and the electrostatic effects due to
the loss of the positive charge can be simulated better with the electrostatic
treatment of an explicit solvent simulation (more distant cut-offs and Particle
Mesh Ewald) than with an implicit solvent simulation (shorted cut-offs and no
Particle Mesh Ewald). Moreover, the overall profiles of QQ and ∆5 are very
similar, supporting the robustness of the method. In agreement with the implicit
solvent simulations, the flexibility of the last residues (mutations in the Ccap)
is lower for ∆5.
The interrepeat salt bridge stability (see figure 17) between the Ncap and
the first repeat, that is between residues R27 (R24 in ∆5) and E64 (E63 in
∆5), respectively, is different between the KK, QQ and ∆5 models. In the fifth
generation implicit solvent simulations (red curves in figure 17), KK and QQ
simulations have a simular broad arginine-glutammate distance distribution,
probably due to at least two superimposing populations, while ∆5 simulations
are more unimodal. The same difference can be more clearly observed in the
explicit solvent simulations (black lines in figure 17). In the explicit solvent
simulations, the effect of the lysine to glutammine mutations introduced in the
internal repeats of the QQ model has an effect on the salt bridge distribution,
which is not observed in the implicit solvent simulations, where the distributions
of the KK and QQ simulations are practically the same. This could be due to the
aforementioned better treatment of electrostatics of explicit solvent simulations.
3.4 Geometrical analysis of YM4A structure
To analyze the dynamical structural behavior of the three models, two geome-
try analyzes were performed. First, the inter-repeat bend and twist angles (see
figure 18) were measured and compared to the ones of the three X-ray struc-
tures used for the generation of the three starting homology models (1EE4,
1Q1T, 2BCT). Second, a RMSD comparison between the conformations of the
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simulations of the models and the three aforementioned X-ray structures was
performed.
The geometry analysis of the explicit solvent simulations showed that KK,
QQ and ∆5 models assumed conformations close to the ones of the X-ray struc-
tures used for building the original homology models. In fact, the interrepeat
bend and twist angles in the range of those assumed in the X-ray structures
(see figures 29-37 in the supplementary materials). RMSD comparisons be-
tween simulations and X-ray structures (see figures 38-46 in the supplementary
materials and table 4) show that all the models are close to 1EE4 and 1Q1T
(yeast and mouse importins, respectively), and none is close to 2BCT (murine
β-catenin), if the superposition is carried out on all four internal repeats, Only
if the superposition is carried out on three internal repeats, a low similarity sim-
ilarity emerges to 2BCT, but this criterion is less stringent. This finding is in
agreement with the higher similarity of the sequence of YM4A internal repeats
to importins rather than to β-catenins.
3.5 Biochemistry and molecular biology
Circular dichroism experiments showed that YM4A QQ and relative mutants
have helical secondary structures (see figure 20).
Size-exclusion chromatography showed that the original YM4A consensus
sequence and the mutants introduced in this work are monomeric species (see
figure 21). The eluition volume of ∆5 is very close to QQ, and all the other
mutants eluite at the same volume of QQ. The monomeric nature of the proteins
was confirmed by MALS (data not shown).
YM4A ∆5 has less solvent exposed hydrophobic surface than YM4A QQ and
other mutants according to the ANS binding (see figure 22).
Thermal and chemical denaturation experiments showed that YM4A ∆5 is
more resistant towards denaturation than other proteins (see figure 23 and 24).
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3.6 Stability evaluation of YM3A, YM4A and their cap
mutants using NMR spectroscopy
In order to evaluate the influence of different mutations or combinations of mu-
tations in the capping repeats of YM3A QQ and YM4A QQ with respect to
conformational rigidity and oligomerization, 1D 1H-NMR spectra of all proteins
were recorded (data not shown). Proteins were ranked according to signal dis-
persion in the amide- and methyl-region as well as the line width of their proton
resonances. A subset of these, namely the original consensus proteins YM3A
QQ and YM4A QQ, and three promising mutants thereof (see table 3), which
appeared to be well structured, were expressed in their uniformly 15N-labeled
form and analyzed using [1H,15N]-HSQC NMR spectra.
The repetitive nature of the sequence and the inherently reduced signal dis-
persion within purely α-helical proteins is expected to result in rather poor
signal dispersion. Accordingly, not all peaks in the [1H, 15N]-HSQC spectra
were individually resolved (see figure 25 and 26). Nevertheless, signal disper-
sion is remarkably good and significantly further improves in the cap mutants.
Interestingly, the effects due to the C-cap mutations Q240L and F241Q are
stronger than those of the N-terminal V24R and R27S mutations and the dele-
tion of R32. The combination of N- and Ccap mutations shows a synergistic
effect resulting in the best signal dispersion for YM3A QQ V24R R27S ∆R32
Q240L F241Q and the respective YM4A QQ construct compared to other con-
structs of the same size. Due to overlap of peaks less than the expected number
of peaks was usually observed, e.g. for YM3A QQ xxx out of the expected zzz
cross-peaks, for YM3A QQ V24R R27S delR32 xxx (yyy expected), for YM3A
QQ Q240L F241Q xxx (yyy expected), and for YM3A QQ V24R R27S delR32
Q240L F241Q xxx (yyy expected). It should be noted that the [1H,15N,]-HSQC
spectra of YM3A QQ and YM4A QQ display reduced signal dispersion such that
the indicated cross-peak numbers are only estimates. The line widths indicate
that all proteins are monomeric species, in agreement with results obtained by
size-exclusion chromatography (see figureo 21).
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4 Discussion and conclusion
The synergistic approach, consisting of coupling static modeling and molecu-
lar dynamics simulations, allowed not only the generation and refinement of a
plausible structure of the YM4A armadillo repeat protein, but also the analysis
and optimization of its dynamical properties.
Predictions of RMSF and conformational entropy analyses of mutants which
show a decrease of flexibility were confirmed by experiments.
NMR measurements showed that the newly designed N- and C-caps mutants
are significantly more stable and better structured than the corresponding initial
constructs YM3A QQ and YM4A QQ. This result is in good agreement with
predictions from molecular dynamics calculations and results from thermal and
chemical unfolding experiments followed by CD spectroscopy, the ANS-binding
behavior of the proteins and gel-filtration experiments.
The reduction of flexibility can not directly explain the increased resistance
towards thermal and chemical denaturation. A possible explanation is that the
solvent exposed hydrophobic surface of the protein is involved in the denatura-
tion process, therefore a reduction of this hydrophobic surface, as measured by
ANS binding, due to the mutations, which is most pronounced the ∆5 mutant,
is beneficial.
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5 Figures
Figure 1: An armadillo repeat protein bound to a peptide. Importin
α (pdb accession code: 1EE5) in complex with a nucleoplasmin NLS peptide
is shown. Every repeat is colored differently and the NLS peptide is in sticks
representation.
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Figure 2: Schematic representation of designed repeat proteins. (a)
Compatible interfaces allow the stacking of repeat modules. (b) The repeat
modules form a continuous hydrophobic core, which is protected on both sides
by capping repeats. In red is represented the variable surface responsible for
binding and that is eventually randomized in a library. The hydrophobic core
is shown in blue and the polar surface of the protein in gray. Reproduced from
the doctoral thesis of Fabio Parmeggiani.
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Figure 3: The quality of the 2D-NMR spectra of YM4A increases in
a more basic environment . Many peaks of the 2D-NMR peaks of appear
between pH 8 and 9, although with low dispersion.
Figure 4: YM4A QQ has a better 2D-NMR spectrum than YM4A
KK at the same pH. The mutation of two lysines into glutammines in every
internal repeat of YM4A improves the dispersion and intensity of the peaks in
the 2D-NMR spectrum.
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Figure 5: Model generation procedure. The optimization proceeds in three
steps having the n-th generation model as input and producing a (n+1)-th
generation model. Step 1: starting from the input model, six independent
MD simulations in an implicit solvent are run to sample the repeat dimers
conformations; step 2: snapshots are extracted from the MD trajectories and
decomposed in adjacent repeat dimers. Dimers are then clustered to find the
most populated conformation; step 3: the most populated conformations are
used to build a new model (see figure 6).
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Figure 6: Superposition procedure. After the representatives of the most
populated clusters are derived for the N-terminal cap and first internal repeat
dimer (Ncap-R1), for the three internal repeat dimers (R1-R2, R2-R3, R3-R4)
and for the fourth repeat and C-terminal cap dimer (R4-Ccap), these are super-
imposed as shown in the scheme. For istance, the dimers Ncap-R1 and R1-R2
are superimposed through the common R1 repeat. Afterwards, the repeat R1
of the dimer R1-R2 is deleted to mantain the original interface between Ncap-
R1, as shown by dashed lines. The procedure is repeated to build the whole
model. Finally, the pair R3-R4 is deleted to mantain the interface between R4
and Ccap.
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Figure 7: Overview of all simulations. Rectangles with round edges repre-
sent implicit solvent simulations, while sharp edges rectangles represent explicit
solvent simulations. Small black horizontal arrows between rectangle pairs indi-
cate models derived by mutations; small vertical black arrows represent the clus-
tering procedure used to derive the starting conformation of the next-generation
model. For instance, the second generation QQ model is derived from the second
generation KK model upon mutation of the corresponding side chains.
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Figure 8: Instability of homology models. Top, implicit solvent MD runs
started from homology models show an increase of RMSD, which indicates struc-
tural instability. In contrast, six MD simulations started from the crystal struc-
ture of the yeast importin α (1EE5, middle) and six MD simulations started
from the first generation KK model (bottom) are stable.
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Figure 9: Water molecules permeate into the R4-C interface. In one
explicit water simulation of first generation KK model, water molecules per-
meate into the hydrophobic surface between the fourth internal repeat and the
C-terminal cap, close to buried Q240.
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Figure 10: RMSF plot of second generation KK simulations. The circles
show the position of the mutated residues V24R, R27S and ∆R32 in the Ncap;
the triangles the internal repeat positions affected by the mutation K26Q and
K29Q; the squares the mutations Q240L and F241Q in the Ccap. The mutation
labels are explained in table 2.
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Figure 11: Quasi harmonic entropy of fifth generation models. The small
filled circles are the individual calculations and the bigger empty circles are the
averages. The entropy values have been divided by the number of residues to
effectively compare the models with the deletion ∆R32 in the Ncap (∆5 and
Ncap). The mutation labels are explained in table 2.
26
Figure 12: Effect of the mutations on the quasiharmonic entropy of
repeat dimers of fifth generation simulations. The error bar is the stan-
dard deviation. Only the error bars of QQ and ∆5 simulations are shown. The
entropy values have been divided by the number of residues in the segments to
effectively compare the models with the deletion ∆R32 in the Ncap (∆5 and
Ncap). The mutation labels are explained in table 2.
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Figure 13: RMSF comparison of fifth generation models simulations.
The topmost plot is the RMSF plot of the KK model. For every mutant, the
RMSF difference to the KK model is plotted. Negative values indicate lower
fluctuations with respect to the KK model. The lysine to glutammine mutations
introduced in the QQ sequence are indicated by red lines; mutations at the N-
terminal cap are indicated by green lines; the cyan and the orange lines the
Q240L and F240Q mutation, respectively. The mutation labels are explained
in table 2.
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Figure 14: Quasi harmonic entropy of explicit water simulations. Three
explicit water simulations were run per model. The small filled circles are the
individual calculations and the bigger empty circles are the averages. The en-
tropy values have been divided by the number of residues to effectively compare
the ∆5 one (deletion ∆R32 in the Ncap). The mutation labels are explained in
table 2.
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Figure 15: Effect of the mutations on the quasiharmonic entropy of
repeat dimers of explicit water simulations. Three explicit water simula-
tions were run per model. The entropy values have been divided by the number
of residues in the segments to effectively compare the models with the deletion
∆R32 in the Ncap (∆5 and Ncap). The mutation labels are explained in table
2.
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Figure 16: RMSF comparison of explicit water models simulations.
The topmost plot is the RMSF plot of the KK model. For every mutant, the
RMSF difference to the KK model is plotted. Negative values indicate lower
fluctuations with respect to the KK model. The lysine to glutammine mutations
introduced in the QQ sequence are indicated by red lines; mutations at the N-
terminal cap are indicated by green lines; the cyan and the orange lines the
Q240L and F240Q mutation, respectively. The mutation labels are explained
in table 2.
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Figure 17: Histogram of the salt bridge between the N-cap and the
first repeat. Histograms of the salt bridge between the N-terminal cap (R27,
R24 in ∆5) and the first repeat (E64, E63 in ∆5). The black line refers to the
explicit water simulations and the red one to the implicit solvent simulations.
Shifting the arginine from position 27 to position 24 in the N-terminal cap,
improves the unimodality of the salt bridge population.
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Figure 18: Geometrical analysis. Figure A shows an armadillo repeat pro-
tein in cartoon representation. Figure B shows how the internal repeats are
considered for geometrical analysis. The segment NM is the axis of the helix
3 of a repeat. Helix 3 is the longest and contains the asparagine responsible
for binding the backbone of the interacting peptide. The point P is the center
of gravity of the helices 1 and 2. The triangle NMP approximates a plane on
which the repeat lies, and the segment NQ is normal to it. Figure C shows how
geometrical parameters are computed. The interrepeat bend angle is the angle
between the normals (NQ) of repeat dimers; the interrepeat twist angle is the
angle between the axes of the helix 3 (NM) of repeat dimers.
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Figure 19: The interrepeat salt bridge and mutations at the Ncap. The
protein shown in green cartoon is the conformation of ∆5 used for starting ex-
plicit solvent simulations. Residues colored in green are from ∆5, while residues
colored in white are from KK, after structural superposition of Ncap-R1. KK
conformation is omitted for clarity reasons. The figure shows the mutations
described in the text and listed in table 2. K60 and K63 are the lysines of the
first repeat mutated to glutammines in the QQ and ∆5 models. The salt bridge
between R27 and E64 (in KK and QQ) and R24 and E63 (in ∆5) is shown as
dashed lines.
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Figure 20: Armadillo repeat proteins have a helical secondary struc-
ture. CD spectra of YM4A and several mutants show the characteristic signal
of helices.
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Figure 21: YM4A QQ and ∆5 are monomeric species. Size-exclusion
chromatography plots show that YM4A QQ and ∆5 are eluited at two very
close volumes and they are monomeric species. Other mutants are monomeric
species, too (data not shown). MALS analysis confirmed the SEC results on all
constructs.
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Figure 22: Reduced hydrophobic surface of ∆5. The fluorescent dye
ANS (1-Anilino-8-naphthalene sulfonate) binds to solvent exposed hydropho-
bic patches of proteins. The difference between the curve of QQ and ∆5 shows
that the mutations reduce the hydrophobic solvent exposed surface.
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Figure 23: Improved thermal stability of ∆5. The temperature of melting of
YM4A QQ deduced from the thermal denaturation curves is 77 Celsius degrees.
The temperature of melting of the N-cap mutant, the C-cap mutant, and of ∆5
is 78.5, 85.0, and 86.3 Celsius degrees, respectively.
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Figure 24: Improved chemical stability of ∆5. The ∆5 and the N-cap mu-
tants denaturate at higher concentrations of guanidinium chloride with respect
to YM4A QQ.
39
Figure 25: 2D-NMR spectrum of YM4A QQ. The dispersion and intensity
of the peaks is lower than in the spectrum of YM4A ∆5 (see figure 26).
40
Figure 26: 2D-NMR spectrum of YM4A ∆5.
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6 Tables
original number of simulation
PDB code internal repeats time
1EE4 8 yeast importin α 48ns
1Q1T 8 mouse importin α 57ns
2BCT 10 murine β-catenin 35ns
Table 1: Simulations run on starting models.
Original sequence Mutations Label
YM4A − KK
YM4A
K60 K102Q K144Q K186Q
QQ
K63Q K105Q K147Q K189Q
QQ Q240L Q240L
QQ R27S V24R ∆R32 Ncap
QQ R27S V24R ∆R32 Q240L F241Q ∆5
Table 2: List of run simulations and studied mutations.
YM3A
QQ
QQ V24R R27S ∆R32
QQ Q240L F241Q
QQ V24R R27S ∆R32 Q240L F241Q
YM4A
QQ
QQ V24R R27S ∆R32
QQ Q240L F241Q
QQ V24R R27S ∆R32 Q240L F241Q
Table 3: Mutants analyzed by NMR experiments.
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KK QQ ∆5
R1-R4
1EE4 54 0 0 34 0 15 49 0 0
1Q1T 76 0 0 20 0 0 48 0 0
2BCT 0 0 0 0 0 0 0 0 0
R1-R3 R2-R4
1EE4 83 0 0 92 0 16 76 0 0
1Q1T 83 0 0 73 0 0 70 0 0
2BCT 8 2 2 17 0 0 27 0 0
Table 4: Superposition of models to the three X-ray structures used for
homology models. For the KK, QQ, and ∆5 model, the three colums shows
data from three explicit water simulations. The numbers indicate the percentage
of the simulation time in which the RMSD to a particular X-ray structure (1EE4,
1Q1T, and 2BCT) is lower than 2 A˚. These three X-ray structures were used
for generating the initial three homology models. The label R1-R4 refers to
the superposition of all four internal repeats to the X-ray structure, while the
labels R1-R3 and R2-R4 refer to the superposition of the first three or the last
three repeats, respectively. The superposition is carried out on the whole x-ray
structure. For the three internal repeats superposition, only the best value is
shown. If only three repeats are considered, the criteria for similarity is less
strict.
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7 Supplementary material
7.1 Complete RMSF plots of implicit and explicit solvent
simulations
Figure 27: RMSF plot superposition of all fifth generation implicit
water simulations.
46
Figure 28: RMSF plot superposition of all explicit water simulations.
47
7.2 Bend and twist angles timeseries
Bend and twist angles were calculated as described in Materials and Methods.
The “Asn Cβ distance” is the distance between two asparagine Cβ atoms of
consecutive repeats. The asparagines occupy the same position repeat wise and
are responsible for interacting with the backbone of the bound peptide in the
crystal structures. The optimal values observed in the crystal structures for
binding the peptide are the two horizonal red lines. The red lines in the bend
and twist angles plots show the range in which the most common values for
the respective measured quantities lie in the three crystal structures used for
generating the homology models.
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Figure 29: Bend and twist angles timeseries of the first KK model
simulation
49
Figure 30: Bend and twist angles timeseries of the second KK model
simulation
50
Figure 31: Bend and twist angles timeseries of the third KK model
simulation
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Figure 32: Bend and twist angles timeseries of the first QQ model
simulation
52
Figure 33: Bend and twist angles timeseries of the second QQ model
simulation
53
Figure 34: Bend and twist angles timeseries of the third QQ model
simulation
54
Figure 35: Bend and twist angles timeseries of the first ∆5 model
simulation
55
Figure 36: Bend and twist angles timeseries of the second ∆5 model
simulation
56
Figure 37: Bend and twist angles timeseries of the third ∆5 model
simulation
57
7.3 RMSD to X-ray structures timeseries
The black timeseries is the RMSD and the red timeseries is the percentage of
kept atom pairs from the initial alignment according to the fit structal algorithm
of Witnotp (see Material and Methods). To be plotted in the same range of the
RMSD, the percentage of kept atom pairs has been normalized to 8, therefore
100% kept atom pairs is equal to 8.
Figure 38: RMSD superposition of KK model on the X-ray structure
1EE4.
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Figure 39: RMSD superposition of QQ model on the X-ray structure
1EE4
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Figure 40: RMSD superposition of ∆5 model on the X-ray structure
1EE4
60
Figure 41: RMSD superposition of KK model on the X-ray structure
1Q1T.
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Figure 42: RMSD superposition of QQ model on the X-ray structure
1Q1T
62
Figure 43: RMSD superposition of ∆5 model on the X-ray structure
1Q1T
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Figure 44: RMSD superposition of KK model on the X-ray structure
2BCT.
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Figure 45: RMSD superposition of QQ model on the X-ray structure
2BCT
65
Figure 46: RMSD superposition of ∆5 model on the X-ray structure
2BCT
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Chapter 7
Conclusions
Structure-based methods were successfully applied to fields such as virtual
screening (cathepsin B and cathepsin K projects), protein design (Armadillo
repeat proteins project), and protein function studies (Chromodomain and
Cryptochrome projects).
Considering all the different projects, I can surely say that the leit motiv
of my doctoral thesis has been protein flexibility and dynamics.
The cathepsin B project showed that protein dynamics, such as the
opening and closing of the occluding loop, which were hidden in the static
representation of a crystal structure, could be exploited for modifying the
activity of the enzyme. Docking of a library of compounds was employed for
finding molecules which could interact with the loop. A compound found
by docking was experimentally confirmed to be an inhibitor of cathepsin B.
Protein flexibility and dynamics played a major role in the cathepsin K
project, where a predicted putative allosteric binding pocket was indepen-
dently confirmed by two methods, normal mode analysis and principal com-
ponent analysis, which rely on the flexible nature of proteins. A virtual
screening campaign by docking a library of small molecules to this pocket
was started and a series of activators of cathepsin K activators were found.
Further experiments, such as the determination of the X-ray structure of
the complex, are needed for the confirmation of the binding pocket.
Understanding the protein dynamics was the basis for the optimization
of the artificial armadillo repeat protein YM4A. The dispersion of the NMR
signals, which depends on the flexibility of the protein, was markedly im-
proved by introducing a few mutations that reduced the flexibility of the
protein in molecular dynamics simulations.
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7. Conclusions
The alteration of protein flexibility by a single point mutation, found
from the analysis of molecular dynamics trajectories, contributed to the
explanation of the difference of activity of a Cryptochrome of Arabidopsis.
These results altogether show an application of computer-based meth-
ods, not only in drug-discovery related fields, but also in basic research.
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